
<html lang="en"     class="pb-page"  data-request-id="1bb303da-16d3-494e-a06e-e375881000c6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b01527;issue:issue:10.1021/jmcmar.2019.62.issue-2;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson’s Disease Therapy" /></meta><meta name="dc.Creator" content="Ji Won  Choi" /></meta><meta name="dc.Creator" content="Siwon  Kim" /></meta><meta name="dc.Creator" content="Jong-Hyun  Park" /></meta><meta name="dc.Creator" content="Hyeon Jeong  Kim" /></meta><meta name="dc.Creator" content="Su Jeong  Shin" /></meta><meta name="dc.Creator" content="Jin Woo  Kim" /></meta><meta name="dc.Creator" content="Seo Yeon  Woo" /></meta><meta name="dc.Creator" content="Changho  Lee" /></meta><meta name="dc.Creator" content="Sang Moon  Han" /></meta><meta name="dc.Creator" content="Jaeick  Lee" /></meta><meta name="dc.Creator" content="Ae Nim  Pae" /></meta><meta name="dc.Creator" content="Gyoonhee  Han" /></meta><meta name="dc.Creator" content="Ki Duk  Park" /></meta><meta name="dc.Description" content="We previously developed a novel series of vinyl sulfones as nuclear factor erythroid 2-related factor 2 (Nrf2) activators with therapeutic potential for Parkinson’s disease (PD). However, the previ..." /></meta><meta name="Description" content="We previously developed a novel series of vinyl sulfones as nuclear factor erythroid 2-related factor 2 (Nrf2) activators with therapeutic potential for Parkinson’s disease (PD). However, the previ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 12, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01527" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01527" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01527" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01527" /></link>
        
    
    

<title>Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson’s Disease Therapy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01527" /></meta><meta property="og:title" content="Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson’s Disease Therapy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0012.jpeg" /></meta><meta property="og:description" content="We previously developed a novel series of vinyl sulfones as nuclear factor erythroid 2-related factor 2 (Nrf2) activators with therapeutic potential for Parkinson’s disease (PD). However, the previously developed lead compound (1) exhibited undesirable druglike properties. Here, we optimized vinyl sulfones by introducing nitrogen heterocycles to improve druglike properties. Among the synthesized compounds, 17e was the most promising drug candidate with good druglike properties. Compound 17e showed superior effects on Nrf2 activation in cell-based assays compared to compound 1 (17e: half-maximal effective concentration (EC50) = 346 nM; 1: EC50 = 530 nM). Compound 17e was further confirmed to induce expression of Nrf2-dependent antioxidant enzymes at both mRNA and protein levels. In a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of PD, 17e significantly attenuated loss of tyrosine hydroxylase-immunopositive dopaminergic neurons, suppressed microglial activation, and alleviated PD-associated motor dysfunction. Thus, 17e is a novel Nrf2 activator with excellent druglike properties and represents a potential therapeutic candidate for PD." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01527"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01527">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01527&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01527&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01527&amp;href=/doi/10.1021/acs.jmedchem.8b01527" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 811-830</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01482" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01550" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson’s Disease Therapy</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ji Won Choi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ji Won Choi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Convergence Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ji+Won++Choi">Ji Won Choi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Siwon Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Siwon Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Convergence Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</div><div class="loa-info-affiliations-info">Division of Bio-Med Science & Technology, KIST School, Korea University of Science and Technology, Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Siwon++Kim">Siwon Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jong-Hyun Park</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jong-Hyun Park</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Convergence Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jong-Hyun++Park">Jong-Hyun Park</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hyeon Jeong Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hyeon Jeong Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Convergence Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</div><div class="loa-info-affiliations-info">Department of Biotechnology, Yonsei University, Seoul 03722, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hyeon+Jeong++Kim">Hyeon Jeong Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Su Jeong Shin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Su Jeong Shin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Convergence Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Su+Jeong++Shin">Su Jeong Shin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jin Woo Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jin Woo Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Convergence Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jin+Woo++Kim">Jin Woo Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Seo Yeon Woo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Seo Yeon Woo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Convergence Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Seo+Yeon++Woo">Seo Yeon Woo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Changho Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Changho Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Functional Food Research, Korea Food Research Institute, Wanju-gun, Jeollabuk-do 55365, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Changho++Lee">Changho Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sang Moon Han</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sang Moon Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Doping Control Center, KIST, Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sang+Moon++Han">Sang Moon Han</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jaeick Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jaeick Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Doping Control Center, KIST, Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jaeick++Lee">Jaeick Lee</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7548-0297" title="Orcid link">http://orcid.org/0000-0001-7548-0297</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ae Nim Pae</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ae Nim Pae</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Convergence Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</div><div class="loa-info-affiliations-info">Division of Bio-Med Science & Technology, KIST School, Korea University of Science and Technology, Seoul 02792, Republic of Korea</div><div class="loa-info-affiliations-info">KHU-KIST Department of Converging Science and Technology, Kyung Hee University, Seoul 02447, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ae+Nim++Pae">Ae Nim Pae</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gyoonhee Han</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gyoonhee Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology, Yonsei University, Seoul 03722, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gyoonhee++Han">Gyoonhee Han</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ki Duk Park</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ki Duk Park</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Convergence Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</div><div class="loa-info-affiliations-info">Division of Bio-Med Science & Technology, KIST School, Korea University of Science and Technology, Seoul 02792, Republic of Korea</div><div class="loa-info-affiliations-info">KHU-KIST Department of Converging Science and Technology, Kyung Hee University, Seoul 02447, Republic of Korea</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#117a756170637a517a7862653f63743f7a63"><span class="__cf_email__" data-cfemail="f09b948091829bb09b998384de8295de9b82">[email protected]</span></a>. Phone: +82-2-9585132. Fax: +82-2-9585189.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ki+Duk++Park">Ki Duk Park</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7753-214X" title="Orcid link">http://orcid.org/0000-0002-7753-214X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01527&amp;href=/doi/10.1021%2Facs.jmedchem.8b01527" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 811–830</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 12, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 October 2018</li><li><span class="item_label"><b>Published</b> online</span>12 December 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 January 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01527" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01527</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D811%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJi%2BWon%2BChoi%252C%2BSiwon%2BKim%252C%2BJong-Hyun%2BPark%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D2%26contentID%3Dacs.jmedchem.8b01527%26title%3DOptimization%2Bof%2BVinyl%2BSulfone%2BDerivatives%2Bas%2BPotent%2BNuclear%2BFactor%2BErythroid%2B2-Related%2BFactor%2B2%2B%2528Nrf2%2529%2BActivators%2Bfor%2BParkinson%25E2%2580%2599s%2BDisease%2BTherapy%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D830%26publicationDate%3DJanuary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01527"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2050</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">24</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01527" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson’s Disease Therapy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ji&quot;,&quot;last_name&quot;:&quot;Won Choi&quot;},{&quot;first_name&quot;:&quot;Siwon&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Jong-Hyun&quot;,&quot;last_name&quot;:&quot;Park&quot;},{&quot;first_name&quot;:&quot;Hyeon&quot;,&quot;last_name&quot;:&quot;Jeong Kim&quot;},{&quot;first_name&quot;:&quot;Su&quot;,&quot;last_name&quot;:&quot;Jeong Shin&quot;},{&quot;first_name&quot;:&quot;Jin&quot;,&quot;last_name&quot;:&quot;Woo Kim&quot;},{&quot;first_name&quot;:&quot;Seo&quot;,&quot;last_name&quot;:&quot;Yeon Woo&quot;},{&quot;first_name&quot;:&quot;Changho&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Sang&quot;,&quot;last_name&quot;:&quot;Moon Han&quot;},{&quot;first_name&quot;:&quot;Jaeick&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Ae&quot;,&quot;last_name&quot;:&quot;Nim Pae&quot;},{&quot;first_name&quot;:&quot;Gyoonhee&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Ki&quot;,&quot;last_name&quot;:&quot;Duk Park&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;811-830&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01527&quot;},&quot;abstract&quot;:&quot;We previously developed a novel series of vinyl sulfones as nuclear factor erythroid 2-related factor 2 (Nrf2) activators with therapeutic potential for Parkinson’s disease (PD). However, the previously developed lead compound (1) exhibited undesirable druglike properties. Here, we optimized vinyl sulfones by introducing nitrogen heterocycles to improve druglike properties. Among the synthesized compounds, 17e was the most promising drug candidate with good druglike properties. Compound 17e showed superior effects on Nrf2 activation in cell-based assays compared to compound 1 (17e: half-maximal effective concentration (EC50) = 346 nM; 1: EC50 = 530 nM). Compound 17e was further confirmed to induce expression of Nrf2-dependent antioxidant enzymes at both mRNA and protein levels. In a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of PD, 17e significantly attenuated loss of tyrosine hydroxylase-immunopositive dopaminergic neurons, suppressed microglial activation, and alleviated PD-associated &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01527&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01527" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01527&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01527" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01527&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01527" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01527&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01527&amp;href=/doi/10.1021/acs.jmedchem.8b01527" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01527" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01527" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01527%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DChoi%26date%3D2019%26atitle%3DOptimization%2Bof%2BVinyl%2BSulfone%2BDerivatives%2Bas%2BPotent%2BNuclear%2BFactor%2BErythroid%2B2-Related%2BFactor%2B2%2B%2528Nrf2%2529%2BActivators%2Bfor%2BParkinson%25E2%2580%2599s%2BDisease%2BTherapy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D2%26spage%3D811%26epage%3D830%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292169" title="Antioxidants">Antioxidants</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/jmcmar.2019.62.issue-2/20190124/jmcmar.2019.62.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We previously developed a novel series of vinyl sulfones as nuclear factor erythroid 2-related factor 2 (Nrf2) activators with therapeutic potential for Parkinson’s disease (PD). However, the previously developed lead compound (<b>1</b>) exhibited undesirable druglike properties. Here, we optimized vinyl sulfones by introducing nitrogen heterocycles to improve druglike properties. Among the synthesized compounds, <b>17e</b> was the most promising drug candidate with good druglike properties. Compound <b>17e</b> showed superior effects on Nrf2 activation in cell-based assays compared to compound <b>1</b> (<b>17e</b>: half-maximal effective concentration (EC<sub>50</sub>) = 346 nM; <b>1</b>: EC<sub>50</sub> = 530 nM). Compound <b>17e</b> was further confirmed to induce expression of Nrf2-dependent antioxidant enzymes at both mRNA and protein levels. In a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of PD, <b>17e</b> significantly attenuated loss of tyrosine hydroxylase-immunopositive dopaminergic neurons, suppressed microglial activation, and alleviated PD-associated motor dysfunction. Thus, <b>17e</b> is a novel Nrf2 activator with excellent druglike properties and represents a potential therapeutic candidate for PD.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55516" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55516" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease and mainly affects the motor system. The incidence of PD is about 1–4% of populations over 60 years of age, and main clinical features often include tremors, rigidity, posture instability, akinesia, and cognitive impairment.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> The major pathophysiology of PD is loss of dopaminergic (DAergic) neurons in the substantia nigra pars compacta (SNpc).<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Hence, most treatment strategies focus on increasing dopamine levels, typically using <span class="smallcaps smallerCapital">l</span>-3,4-dihydroxyphenylalanine (<span class="smallcaps smallerCapital">l</span>-DOPA) as a precursor, to alleviate symptoms. However, <span class="smallcaps smallerCapital">l</span>-DOPA only ameliorates motor symptoms for a short period of time and can cause side effects, such as <span class="smallcaps smallerCapital">l</span>-DOPA-induced dyskinesia, when taken for long periods.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> Therefore, it is important to develop new therapies that prevent the death of DAergic neurons in PD-affected brain areas and increase dopamine levels.<a onclick="showRef(event, 'ref3 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref3 ref8 ref9">(3,8,9)</a></div><div class="NLM_p">Unfortunately, the exact mechanism of DAergic neuronal cell death in PD patients remains unclear, but many recent studies have shown that oxidative stress plays an important role.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> Oxidative stress is caused by an imbalance in the production of reactive oxygen species and cellular antioxdant defense systems.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13−16)</a> Thus, upregulation of endogenous antioxidant defense genes is an attractive strategy for the treatment of various brain diseases associated with oxidative stress, including Alzheimer’s disease, PD, and epilepsy.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17−20)</a></div><div class="NLM_p">The Kelch-like ECH-associated protein 1 (Keap1)–nuclear factor erythroid 2-related factor 2 (Nrf2) system is the main signaling pathway involved cellular defense against oxidative stress. Nrf2 is a transcription factor that regulates oxidative stress by inducing expression of antioxidant enzyme genes, such as heme oxygenase-1 (HO-1), reduced nicotinamide adenine dinucleotide phosphate (NAD(P)H) quinone oxidoreductase 1, glutamate–cysteine ligase (GCL), and several members of the glutathione <i>S</i>-transferase family.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Under normal conditions, Nrf2 binding to the repressor protein Keap1 is maintained at low levels in the cytoplasm through Keap1-dependent ubiquitination and proteasomal degradation. Under conditions of oxidative stress, Nrf2 is released from Keap1 and translocates into the nucleus, where it binds the promoter region of the antioxidant response element that is associated with expression of antioxidant genes.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17−20)</a> Therefore, targeting the Keap1–Nrf2 signaling pathway has been considered for the reduction or prevention of neuronal cell death, with Nrf2 activation representing a promising avenue for PD therapy.</div><div class="NLM_p">In our previous studies<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> we developed a series of neuroprotective vinyl sulfones, which targeted the Keap1–Nrf2 signaling pathway. In particular, the lead compound (<b>1</b>) was found to exhibit the most potent Nrf2 activation and subsequent dose-dependent induction of Nrf2-dependent antioxidant enzyme expression. Compound <b>1</b> also exhibited promising efficacy in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model but had poor druglike properties, such as low solubility, metabolic stability, cytochrome P (CYP) inhibition, and human ether-a-go-go-related gene (<i>hERG</i>) safety.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0013.gif" alt="" id="fx1" /></img></div><div class="NLM_p last">In the present study, we attempted to improve the druglike properties of compound <b>1</b> by introducing nitrogen heterocycles because nitrogen heterocycles are among the most significant structural components of pharmaceuticals and 59% of unique small-molecule drugs in U.S. Food and Drug Administration-approved drugs contain a nitrogen heterocycle.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> In addition, recent studies suggested that a morpholine moiety seemed to improve druglike properties of molecules.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> Herein, the design, synthesis, and biological evaluation of a series of vinyl sulfone derivatives with heterocycles is described. The in vitro absorption, distribution, metabolism, and excretion/toxicity (ADME/Tox) profiles of synthesized compounds as well as their ability to induce expression of various antioxidant enzyme genes was also evaluated. Furthermore, the selected compound was tested in an MPTP-induced PD mouse model to assess its ability to protect DAergic neurons from cytotoxic damage and attenuate PD-associated behavioral deficits.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemical Synthesis</h3><div class="NLM_p">We used our previously developed lead compound (<b>1</b>), which contained an α,β-unsaturated sulfone moiety, as our structural template and prepared various derivatives by introducing nitrogen heterocycles, which are among the most significant structural components of pharmaceuticals.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> According to the synthetic methods, the synthesized derivatives were divided into three scaffolds: pyridinyl, morpholinyl, and piperazinyl vinyl sulfones. First, we substituted a pyridine group as a nitrogen heterocycle instead of the benzyl group in the ring B of the lead compound <b>1</b>. Synthesis of the pyridinyl vinyl sulfones (<b>5a</b>–<b>o</b>, <b>6a</b>–<b>i</b>, <b>7a</b>–<b>c</b>, <b>8a</b>–<b>d</b>, <b>11a</b>–<b>d</b>, and <b>12</b>) followed standard protocols (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Synthesis began with commercially available benzenethiols coupled with (diethoxyphosphoryl)methyl-4-methylbenzenesulfonate (<b>2</b>) in the presence of Cs<sub>2</sub>CO<sub>3</sub> to give substituted sulfides (<b>3</b> and <b>9</b>). Oxidation of the substituted sulfides with a 2.2 equiv of <i>m</i>-chloroperoxybenzoic acid at room temperature provided the desired sulfones (<b>4</b> and <b>10</b>). The Horner–Emmons olefination reaction with commercially available formylpyridine gave the final compounds <b>5</b>–<b>8</b>, <b>11</b>, and <b>12</b>. Second, we further introduced a morpholinyl group into ring A to improve microsomal stability while increasing solubility through the HCl salt form. The synthetic pathway used to prepare morpholinyl vinyl sulfones (<b>17a</b>–<b>f</b>, <b>18a</b>, <b>18b</b>, and <b>19a</b>–<b>f</b>) is provided in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. First, commercially available hydroxylbenzenethiols were coupled with (diethoxyphosphoryl)methyl-4-methylbenzenesulfonate (<b>2</b>) in the presence of Cs<sub>2</sub>CO<sub>3</sub> to give the sulfides (<b>13</b>). Oxidation of the sulfides with a 2.2 equiv of <i>m</i>-chloroperoxybenzoic acid at room temperature provided the corresponding sulfones (<b>14</b>). The sulfones were coupled with 3-morpholinoprorpyl-4-methylbenzene-sulfonate (<b>15</b>) in the presence of K<sub>2</sub>CO<sub>3</sub> to incorporate a morpholine group in the sulfones (<b>16</b>). The final compounds (<b>17</b>–<b>19</b>) were synthesized using the Horner–Emmons olefination reaction with commercially available formylpyridine. Preparation of the piperazinyl vinyl sulfones (<b>23a</b> and <b>23b</b>) followed a standard protocol (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The intermediate (<b>14c</b>) was coupled with ethyl-2-bromoacetate in the presence of K<sub>2</sub>CO<sub>3</sub> to give compound <b>20</b>. The ester of <b>20</b> was converted to its free acid form (<b>21</b>) using stoichiometric amounts of NaOH. Coupling of <b>21</b> and 1-methylpiperazine using carbonyldiimidazole gave <b>22</b>. The final compounds (<b>23</b>) were obtained in salt forms by the Horner–Emmons olefination followed by addition of excess 4.0 M HCl.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>5</b>–<b>8</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>11</b> and <b>12</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>17</b>–<b>19</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>23</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Evaluation of the Synthesized Compounds for Nrf2 Activation</h3><div class="NLM_p">To evaluate the Nrf2 activating ability of all of the synthesized compounds, we assessed their ability to release Nrf2 from Keap1 and translocate Nrf2 into the nucleus using our previously reported cell-based assay system.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The potency of Nrf2 activation is shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> as half-maximal effective concentration (EC<sub>50</sub>) values. The optimization process was designed to improve the potency and ADME/Tox profiles of lead compound <b>1</b>. First, we introduced <i>o</i>-pyridine as a heterocycle into ring B of <b>1</b> (<b>5a</b>), but this reduced Nrf2 activation by 17-fold (<b>1</b>: EC<sub>50</sub> = 0.53 μM; <b>5a</b>: EC<sub>50</sub> = 9.07 μM). However, addition of a Cl group to <i>o</i>-pyridine (<b>5b</b>, <b>5c</b>, and <b>5e</b>) enhanced the Nrf2 activation effect relative to <b>5a</b>; <b>5e</b> had its Cl group in the ortho position, as in <b>1</b>, and induced the highest Nrf2 activity (<b>5e</b>: EC<sub>50</sub> = 0.142 μM). Substitution with a F instead of Cl group in compound <b>5e</b> resulted in a 6-fold reduction in Nrf2 activation (<b>5d</b>: EC<sub>50</sub> = 0.877 μM). Next, we systematically placed a methoxy group at the 2-, 3-, and 4-positions of ring A. In these three series of compounds, the 3-methoxy derivatives (<b>5f</b>–<b>j</b>) were more Nrf2-active than the corresponding 2- and 4-methoxy derivatives (<b>5a</b>–<b>e</b> and <b>5k</b>–<b>o</b>, respectively; 3-OMe > 2-OMe > 4-OMe). In our previous study, 2-methoxy compounds, including <b>1</b>, were the most active; however, in the present study, 3-methoxy compounds in which a pyridine ring was introduced as the ring B were more Nrf2-active.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effects of Synthesized Compounds <b>5</b>–<b>12</b> on Nrf2 Activation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The Keap1–Nrf2 functional assay was performed using a PathHunter U2OS Keap1–Nrf2 nuclear translocation cell line (93-0821C3, DiscoveRx). U2OS cells were plated at 13 000 cells/well in triplicate with various compound concentrations for 6 h. The activation-dependent nuclear factor (erythroid-derived 2)-like 2 (Nrf2) translocation was determined using a cell-based functional assay, with mean ± standard error of the mean half-maximal effective concentration (EC<sub>50</sub>) values.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Compound <b>1</b> developed in previous study as an Nrf2 activator.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">SFN, sulforaphane: a well-known potent activator of Nrf2.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effects of Synthesized Compounds <b>17</b>–<b>23</b> on Nrf2 Activation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0010.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">U2OS cells were plated at 13 000 cells/well in triplicate with various compound concentrations for 6 h. Activation-dependent nuclear factor (erythroid-derived 2)-like 2 (Nrf2) translocation was determined using a cell-based functional assay mean ± standard error of the mean half-maximal effective concentration (EC<sub>50</sub>) values.</p></div></div><div></div></div><div class="NLM_p">Next, we examined whether Nrf2 activation was improved by introduction of an <i>o</i>-pyridine versus a <i>m</i>- or <i>p</i>-pyridine. <i>m</i>-Pyridine derivatives (<b>6</b>) were generally less potent than <i>o</i>-pyridine derivatives (<b>5</b>) with respect to Nrf2 activation. On the other hand, while <i>p</i>-pyridine derivatives (<b>7</b>) showed a significant increase in Nrf2 activation, they were also more cytotoxic than both <i>o</i>- and <i>m</i>-pyridine derivatives (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In addition, conversion of the pyridine in ring B to a pyrimidine (<b>8</b>) had little effect on Nrf2 activation ability. Next, we prepared compounds <b>11</b> and <b>12</b> to investigate whether introduction of a pyridine group into ring A would enhance the potency of Nrf2 activation. Among this series, electron-withdrawing groups were inserted into the pyridine (<b>11c</b> and <b>12</b>) and exerted significant Nrf2 activation effects (<b>11c</b>: EC<sub>50</sub> = 0.124 μM; <b>12</b>: EC<sub>50</sub> = 0.202 μM).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. CYP Inhibition, Microsomal Stability, and Cell Viability Tests of the Synthesized Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">CYP enzyme activities<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (%)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">CYP enzyme activities<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (%)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">comp</th><th class="colsep0 rowsep0" align="center" char=".">2C19</th><th class="colsep0 rowsep0" align="center" char=".">2D6</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center" char=".">1A2</th><th class="colsep0 rowsep0" align="center" char=".">3A4</th><th class="colsep0 rowsep0" align="center">microsomal stability<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (%, human)</th><th class="colsep0 rowsep0" align="center">cell viability<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> at 10 and 50 μM (%)</th><th class="colsep0 rowsep0" align="center">comp</th><th class="colsep0 rowsep0" align="center" char=".">2C19</th><th class="colsep0 rowsep0" align="center" char=".">2D6</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center" char=".">1A2</th><th class="colsep0 rowsep0" align="center" char=".">3A4</th><th class="colsep0 rowsep0" align="center">microsomal stability<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (%, human)</th><th class="colsep0 rowsep0" align="center">cell viability<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> at 10 and 50 μM (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="char" char=".">47.8</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">97.7</td><td class="colsep0 rowsep0" align="char" char=".">72.5</td><td class="colsep0 rowsep0" align="char" char=".">38.4</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left">100 ± 0.1, 100 ± 2.9</td><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">23.0</td><td class="colsep0 rowsep0" align="char" char=".">38.8</td><td class="colsep0 rowsep0" align="char" char=".">65.9</td><td class="colsep0 rowsep0" align="char" char=".">76.9</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">71.0 ± 1.2, 69.0 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="char" char=".">18.9</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">69.2</td><td class="colsep0 rowsep0" align="char" char=".">64.6</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 2.9, 80.5 ± 0.8</td><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">80.5</td><td class="colsep0 rowsep0" align="char" char=".">86.6</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">81.6</td><td class="colsep0 rowsep0" align="char" char=".">84.4</td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left">100 ± 2.4, 97.9 ± 3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="char" char=".">7.40</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">73.6</td><td class="colsep0 rowsep0" align="char" char=".">82.4</td><td class="colsep0 rowsep0" align="char" char=".">83.1</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 1.5, 92.6 ± 0.6</td><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="char" char=".">16.9</td><td class="colsep0 rowsep0" align="char" char=".">96.4</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">57.5</td><td class="colsep0 rowsep0" align="char" char=".">78.5</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 1.3, 79.9 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="char" char=".">19.5</td><td class="colsep0 rowsep0" align="char" char=".">91.9</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">85.2</td><td class="colsep0 rowsep0" align="char" char=".">75.9</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 1.2, 99.2 ± 1.3</td><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="char" char=".">57.1</td><td class="colsep0 rowsep0" align="char" char=".">89.8</td><td class="colsep0 rowsep0" align="char" char=".">87.5</td><td class="colsep0 rowsep0" align="char" char=".">85.9</td><td class="colsep0 rowsep0" align="char" char=".">86.9</td><td class="colsep0 rowsep0" align="left">96</td><td class="colsep0 rowsep0" align="left">100 ± 3.0, 100 ± 4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="char" char=".">11.1</td><td class="colsep0 rowsep0" align="char" char=".">98.4</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">78.5</td><td class="colsep0 rowsep0" align="char" char=".">48.6</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 2.7, 100 ± 3.2</td><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="char" char=".">57.8</td><td class="colsep0 rowsep0" align="char" char=".">86.6</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">63.0</td><td class="colsep0 rowsep0" align="char" char=".">90.7</td><td class="colsep0 rowsep0" align="left">94</td><td class="colsep0 rowsep0" align="left">100 ± 1.0, 100 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="char" char=".">82.7</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">84.1</td><td class="colsep0 rowsep0" align="char" char=".">83.7</td><td class="colsep0 rowsep0" align="left">74</td><td class="colsep0 rowsep0" align="left">100 ± 2.0, 98.9 ± 1.3</td><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="char" char=".">47.4</td><td class="colsep0 rowsep0" align="char" char=".">91.1</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">47.1</td><td class="colsep0 rowsep0" align="char" char=".">98.8</td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left">100 ± 0.9, 93.4 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="char" char=".">2.35</td><td class="colsep0 rowsep0" align="char" char=".">91.2</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">82.7</td><td class="colsep0 rowsep0" align="char" char=".">36.7</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">100 ± 2.3, 89.3 ± 2.4</td><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="char" char=".">37.4</td><td class="colsep0 rowsep0" align="char" char=".">99.1</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">74.9</td><td class="colsep0 rowsep0" align="char" char=".">98.8</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left">100 ± 2.0, 98.6 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5h</b></td><td class="colsep0 rowsep0" align="char" char=".">3.33</td><td class="colsep0 rowsep0" align="char" char=".">81.8</td><td class="colsep0 rowsep0" align="char" char=".">39.5</td><td class="colsep0 rowsep0" align="char" char=".">80.8</td><td class="colsep0 rowsep0" align="char" char=".">40.6</td><td class="colsep0 rowsep0" align="left">9.6</td><td class="colsep0 rowsep0" align="left">100 ± 3.1, 67.6 ± 1.4</td><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="char" char=".">24.8</td><td class="colsep0 rowsep0" align="char" char=".">74.0</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">71.5</td><td class="colsep0 rowsep0" align="char" char=".">75.2</td><td class="colsep0 rowsep0" align="left">97</td><td class="colsep0 rowsep0" align="left">100 ± 2.5, 100 ± 3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">97.2</td><td class="colsep0 rowsep0" align="char" char=".">86.6</td><td class="colsep0 rowsep0" align="char" char=".">68.8</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">100 ± 0.8, 97.4 ± 0.3</td><td class="colsep0 rowsep0" align="left"><b>11d</b></td><td class="colsep0 rowsep0" align="char" char=".">33.7</td><td class="colsep0 rowsep0" align="char" char=".">84.2</td><td class="colsep0 rowsep0" align="char" char=".">92.0</td><td class="colsep0 rowsep0" align="char" char=".">8.8</td><td class="colsep0 rowsep0" align="char" char=".">74.3</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">100 ± 1.6, 100 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5j</b></td><td class="colsep0 rowsep0" align="char" char=".">3.40</td><td class="colsep0 rowsep0" align="char" char=".">93.2</td><td class="colsep0 rowsep0" align="char" char=".">31.9</td><td class="colsep0 rowsep0" align="char" char=".">81.3</td><td class="colsep0 rowsep0" align="char" char=".">38.0</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">100 ± 2.9, 82.2 ± 4.3</td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">22.6</td><td class="colsep0 rowsep0" align="char" char=".">72.2</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">65.1</td><td class="colsep0 rowsep0" align="char" char=".">78.3</td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left">100 ± 1.1, 84.1 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5k</b></td><td class="colsep0 rowsep0" align="char" char=".">9.70</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">82.8</td><td class="colsep0 rowsep0" align="char" char=".">82.9</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">100 ± 1.7, 100 ± 1.2</td><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="char" char=".">87.4</td><td class="colsep0 rowsep0" align="char" char=".">86.7</td><td class="colsep0 rowsep0" align="char" char=".">87.9</td><td class="colsep0 rowsep0" align="char" char=".">97.3</td><td class="colsep0 rowsep0" align="char" char=".">91.8</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 1.2, 87.8 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5l</b></td><td class="colsep0 rowsep0" align="char" char=".">1.16</td><td class="colsep0 rowsep0" align="char" char=".">90.7</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">87.8</td><td class="colsep0 rowsep0" align="char" char=".">70.0</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">97.0 ± 0.9, 85.0 ± 1.0</td><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="char" char=".">68.7</td><td class="colsep0 rowsep0" align="char" char=".">66.7</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">53.2</td><td class="colsep0 rowsep0" align="char" char=".">62.8</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 2.0, 92.2 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5m</b></td><td class="colsep0 rowsep0" align="char" char=".">1.90</td><td class="colsep0 rowsep0" align="char" char=".">89.0</td><td class="colsep0 rowsep0" align="char" char=".">59.0</td><td class="colsep0 rowsep0" align="char" char=".">75.6</td><td class="colsep0 rowsep0" align="char" char=".">85.8</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">100 ± 2.0, 84.1 ± 0.8</td><td class="colsep0 rowsep0" align="left"><b>17c</b></td><td class="colsep0 rowsep0" align="char" char=".">63.1</td><td class="colsep0 rowsep0" align="char" char=".">96.0</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">98.1</td><td class="colsep0 rowsep0" align="char" char=".">80.7</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">100 ± 1.6, 92.6 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5n</b></td><td class="colsep0 rowsep0" align="char" char=".">1.50</td><td class="colsep0 rowsep0" align="char" char=".">89.7</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">83.5</td><td class="colsep0 rowsep0" align="char" char=".">70.4</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">94.2 ± 0.3, 86.6 ± 1.7</td><td class="colsep0 rowsep0" align="left"><b>17d</b></td><td class="colsep0 rowsep0" align="char" char=".">87.7</td><td class="colsep0 rowsep0" align="char" char=".">99.3</td><td class="colsep0 rowsep0" align="char" char=".">90.7</td><td class="colsep0 rowsep0" align="char" char=".">92.3</td><td class="colsep0 rowsep0" align="char" char=".">84.8</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">96.3 ± 2.5, 93.0 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5o</b></td><td class="colsep0 rowsep0" align="char" char=".">3.80</td><td class="colsep0 rowsep0" align="char" char=".">97.5</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">88.2</td><td class="colsep0 rowsep0" align="char" char=".">91.8</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">94.7 ± 0.1, 89.8 ± 2.0</td><td class="colsep0 rowsep0" align="left"><b>17e</b></td><td class="colsep0 rowsep0" align="char" char=".">77.4</td><td class="colsep0 rowsep0" align="char" char=".">99.7</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">87.2</td><td class="colsep0 rowsep0" align="char" char=".">97.4</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">100 ± 1.3, 99.0 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">68.5</td><td class="colsep0 rowsep0" align="char" char=".">49.4</td><td class="colsep0 rowsep0" align="char" char=".">88.7</td><td class="colsep0 rowsep0" align="char" char=".">33.2</td><td class="colsep0 rowsep0" align="left">97</td><td class="colsep0 rowsep0" align="left">100 ± 2.1, 92.0 ± 3.7</td><td class="colsep0 rowsep0" align="left"><b>17f</b></td><td class="colsep0 rowsep0" align="char" char=".">53.6</td><td class="colsep0 rowsep0" align="char" char=".">89.6</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">98.6</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 2.9, 83.4 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="char" char=".">20.1</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">54.0</td><td class="colsep0 rowsep0" align="char" char=".">75.7</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 0.5, 81.9 ± 1.8</td><td class="colsep0 rowsep0" align="left"><b>18a</b></td><td class="colsep0 rowsep0" align="char" char=".">93.6</td><td class="colsep0 rowsep0" align="char" char=".">87.9</td><td class="colsep0 rowsep0" align="char" char=".">93.0</td><td class="colsep0 rowsep0" align="char" char=".">86.3</td><td class="colsep0 rowsep0" align="char" char=".">79.9</td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left">88.2 ± 1.9, 80.1 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="char" char=".">29.0</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">82.0</td><td class="colsep0 rowsep0" align="char" char=".">92.0</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">99.7 ± 1.0, 87.5 ± 0.9</td><td class="colsep0 rowsep0" align="left"><b>18b</b></td><td class="colsep0 rowsep0" align="char" char=".">80.1</td><td class="colsep0 rowsep0" align="char" char=".">91.7</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">77.8</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">84.5 ± 2.2, 80.8 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="char" char=".">13.0</td><td class="colsep0 rowsep0" align="char" char=".">84.3</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">46.3</td><td class="colsep0 rowsep0" align="char" char=".">56.3</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">100 ± 3.2, 99.8 ± 2.0</td><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="char" char=".">43.6</td><td class="colsep0 rowsep0" align="char" char=".">89.6</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">95.1</td><td class="colsep0 rowsep0" align="char" char=".">56.6</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">91.0 ± 0.7, 74.3 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6e</b></td><td class="colsep0 rowsep0" align="char" char=".">22.0</td><td class="colsep0 rowsep0" align="char" char=".">91.9</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">69.7</td><td class="colsep0 rowsep0" align="char" char=".">63.3</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">100 ± 0.6, 90.8 ± 0.8</td><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="char" char=".">43.0</td><td class="colsep0 rowsep0" align="char" char=".">71.9</td><td class="colsep0 rowsep0" align="char" char=".">78.4</td><td class="colsep0 rowsep0" align="char" char=".">93.1</td><td class="colsep0 rowsep0" align="char" char=".">53.2</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 1.2, 71.6 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6f</b></td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">90.0</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">76.8</td><td class="colsep0 rowsep0" align="char" char=".">44.3</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">100 ± 0.4, 78.8 ± 0.8</td><td class="colsep0 rowsep0" align="left"><b>19c</b></td><td class="colsep0 rowsep0" align="char" char=".">59.8</td><td class="colsep0 rowsep0" align="char" char=".">70.3</td><td class="colsep0 rowsep0" align="char" char=".">60.8</td><td class="colsep0 rowsep0" align="char" char=".">89.7</td><td class="colsep0 rowsep0" align="char" char=".">83.0</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">94.5 ± 0.1, 78.5 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6g</b></td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">84.0</td><td class="colsep0 rowsep0" align="char" char=".">76.5</td><td class="colsep0 rowsep0" align="char" char=".">75.1</td><td class="colsep0 rowsep0" align="char" char=".">80.5</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">99.5 ± 3.8, 85.8 ± 1.5</td><td class="colsep0 rowsep0" align="left"><b>19d</b></td><td class="colsep0 rowsep0" align="char" char=".">56.2</td><td class="colsep0 rowsep0" align="char" char=".">83.6</td><td class="colsep0 rowsep0" align="char" char=".">97.6</td><td class="colsep0 rowsep0" align="char" char=".">93.6</td><td class="colsep0 rowsep0" align="char" char=".">89.7</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">77.4 ± 3.1, 70.2 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6h</b></td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">95.5</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">91.8</td><td class="colsep0 rowsep0" align="char" char=".">96.4</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 2.3, 76.3 ± 0.2</td><td class="colsep0 rowsep0" align="left"><b>19e</b></td><td class="colsep0 rowsep0" align="char" char=".">63.8</td><td class="colsep0 rowsep0" align="char" char=".">46.8</td><td class="colsep0 rowsep0" align="char" char=".">84.9</td><td class="colsep0 rowsep0" align="char" char=".">88.0</td><td class="colsep0 rowsep0" align="char" char=".">91.3</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 1.4, 82.4 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6i</b></td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">87.9</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">64.7</td><td class="colsep0 rowsep0" align="char" char=".">98.2</td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">100 ± 2.4, 95.7 ± 0.3</td><td class="colsep0 rowsep0" align="left"><b>19f</b></td><td class="colsep0 rowsep0" align="char" char=".">82.8</td><td class="colsep0 rowsep0" align="char" char=".">57.7</td><td class="colsep0 rowsep0" align="char" char=".">80.1</td><td class="colsep0 rowsep0" align="char" char=".">87.1</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">100 ± 0.8, 90.4 ± 3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="char" char=".">14.2</td><td class="colsep0 rowsep0" align="char" char=".">78.6</td><td class="colsep0 rowsep0" align="char" char=".">52.2</td><td class="colsep0 rowsep0" align="char" char=".">53.4</td><td class="colsep0 rowsep0" align="char" char=".">85.0</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">96.8 ± 0.4, 78.9 ± 0.4</td><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char=".">83.9</td><td class="colsep0 rowsep0" align="char" char=".">93.0</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">95.6</td><td class="colsep0 rowsep0" align="char" char=".">96.2</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">100 ± 0.8, 100 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">34.2</td><td class="colsep0 rowsep0" align="char" char=".">44.4</td><td class="colsep0 rowsep0" align="char" char=".">36.0</td><td class="colsep0 rowsep0" align="char" char=".">49.7</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">84.3 ± 1.0, 21.3 ± 0.1</td><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="char" char=".">71.9</td><td class="colsep0 rowsep0" align="char" char=".">89.9</td><td class="colsep0 rowsep0" align="char" char=".">73.4</td><td class="colsep0 rowsep0" align="char" char=".">93.9</td><td class="colsep0 rowsep0" align="char" char=".">91.1</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">100 ± 1.0, 88.5 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">88.1</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">41.7</td><td class="colsep0 rowsep0" align="char" char=".">42.3</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">100 ± 1.4, 82.5 ± 1.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Cytochrome P450 (CYP) inhibition assay was performed using a P450-Glo assay system (Promega).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">In vitro microsomal stability of the synthesized compound; % remaining was determined after 30 min incubation with human microsomes. The % of parent compound remaining was calculated by comparing peak areas.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Cell viability was determined using Ez-Cytox. BV2 cells (10 000 cells/well) were treated with test compounds (10 or 50 μM) and incubated for 24 h before EZ-cytox assay. All experiments were performed in triplicate cultures, and the data were averaged and expressed as percent of untreated control ± standard error of the mean.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">nd, not determined.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">Compound <b>1</b> developed in a previous study.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></p></div></div></div><div class="NLM_p">To improve the solubility and other druglike properties of potent compounds, we synthesized the salt forms of each by adding morpholine or piperazine groups. On the basis of the above-described results of Nrf2 activation efficacy and cell viability, we prepared a series of compounds in which the <i>o</i>-pyridine group was maintained in ring B and the morpholine or piperazine group was introduced into ring A instead of the methoxy group. Unlike the above results showing the highest Nrf2 activity when a methoxy group was introduced at 3-position of ring A (<b>5</b>, 3-OMe > 2-OMe > 4-OMe), the most potent Nrf2 activating effect was observed when the propylmorpholine group was introduced at the 4-position of ring A (<b>17</b>, <b>17e</b> > <b>17c</b> > <b>17b</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Among the compounds <b>17</b>, <b>17e</b>, and <b>17f</b> included electron-withdrawing groups (F or Cl) on the pyridine exerted remarkable Nrf2 activation effects as compared to the other <b>17</b> series (<b>17e</b>: EC<sub>50</sub> = 0.346 μM; <b>17f</b>: EC<sub>50</sub> = 0.246 μM). We further investigated whether replacement of the <i>o</i>-pyridine group of compound <b>17</b> by either <i>m</i>-pyridine (<b>18</b>) or benzene groups (<b>19</b>) affects the efficacy of Nrf2 activation. Compounds <b>18a</b> and <b>18b</b> exhibited significantly lower activity than compound <b>17</b>, and most of the compounds included benzene groups as ring B instead of <i>o</i>-pyridine group (<b>19</b>) showed no activity. Finally, on the basis of the potency of morpholine compounds with 3′-F or 3′-Cl on <i>o</i>-pyridine (<b>17e</b> and <b>17f</b>), we attempted to introduce a 4-piperazine group instead of 4-morpholine. Interestingly, the 4-piperazinyl compound with 3′-Cl on <i>o</i>-pyridine (<b>23b</b>) had 3.7 times higher Nrf2 activation efficacy than that with a 3′-F (<b>23a</b>).</div><div class="NLM_p">On the basis of the ability of Nrf2 to translocate, compounds <b>5e</b>, <b>5h</b>, <b>5i</b>, <b>5j</b>, <b>5o</b>, <b>6d</b>, <b>6f</b>, <b>8b</b>, <b>11c</b>, <b>11d</b>, <b>12</b>, <b>17e</b>, <b>17f</b>, and <b>23b</b> were identified as the most potent Nrf2 activators (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Most of the synthesized compounds were not cytotoxic at 10 μM, whereas compounds of series <b>7</b> containing <i>p</i>-pyridine on the right ring were cytotoxic. Among the compounds containing 4-morpholine or 4-piperazine, those with a 3′-Cl on <i>o</i>-pyridine (<b>17f</b> and <b>23b</b>) showed lower cell viability than <b>17e</b> and <b>23a</b> which contained a 3′-F at 50 μM (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_p last">In our previous study,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> we compared Nrf2 activating efficacy among the synthesized compounds by determining the ability to induce expression of HO-1, a major Nrf2-dependent gene, using a sandwich enzyme-linked immunosorbent assay (ELISA). To confirm the effects of the present class of molecules on Nrf2 activation, we also performed an ELISA assay for a positive control and the selected 15 compounds. We observed that the Nrf2 activation effect confirmed by ELISA analysis tended to be the same as in the Keap1–Nrf2 functional assay (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_001.pdf" class="ext-link">Table S1</a>, Supporting Information).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vitro ADME/Tox Profiles of the Synthesized Compounds</h3><div class="NLM_p">The druglike properties of the synthesized compounds were examined through CYP inhibition and microsomal stability tests. The inhibitory effects of the all compounds on CYP enzymes (subtypes 2C19, 2D6, 2C9, 1A2, and 3A4) were tested to assess the possibility of drug–drug interactions. The results are expressed as the percentage of CYP activity remaining after treatment with 10 μM of each compound (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The lead compound (<b>1</b>) from our previous study showed unfavorable safety as it blocked more than 50% of CYP 2C19, 1A2, and 3A4 activity. Introduction of an <i>o</i>-pyridine into ring B of compound <b>1</b> (<b>5a</b>–<b>o</b>) significantly reduced CYP 1A2 and 3A4 inhibition (improved safety), but not 2C19 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In addition, most of the low-molecular-size compounds containing a pyridine ring (<b>5</b>–<b>8</b>, <b>11</b>, and <b>12</b>) also showed significant inhibition of CYP 2C19, except for <b>6a</b>, <b>8a</b>, <b>8c</b>, and <b>8d</b>, which do not have the ability to activate Nrf2 (EC<sub>50</sub> > 10 μM). However, the CYP 2C19 inhibition issue was addressed by introducing bulky groups, such as morpholine or piperazine, into ring A (<b>17</b>–<b>19</b>, and <b>23</b>); these compounds also had good Nrf2 activation effects.</div><div class="NLM_p">The stability of each synthesized compound was determined from the percentage of parent compound remaining after a 30 min incubation with human liver microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The previous lead compound (<b>1</b>) showed was metabolically unstable, with only 20% of the parent compound remaining after incubation with human liver microsomes. Although inclusion of a pyridine group (<b>5</b>–<b>8</b>) did not produce a clear trend regarding microsomal stability, the most potent Nrf2-inducing compounds (<b>5h</b>: EC<sub>50</sub> = 0.132 μM; <b>5j</b>: EC<sub>50</sub> = 0.098 μM; <b>6d</b>: EC<sub>50</sub> = 0.178 μM) exhibited unfavorable microsomal stabilities (9.6, 22, and 18%, respectively). In contrast, most compounds containing morpholine or piperazine groups (<b>17</b>–<b>19</b> and <b>23</b>) showed outstanding microsomal stability. On the basis of these results, compound <b>17e</b> was selected for its excellent Nrf2 activation potency, safety, and stability for further ADME/Tox studies (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summary of <b>17e</b> Properties<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0011.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">aqueous solubility</th><th class="colsep0 rowsep0" align="center">>30 mg/mL</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub>, log<i> P</i> (<i>c</i> log<i> P</i>)</td><td class="colsep0 rowsep0" align="left">7.58, 2.29 (2.49)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">activation of the Nrf2 response (EC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">0.346 ± 0.050</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cell viability in 50 μM (%)</td><td class="colsep0 rowsep0" align="left">99.0 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP inhibition (% of control activity)</td><td class="colsep0 rowsep0" align="left">77.4 (2C19), 99.7 (2D6), 96.7 (2C9), 87.2 (1A2), 97.4 (3A4),</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human microsomal stability (% remaining)</td><td class="colsep0 rowsep0" align="left">84.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PAMPA-BBB (<i>P</i><sub>e</sub>, cm/s)</td><td class="colsep0 rowsep0" align="left">15.63 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma stability (% remaining)</td><td class="colsep0 rowsep0" align="left">98.2 (human), 90.2 (rat)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG toxicity (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">112.1 ± 13.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mutagenic toxicity (TA98, TA100, fold induction over the negative control)</td><td class="colsep0 rowsep0" align="left">negative</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">All experiments were performed in triplicate except for microsomal and plasma stability tests. The predicted p<i>K</i><sub>a</sub> and <i>c</i> log <i>P</i> values were calculated using ChemDraw v15.1. PAMPA-BBB, parallel artificial membrane permeability assay-blood–brain barrier; CYP, cytochrome P; hERG, human ether-a-go-go-related gene; Nrf2, nuclear factor (erythroid-derived 2)-like 2; IC<sub>50</sub>, half-maximal inhibitory concentration; <i>P</i><sub>e</sub>, permeability.</p></div></div></div><div class="NLM_p last">The plasma stability of <b>17e</b> in both humans and rats was also excellent, with 98.2 and 90.2% of the parent compound remaining after a 30 min incubation, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_001.pdf" class="ext-link">S2</a> in Supporting Information). In the <i>hERG</i> channel-binding assay, <b>17e</b> exerted low inhibitory effects against <i>hERG</i>, which produces an important cardiac ion channel subunit protein, indicating that it is unlikely to cause human cardiotoxicity (half-maximal inhibitory concentration (IC<sub>50</sub>): 112.1 μM, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_001.pdf" class="ext-link">Figure S1</a> in the Supporting Information). To predict the blood–brain barrier permeability of <b>17e</b>, we performed a parallel artificial membrane permeability assay-blood–brain barrier test using a commercial kit. In this test, permeability (<i>P</i><sub>e</sub>, cm/s) was divided into two classifications: central nervous system-positive (<i>P</i><sub>e</sub> > 10 × 10<sup>–6</sup>) and -negative (<i>P</i><sub>e</sub> < 10 × 10<sup>–6</sup>). The permeability of <b>17e</b> was found to be favorable for a central nervous system (CNS) drug (<i>P</i><sub>e</sub>: 15.6 × 10<sup>–6</sup>, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_001.pdf" class="ext-link">Table S3</a> in the Supporting Information). Finally, the Ames test was used to test mutagenesis. The fold induction with <b>17e</b> was lower than baseline in both TA98 and TA100 strains and did not induce reverse mutation (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_001.pdf" class="ext-link">Figure S2</a> in the Supporting Information). In addition, the physicochemical properties of <b>17e</b> were confirmed to be compatible with beneficial druglike properties (<b>17e</b> solubility: >30 mg/mL vs <b>1</b> solubility: <0.01 mg/mL in H<sub>2</sub>O; the predicted p<i>K</i><sub>a</sub>: 7.58; <i>c</i> log <i>P</i>: 2.49). A summary of data related to compound <b>17e</b> is shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. In a pharmacokinetic study, we observed that <b>17e</b> dosed as an oral solution was rapidly absorbed and achieved a maximum concentration at 0.4 h after dosing. Oral bioavailability was calculated at 45.3% in rats (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_001.pdf" class="ext-link">Table S4</a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> <b>17e</b> Activates Nrf2 Nuclear Translocation and Induces <i>HO-1</i> and <i>GCL</i> Gene Expression</h3><div class="NLM_p">Compound <b>17e</b> was further evaluated for its ability to induce nuclear translocation of Nrf2 and subsequent expression of various antioxidant enzymes in BV2 cells.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Initial assessment of the cytotoxic potential of <b>17e</b> in BV2 cells showed no apparent cytotoxicity up to 100 μM (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b). To evaluate its ability to translocate Nrf2 into the nucleus, BV2 cells were treated with various concentrations of <b>17e</b> for 6 h before measuring the nuclear Nrf2 levels by Western blot. Nrf2 protein levels in the nucleus were significantly increased in a dose-dependent manner (2-fold at 0.1 μM; 9-fold at 10 μM; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c). In several studies, Nrf2 activation has been shown without degradation by the Keap1-mediated ubiquitin proteasome system when released from the cytosolic inhibitor Keap1.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> Therefore, Western blot with whole cell lysate was performed to determine whether Nrf2 activation by <b>17e</b> increased the total amount of Nrf2 in BV2 cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>d, total Nrf2 levels were elevated in a dose-dependent manner, indicating accumulation of Nrf2 with <b>17e</b> treatment.</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. <b>17e</b> induces nuclear translocation of Nrf2. (a) The Keap1–Nrf2 functional assay of engineered U2OS cells treated with various concentrations of <b>17e</b> for 6 h. Signal was detected as relative luminescence units of the saturated concentration using a chemiluminescent substrate. Cell viability assay of BV2 cells treated with various concentrations of <b>17e</b> for 24 (b) or 6 h (c, d). The amount of nuclear and total Nrf2 was measured by Western blot with lamin B1 as a nuclear marker; β-actin was used as an internal control. All experiments were performed in triplicate. Data are shown as mean ± standard error of the means and analyzed by Student’s <i>t</i>-test; * <i>P</i> < 0.05, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001 vs the vehicle-treated control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we investigated whether expression of target antioxidant enzymes was induced upon as a result of Nrf2 activation. HO-1 is major Nrf2-dependent enzyme that converts heme to biliverdin and CO, which is known to have antioxidant and neuroprotective properties.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Western blot analysis of <b>17e</b>-treated cells showed a dose-dependent increase in the amount of HO-1. A concentration of 0.3 μM was sufficient to cause a statistically significant change in HO-1 protein levels, and 10 μM <b>17e</b> resulted in a 2.9 ± 0.1-fold increase (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a,b). Real-time quantitative polymerase chain reaction (RT-qPCR) assay of HO-1 mRNA isolated from BV2 cells treated with <b>17e</b> revealed a dramatic and dose-dependent increase. Significant induction was observed at 1 μM (2.7 ± 0.1-fold), reaching 7.5 ± 0.5-fold with 10 μM <b>17e</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c). GCL is an important antioxidant enzyme responsible for the biosynthesis of glutathione, a major antioxidant enzyme in cells that consists of a modulatory (GCLM) and catalytic (GCLC) subunit. Western blot analysis (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a,b) revealed dose-dependent elevation of both GCLM and GCLC protein levels, reaching 12.4 ± 0.5-fold and 2.7 ± 0.2-fold increases with 10 μM <b>17e</b>, respectively. RT-qPCR assay of GCLM and GCLC showed that both were significantly upregulated with 0.3 μM <b>17e</b> treatment (1.7 ± 0.2-fold and 1.2 ± 0.1-fold, respectively), and reached 5.3 ± 0.4-fold and 2.1 ± 0.1-fold induction, respectively, with 10 μM <b>17e</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c). Taken together, <b>17e</b> was able to induce nuclear translocation of Nrf2 and upregulate expression of HO-1 and GCL enzymes in BV2 cells.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <b>17e</b> dose-dependently induced expression of antioxidant enzymes in BV2 cells. (a, b) BV2 cells were treated with various concentrations of <b>17e</b> for 24 h and then subjected to Western blot analysis of HO-1, GCLM, and GCLC using β-actin as an internal control. (c) BV2 cells were treated with various concentrations of <b>17e</b> for 6 h, and relative mRNA levels of Nrf2-dependent genes were measured by RT-qPCR; hypoxanthine-guanine phosphoribosyltransferase was used as an internal control. All experiments were performed in triplicate. Data are shown as mean ± standard error of the means and analyzed by Student’s <i>t</i>-test. * <i>P</i> < 0.05, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001 vs the vehicle-treated control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <b>17e</b> Alleviates Movement Abnormalities in Acute MPTP-Induced PD Mice</h3><div class="NLM_p">We previously reported synthesis of potent Nrf2 activators that exhibited positive therapeutic effects in an MPTP-induced mouse model of PD;<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> MPTP treatment causes PD-like motor dysfunctions in mice. Here, we investigated whether <b>17e</b> can alleviate movement abnormalities in MPTP-induced PD mice as well. The motor activity of MPTP-treated animals can be evaluated by vertical grid and coat-hanger behavioral tests (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a). In the vertical grid test (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b), MPTP injection significantly delayed the time to turn and total time (time to turn: 4.2 ± 0.5 s; total time: 9.4 ± 0.6 s) compared to saline-injected mice (time to turn: 2.3 ± 0.2 s; total time: 6.2 ± 0.4 s), whereas <b>17e</b> treatment significantly alleviated abnormal movement caused by MPTP (time to turn: 2.6 ± 0.2 s; total time: 7.4 ± 0.5 s). In the coat-hanger test (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a), saline-injected mice climbed the coat-hanger and reached the safety zone (score: 4.5 ± 0.2), whereas MPTP-injected mice generally stayed at the edge of the coat-hanger and failed to climb (score: 2.7 ± 0.1). On the other hand, MPTP-injected mice treated with <b>17e</b> showed dramatic improvement in the ability to climb to the top of the coat-hanger and reach the safety zone (score: 4.1 ± 0.3). Taken together, these behavioral results suggest that <b>17e</b> could effectively alleviate movement disorders related to PD.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>17e</b> attenuates motor abnormalities in MPTP-induced PD mice. (a) Experimental protocols for vertical grid and coat-hanger behavioral tests. (b) Time to turn and total time were measured in the vertical grid test. (c) Coat-hanger test scores measured according to the position of the mouse. Data are shown as means ± standard error of the mean (<i>n</i> = 10 per group); * <i>P</i> < 0.05, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001 vs the MPTP-treated group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <b>17e</b> Protects DAergic Neurons and Attenuates Microglial Activation against MPTP in the Striatum and SNpc</h3><div class="NLM_p">We next assessed whether <b>17e</b> could protect against DAergic neurotoxicity in MPTP-induced PD mice. First, immunohistochemical staining for tyrosine hydroxylase (TH) in the nigrostriatal pathway was performed (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a). TH is known to be involved in motor movement and is used as a marker for DAergic neurons. Although the striatal TH-immunopositive nerve fibers significantly decreased after MPTP injection (18.8 ± 3.5%) compared to controls, they increased 3-fold with <b>17e</b> treatment (59.6 ± 5.7%). TH-immunostaining in the SNpc showed similar results as the substantial reduction in TH-immunopositivity with MPTP (32.0 ± 2.6%) was significantly moderated by <b>17e</b> (76.7 ± 2.2%). These results indicate that <b>17e</b> elicits neuroprotective effects against DAergic neuronal cell death in PD. Ionized calcium-binding adapter molecule 1 (Iba-1) immunofluorescent staining in the SNpc was also performed to determine whether <b>17e</b> suppressed microglial activation related to neuroinflammation. In MPTP-injected mice, the immunofluorescence intensity of Iba-1 was 3-fold higher than that of saline-injected mice (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b). However, treatment of MPTP-injected mice with <b>17e</b> dramatically reduced Iba-1 immunoreactivity, indicating that <b>17e</b> suppresses microglial activation. Double immunofluorescent staining for TH and Iba-1 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b) confirmed the neuroprotective and anti-inflammatory effects of <b>17e</b>.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>17e</b> protects DAergic neurons and reduces microglial activation in MPTP-induced PD mice. (a) Representative immunohistochemical staining (brown, TH) in the striatum and SNpc. Bar graphs summarize TH-immunopositive density and cell numbers. (b) Representative double immunofluorescent staining in the SNpc (green, TH; red, Iba-1). Bar graph summarizing analysis of Iba-1 immunofluorescence intensity. Data are shown as the mean ± standard error of the mean (<i>n</i> = 6 per group); *** <i>P</i> < 0.001 vs the MPTP-treated group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We previously developed a novel neuroprotective compound (<b>1</b>) that induces Nrf2 activity and subsequent expression of antioxidant genes, but exhibits unfavorable druglike properties. In the present study, we improved the druglike properties and Nrf2 activation potency of compound <b>1</b> by introducing morpholine and pyridine groups. Further examination of these compounds revealed that <b>17e</b> dose-dependently induced optimal Nrf2 activity, nuclear translocation, and related upregulation of antioxidant enzymes (HO-1, GCLM, and GCLC), as well as excellent druglike properties. In MPTP-induced PD mice, treatment with <b>17e</b> was neuroprotective, alleviating loss of DAergic neurons and preventing microglia activation. These effects were accompanied by improvement of movement ability. In conclusion, <b>17e</b> represents a novel therapeutic agent with potential for treating PD.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Methods</h3><div class="NLM_p">All chemicals, solvents, and reagents were obtained from commercial sources as reagent grade without further purification. Yields reported are for purified products and were not optimized.</div><div class="NLM_p last">Synthesized compounds were checked by thin-layer chromatography (TLC) and <sup>1</sup>H and <sup>13</sup>C nuclear magnetic resonance, melting point, high-resolution mass spectrometry (HRMS), and high-performance liquid chromatography (HPLC) analyses. Reactions were monitored by analytical thin-layer chromatography plates (Merck, Cat No. 1.05715) and analyzed by ultraviolet light at 254 nm. The reactions were purified by column chromatography using silica gel (Merck, Cat Nos. 1.07734 and 1.09385). Melting points were measured in open capillary tubes using OptiMelt melting point equipment (Stanford Research Systems, Inc.). Nuclear magnetic resonance spectra were recorded at 400 MHz (<sup>1</sup>H)/100 MHz (<sup>13</sup>C) or 300 MHz (<sup>1</sup>H)/75 MHz (<sup>13</sup>C) using Bruker spectrometers. Chemical shifts (δ) were reported in ppm downfield from tetramethylsilane. HPLC analysis was performed using a Waters E2695 system equipped with a Capcell Pak C18 column (4.6 mm × 75 mm; 3 μm particle size). HPLC data were recorded using the following parameters: H<sub>2</sub>O/acetonitrile, 100/0 → 0/100 in 20 min, +5 min isocratic, flow rate of 0.5 mL/min, λ = 254 and 280 nm. All compounds were >95% pure. High-resolution MS was performed with electron scatter ionization on an LTQ Orbitrap (Thermo Electron Corp.) instrument.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure for the Compounds</h3><div class="NLM_p last">To a cooled anhydrous tetrahydrofuran solution (−78 °C) of phosphonate derivatives (<b>4</b>, <b>10</b>, <b>16</b> and <b>22</b>) was added 2 M <i>n</i>-BuLi solution in cyclohexane (1.1 equiv). The reaction mixture was stirred at −78 °C (1 h) and then the desired substituted benzaldehyde (1.1 equiv) was added at −78 °C. The reaction mixture was stirred at room temperature (1 h) and then quenched with H<sub>2</sub>O (∼50 mL). The reaction mixture was diluted with EtOAc (∼200 mL) and washed with H<sub>2</sub>O (2 × ∼200 mL) and brine (2 × ∼200 mL). The organic layer was dried with anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography on SiO<sub>2</sub>. In the final step, the production rates of the (E) and (Z)-isomers are changed according to the reaction temperature. At room temperature, the (E)-isomer is predominantly formed and at very low temperatures (−78 °C), the (Z)-isomer is also formed. In our previous study,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> we observed that each isomer of vinyl sulfone showed a distinct <i>R</i><sub>f</sub> value difference on TLC, and thus could be separated by silica column chromatography. The major product of vinyl sulfone derivatives synthesized at room temperature is the (E)-isomer, which has a lower <i>R</i><sub>f</sub> value than the (Z)-isomer on TLC. The (E)-isomer showed a different <i>J</i>-value from the (Z)-isomer in the NMR spectrum ((E): <i>J</i> = 14–16 Hz, (Z): <i>J</i> = 8–10 Hz) and was confirmed when it was not overlapped with other aromatic peaks. Among the final compounds, the morpholinyl and piperazinyl compounds (<b>17</b>–<b>19</b> and <b>23</b>), were prepared the salt forms by addition of 4.0 M HCl to EtOAc solutions. Synthetic procedures for all intermediates were reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>E</i>)-2′-(2-((2-Methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5a</b>)</h3><div class="NLM_p last">Diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate (0.50 g, 1.55 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.85 mL, 1.71 mmol), and 2-pyridinecarboxaldehyde (0.19 mL, 1.71 mmol) gave 0.34 g (83%) of <b>5a</b> as a white solid; <i>R</i><sub>f</sub> = 0.45 (<i>n</i>-hexane/EtOAc 1/1); mp: 123–124 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.63 (d, <i>J</i> = 4.2 Hz, Ar<b>H</b>), 8.02 (dd, <i>J</i> = 1.5, 7.8 Hz, Ar<b>H</b>), 7.73 (td, <i>J</i> = 1.5, 7.6 Hz, Ar<b>H</b>), 7.67 (s, (<i>E</i>)-isomeric 2<b>H</b>), 7.42–7.59 (m, Ar<b>H</b>), 7.41 (d, <i>J</i> = 7.7 Hz, Ar<b>H</b>), 7.27–7.31 (m, Ar<b>H</b>), 7.10 (t, <i>J</i> = 7.6 Hz, Ar<b>H</b>), 7.01 (d, <i>J</i> = 8.4 Hz, Ar<b>H</b>), 3.97 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 157.7, 151.6, 150.4, 141.6, 137.1, 135.7, 131.6, 129.9, 128.3, 125.4, 124.9, 120.8, 112.5, 56.4 (O<b>C</b>H<sub>3</sub>); HPLC purity: 12.1 min, 98.2%; HRMS (M + H)<sup>+</sup> (positive electrospray ionization (ESI<sup>+</sup>)) 276.0687 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>13</sub>NO<sub>3</sub>SH<sup>+</sup> 276.0689).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>E</i>)-2′-Chloro-6′-(2-((2-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5b</b>)</h3><div class="NLM_p last">Diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.42 mL, 0.85 mmol), and 6-chloropyridine-2-carboxaldehyde (0.12 g, 0.85 mmol) gave 0.22 g (93%) of <b>5b</b> as a white powder; <i>R</i><sub>f</sub> = 0.34 (<i>n</i>-hexane/EtOAc 1/1); mp: 104–105 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.98 (t, <i>J</i> = 7.7 Hz, Ar<b>H</b>), 7.88 (m, 2Ar<b>H</b>), 7.57–7.75 (m, 2Ar<b>H</b>, (<i>E</i>)-isomeric 2<b>H</b>), 7.29 (d, <i>J</i> = 8.3 Hz, Ar<b>H</b>), 7.20 (t, <i>J</i> = 8.0 Hz, Ar<b>H</b>), 3.94 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.7, 152.0, 151.0, 141.6, 140.5, 136.7, 132.6, 129.3, 127.7, 126.5, 125.2, 121.3, 114.0, 57.0 (O<b>C</b>H<sub>3</sub>); HPLC purity: 14.4 min, 95.8%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 310.0295 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>ClNO<sub>3</sub>S<sup>+</sup> 310.0299).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>E</i>)-5′-Chloro-2′-(2-((2-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5c</b>)</h3><div class="NLM_p last">Diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.42 mL, 0.85 mmol), and 5-chloropyridine-2-carboxaldehyde (0.12 g, 0.85 mmol) gave 0.16 g (68%) of <b>5c</b> as a white powder; <i>R</i><sub>f</sub> = 0.40 (<i>n</i>-hexane/EtOAc 2/1); mp: 153–154 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.71 (d, <i>J</i> = 2.4 Hz, Ar<b>H</b>), 8.06 (dd, <i>J</i> = 2.4, 8.4 Hz, ArH), 7.87–7.91 (m, 2Ar<b>H</b>), 7.68–7.75 (m, Ar<b>H</b>, (<i>E</i>)-isomeric 2<b>H</b>), 7.29 (d, <i>J</i> = 8.4 Hz, Ar<b>H</b>), 7.19 (t, <i>J</i> = 7.5 Hz, Ar<b>H</b>), 3.94 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.6, 149.9, 149.4, 141.0, 137.6, 136.7, 133.0, 131.9, 129.1, 127.9, 127.1, 121.2, 113.9, 56.9 (O<b>C</b>H<sub>3</sub>); HPLC purity: 14.3 min, 99.0%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 310.0292 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>ClO<sub>3</sub>SH<sup>+</sup> 310.0299).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>E</i>)-3′-Fluoro-2′-(2-((2-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5d</b>)</h3><div class="NLM_p last">Diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.46 mL, 0.85 mmol), and 3-fluoropyridine-2-carboxaldehyde (0.11 g, 0.85 mmol) gave 0.17 g (77%) of <b>5d</b> as a white powder; <i>R</i><sub>f</sub> = 0.23 (<i>n</i>-hexane/EtOAc 1/1); mp: 119–120 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54 (d, <i>J</i> = 4.4 Hz, Ar<b>H</b>), 7.86–7.91 (m, 2Ar<b>H</b>), 7.67–7.76 (m, Ar<b>H</b>, (<i>E</i>)-isomeric 2<b>H</b>), 7.59–7.64 (m, Ar<b>H</b>), 7.31 (d, <i>J</i> = 8.4 Hz, Ar<b>H</b>), 7.20 (t, <i>J</i> = 7.6 Hz, Ar<b>H</b>), 3.95 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.0 (d, <i>J</i><sub>C–F</sub> = 261.4 Hz), 157.1, 146.5 (d, <i>J</i><sub>C–F</sub> = 4.8 Hz), 138.6 (d, <i>J</i><sub>C–F</sub> = 10.9 Hz), 136.3, 133.5, 132.3 (d, <i>J</i><sub>C–F</sub> = 4.3 Hz), 128.7, 127.8 (d, <i>J</i><sub>C–F</sub> = 4.8 Hz), 127.0, 124.8 (d, <i>J</i><sub>C–F</sub> = 18.9 Hz), 120.8, 113.4, 56.5 (O<b>C</b>H<sub>3</sub>); HPLC purity: 7.3 min, 99.1%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 294.0590 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>FNO<sub>3</sub>SH<sup>+</sup> 294.0595).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (<i>E</i>)-3′-Chloro-2′-(2-((2-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5e</b>)</h3><div class="NLM_p last">Diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.42 mL, 0.85 mmol), and 3-chloropyridine-2-carboxaldehyde (0.12 g, 0.85 mmol) gave 0.18 g (75%) of <b>5e</b> as a pale yellow powder; <i>R</i><sub>f</sub> = 0.32 (<i>n</i>-hexane/EtOAc 1/1); mp: 113–114 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.62–8.63 (m, Ar<b>H</b>), 8.08 (dd, <i>J</i> = 1.2, 8.2 Hz, Ar<b>H</b>), 7.96 (d, <i>J</i> = 14.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.90 (dd, <i>J</i> = 1.5, 7.8 Hz, Ar<b>H</b>), 7.74–7.76 (m, Ar<b>H</b>), 7.70 (d, <i>J</i> = 14.9 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.52–7.55 (m, Ar<b>H</b>), 7.30 (d, <i>J</i> = 8.4 Hz, Ar<b>H</b>), 7.20 (t, <i>J</i> = 7.6 Hz, Ar<b>H</b>), 3.95 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.6, 149.2, 147.6, 138.9, 136.9, 136.6, 133.9, 132.6, 129.3, 127.5, 127.4, 121.3, 113.9, 57.0 (O<b>C</b>H<sub>3</sub>); HPLC purity: 10.9 min, 98.5%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 310.0294 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>ClNO<sub>3</sub>SH<sup>+</sup> 310.0299).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>E</i>)-2′-(2-((3-Methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5f</b>)</h3><div class="NLM_p last">Diethyl (((3-methoxyphenyl)sulfonyl)methyl)phosphonate (0.30 g, 0.93 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.51 mL, 1.02 mmol), and 2-pyridinecarboxaldehyde (0.11 mL, 1.02 mmol) gave 0.24 g (93%) of <b>5f</b> as a brown oil; <i>R</i><sub>f</sub> = 0.26 (<i>n</i>-hexane/EtOAc 2/1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.61 (d, <i>J</i> = 4.1 Hz, Ar<b>H</b>), 7.72–7.76 (m, Ar<b>H</b>), 7.64 (d, <i>J</i> = 14.9 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.54 (d, <i>J</i> = 7.7 Hz, Ar<b>H</b>), 7.40–7.47 (m, 3Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 7.26–7.31 (m, Ar<b>H</b>), 7.13 (m, Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.1, 151.0, 150.3, 141.4, 140.5, 137.1, 131.8, 130.5, 125.5, 125.0, 120.2, 120.1, 112.2, 55.7 (O<b>C</b>H<sub>3</sub>); HPLC purity: 4.4 min, 97.3%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 276.0685 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>13</sub>NO<sub>3</sub>SH<sup>+</sup> 276.0689).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (<i>E</i>)-2′-Chloro-6′-(2-((3-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5g</b>)</h3><div class="NLM_p last">Diethyl (((3-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.42 mL, 0.85 mmol), and 6-chloropyridine-2-carboxaldehyde (0.12 g, 0.85 mmol) gave 0.22 g (94%) of <b>5g</b> as a white powder; <i>R</i><sub>f</sub> = 0.31 (<i>n</i>-hexane/EtOAc 2/1); mp: 101–103 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.98 (t, <i>J</i> = 7.7 Hz, Ar<b>H</b>), 7.84 (d, <i>J</i> = 7.5 Hz, Ar<b>H</b>), 7.73 (d, <i>J</i> = 15.0 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.67 (d, <i>J</i> = 15.1 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.31–7.62(m, 5Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.2, 151.9, 151.0, 141.5, 141.5, 139.8, 133.2, 131.4, 126.5, 125.2, 120.6, 120.1, 112.7, 56.2 (O<b>C</b>H<sub>3</sub>); HPLC purity: 12.6 min, 99.8%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 310.0296 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>13</sub>ClNO<sub>3</sub>SH<sup>+</sup> 310.0299).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>E</i>)-5′-Chloro-2′-(2-((3-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5h</b>)</h3><div class="NLM_p last">Diethyl (((3-methoxyphenyl)sulfonyl)methyl)phosphonate (0.29 g, 0.90 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.50 mL, 0.99 mmol), and 5-chloropyridine-2-carboxaldehyde (0.14 g, 0.99 mmol) gave 0.22 g (78%) of <b>5h</b> as a white powder, <i>R</i><sub>f</sub> = 0.40 (<i>n</i>-hexane/EtOAc 2/1); mp: 92–93 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.60 (dd, <i>J</i> = 1.0, 4.4 Hz, Ar<b>H</b>), 8.07 (dd, <i>J</i> = 1.2, 8.2 Hz, Ar<b>H</b>), 7.93 (d, <i>J</i> = 14.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.80 (d, <i>J</i> = 14.8, (<i>E</i>)-isomeric <b>H</b>), 7.50–7.62 (m, 4Ar<b>H</b>), 7.33 (m, Ar<b>H</b>), 3.87 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.7, 148.6, 147.0, 140.7, 138.4, 135.0, 134.0, 132.2, 131.0, 127.0, 120.2, 119.6, 112.1, 55.8 (O<b>C</b>H<sub>3</sub>); HPLC purity: 15.9 min, 99.5%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 310.0290 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>ClNO<sub>3</sub>SH<sup>+</sup> 310.0299).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>E</i>)-3′-Fluoro-2′-(2-((3-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5i</b>)</h3><div class="NLM_p last">Diethyl (((3-methoxyphenyl)sulfonyl)methyl)phosphonate (0.70 g, 2.17 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (1.20 mL, 2.39 mmol), and 3-fluoropyridine-2-carboxaldehyde (0.31 g, 2.39 mmol) gave 0.50 g (43%) of <b>5i</b> as a white powder; <i>R</i><sub>f</sub> = 0.33 (<i>n</i>-hexane/EtOAc 2/1); mp: 113–114 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.51 (d, <i>J</i> = 4.4 Hz, Ar<b>H</b>), 7.88 (t, <i>J</i> = 9.2 Hz, Ar<b>H</b>), 7.76 (d, <i>J</i> = 15.2 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.71 (d, <i>J</i> = 14.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.49–7.63 (m, 4Ar<b>H</b>), 7.31 (m, Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.7, 158.1 (d, <i>J</i><sub>C–F</sub> = 261.8 Hz), 146.3 (d, <i>J</i><sub>C–F</sub> = 4.7 Hz), 140.8, 138.5 (d, <i>J</i><sub>C–F</sub> = 10.9 Hz), 132.8 (d, <i>J</i><sub>C–F</sub> = 4.2 Hz), 132.7, 131.0, 127.9 (d, <i>J</i><sub>C–F</sub> = 4.6 Hz), 124.8 (d, <i>J</i><sub>C–F</sub> = 18.8 Hz), 120.2, 119.6, 112.1, 55.7 (O<b>C</b>H<sub>3</sub>); HPLC purity: 14.9 min, 99.7%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 294.0590 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>FNO<sub>3</sub>SH<sup>+</sup> 294.0595).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>E</i>)-3′-Chloro-2′-(2-((3-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5j</b>)</h3><div class="NLM_p last">Diethyl (((3-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.42 mL, 0.85 mmol), and 3-chloropyridine-2-carboxaldehyde (0.12 g, 0.85 mmol) gave 0.20 g (84%) of <b>5j</b> as pale yellow powder; <i>R</i><sub>f</sub> = 0.28 (<i>n</i>-hexane/EtOAc 2/1); mp: 89–90 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.59–8.61 (m, Ar<b>H</b>), 8.07 (dd, <i>J</i> = 1.2, 8.2 Hz, Ar<b>H</b>), 7.93 (d, <i>J</i> = 14.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.80 (d, <i>J</i> = 14.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.50–7.62 (m, 4Ar<b>H</b>), 7.32–7.34 (m, Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.2, 149.1, 147.5, 141.2, 138.9, 135.5, 134.5, 132.7, 131.5, 127.5, 120.8, 120.1, 112.6, 56.3 (O<b>C</b>H<sub>3</sub>); HPLC purity: 11.3 min, 99.5%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 310.0292 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>ClNO<sub>3</sub>SH<sup>+</sup> 310.0299).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>E</i>)-2′-(2-((4-Methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5k</b>)</h3><div class="NLM_p last">Diethyl (((4-methoxyphenyl)sulfonyl)methyl)phosphonate (0.50 g, 1.55 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.85 mL, 1.71 mmol), and 2-pyridinecarboxaldehyde (0.19 mL, 1.71 mmol) gave 0.36 g (85%) of <b>5k</b> as a pale yellow solid; <i>R</i><sub>f</sub> = 0.45 (<i>n</i>-hexane/EtOAc 1/2); mp: 97–98 °C; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.61–8.62 (m, Ar<b>H</b>), 7.86–7.92 (m, 3Ar<b>H</b>), 7.78–7.81 (m, Ar<b>H</b>), 7.65 (d, <i>J</i> = 15.1 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.60 (d, <i>J</i> = 15.1 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.42–7.46 (m, Ar<b>H</b>), 7.16–7.21 (m, 2Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.7, 151.2, 150.3, 139.5, 137.0, 132.4, 131.7, 130.1, 125.3, 124.9, 114.6, 55.7 (O<b>C</b>H<sub>3</sub>); HPLC purity: 12.6 min, 99.0%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 276.0687 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>13</sub>NO<sub>3</sub>SH<sup>+</sup> 276.0689).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>E</i>)-2′-Chloro-6′-(2-((4-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5l</b>)</h3><div class="NLM_p last">Diethyl (((4-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.42 mL, 0.85 mmol), and 6-chloropyridine-2-carboxaldehyde (0.12 g, 0.85 mmol) gave 0.16 g (66%) of <b>5l</b> as a white powder; <i>R</i><sub>f</sub> = 0.28 (<i>n</i>-hexane/EtOAc 2/1); mp: 118–120 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.96 (t, <i>J</i> = 7.8 Hz, Ar<b>H</b>), 7.89 (d, <i>J</i> = 8.9 Hz, 2Ar<b>H</b>), 7.81 (d, <i>J</i> = 7.4 Hz, Ar<b>H</b>), 7.64 (d, <i>J</i> = 15.1 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.56–7.60 (m, Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 7.18 (d, <i>J</i> = 8.9 Hz, 2Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.0, 152.0, 151.0, 141.5, 138.6, 134.0, 131.6, 130.4, 126.3, 125.0, 115.5, 56.3 (O<b>C</b>H<sub>3</sub>); HPLC purity: 13.3 min, 98.0%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 310.0296 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>ClNO<sub>3</sub>SH<sup>+</sup> 310.0299).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>E</i>)-5′-Chloro-2′-(2-((4-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5m</b>)</h3><div class="NLM_p last">Diethyl (((4-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.42 mL, 0.85 mmol), and 5-chloropyridine-2-carboxaldehyde (0.12 g, 0.85 mmol) gave 0.14 g (58%) of <b>5m</b> as a white solid; <i>R</i><sub>f</sub> = 0.40 (<i>n</i>-hexane/EtOAc 2/1); mp: 138.0–139.7 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (d, <i>J</i> = 2.4 Hz, Ar<b>H</b>), 8.05 (dd, <i>J</i> = 8.9 Hz, Ar<b>H</b>), 7.85–7.89 (m, 3Ar<b>H</b>), 7.67 (d, <i>J</i> = 15.1 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.62 (d, <i>J</i> = 15.1 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.18 (d, <i>J</i> = 8.9 Hz, Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.9, 149.9, 149.2, 139.1, 137.6, 133.3, 132.9, 131.7, 130.3, 126.8, 115.4, 56.3 (O<b>C</b>H<sub>3</sub>); HPLC purity: 11.7 min, 99.0%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 310.0293 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>ClNO<sub>3</sub>SH<sup>+</sup> 310.0299).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>E</i>)-3′-Fluoro-2′-(2-((4-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5n</b>)</h3><div class="NLM_p last">Diethyl (((4-methoxyphenyl)sulfonyl)methyl)phosphonate (0.75 g, 2.33 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (1.28 mL, 2.56 mmol), and 3-fluoropyridine-2-carboxaldehyde (0.32 g, 2.56 mmol) gave 0.46 g (68%) of <b>5n</b> as a pale yellow powder; <i>R</i><sub>f</sub> = 0.28 (<i>n</i>-hexane/EtOAc 1/1); mp: 84–85 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.50 (d, <i>J</i> = 4.4 Hz, Ar<b>H</b>), 7.85–7.92 (m, 3Ar<b>H</b>), 7.66 (s, (<i>E</i>)-isomeric 2<b>H</b>), 7.57–7.61 (m, Ar<b>H</b>), 7.17–7.26 (m, 2Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.8, 158.3 (d, <i>J</i><sub>C–F</sub> = 263.8 Hz), 145.9 (d, <i>J</i><sub>C–F</sub> = 5.0 Hz), 139.8 (d, <i>J</i><sub>C–F</sub> = 11.2 Hz), 133.9 (d, <i>J</i><sub>C–F</sub> = 4.4 Hz), 132.0, 131.5, 130.2, 126.5 (d, <i>J</i><sub>C–F</sub> = 4.2 Hz), 124.1 (d, <i>J</i><sub>C–F</sub> = 19.0 Hz), 114.7, 55.7 (O<b>C</b>H<sub>3</sub>); HPLC purity: 8.5 min, 98.9%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 294.0588 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>FNO<sub>3</sub>SH<sup>+</sup> 294.0595).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>E</i>)-3′-Chloro-2′-(2-((4-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>5o</b>)</h3><div class="NLM_p last">Diethyl (((4-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.42 mL, 0.85 mmol), and 3-chloropyridine-2-carboxaldehyde (0.12 g, 0.85 mmol) gave 0.14 g (58%) of <b>5o</b> as a white powder; <i>R</i><sub>f</sub> = 0.24 (<i>n</i>-hexane/EtOAc 2/1); mp: 134–135 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.59 (d, <i>J</i> = 3.6 Hz, Ar<b>H</b>), 8.06 (dd, <i>J</i> = 1.1, 8.2 Hz, Ar<b>H</b>) 7.92 (d, <i>J</i> = 8.9 Hz, 2Ar<b>H</b>), 7.87 (d, <i>J</i> = 14.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.70 (d, <i>J</i> = 14.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.50–7.53 (m, Ar<b>H</b>), 7.18 (d, <i>J</i> = 8.9 Hz, 2Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.0, 149.0, 147.6, 138.9, 135.3, 134.3, 132.5, 131.3, 130.5, 127.4, 115.5, 56.4 (O<b>C</b>H<sub>3</sub>); HPLC purity: 12.2 min, 98.0%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 310.0294 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>ClNO<sub>3</sub>SH<sup>+</sup> 310.0299).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>E</i>)-3′-(2-((2-Methoxyphenyl)sulfonyl)vinyl)pyridine (<b>6a</b>)</h3><div class="NLM_p last">Diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.43 mL, 0.85 mmol), and 3-pyridinecarboxaldehyde (0.09 g, 0.85 mmol) gave 0.22 g (97%) of <b>6a</b> as a white solid; <i>R</i><sub>f</sub> = 0.25 (<i>n</i>-hexane/EtOAc 1/3); mp: 128–129 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.74 (d, <i>J</i> = 2.1 Hz, Ar<b>H</b>), 8.63 (dd, <i>J</i> = 1.6, 4.8 Hz, Ar<b>H</b>), 8.03 (dd, <i>J</i> = 4.7, 7.8 Hz, Ar<b>H</b>), 7.81 (dd, <i>J</i> = 1.9, 7.9 Hz, Ar<b>H</b>), 7.69 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.59 (m, Ar<b>H</b>), 7.35 (m, Ar<b>H</b>), 7.23 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.12 (t, <i>J</i> = 8.0 Hz, Ar<b>H</b>), 7.03 (d, <i>J</i> = 8.3 Hz, Ar<b>H</b>), 3.98 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 157.5, 151.7, 150.0, 139.7, 135.8, 134.9, 129.7, 129.4, 128.9, 128.3, 123.9, 121.0, 112.6, 56.5; HPLC purity: 4.4 min, 98.0%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 276.0687 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>13</sub>NO<sub>3</sub>SH<sup>+</sup> 276.0689).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>E</i>)-2′-Methoxy-3′-(2-((2-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>6b</b>)</h3><div class="NLM_p last">Diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.43 mL, 0.85 mmol), and 2-methoxypyridine-3-carboxaldehyde (0.12 g, 0.85 mmol) gave 0.17 g (72%) of <b>6b</b> as a white powder; <i>R</i><sub>f</sub> = 0.26 (<i>n</i>-hexane/EtOAc 1/2); mp: 123–125 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.02–8.13 (m, 2Ar<b>H</b>), 7.74 (d, <i>J</i> = 15.5 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.51–7.69 (m, Ar<b>H</b>), 7.56 (td, <i>J</i> = 1.6, 7.6 Hz, Ar<b>H</b>), 7.41 (d, <i>J</i> = 15.5 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.10 (t, <i>J</i> = 7.6 Hz, Ar<b>H</b>), 7.01 (d, <i>J</i> = 8.3 Hz, Ar<b>H</b>), 6.74–6.95 (m, Ar<b>H</b>), 4.03 (s, OC<b>H</b><sub><b>3</b></sub>), 3.97 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 162.2, 157.5, 149.0, 139.5, 138.1, 135.5, 129.7, 129.6, 128.8, 120.8, 117.2, 116.6, 112.5, 56.3, 53.9; HPLC purity: 8.2 min, 97.1%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 306.0786 [M + H]<sup>+</sup> (calcd for C<sub>15</sub>H<sub>15</sub>NO<sub>4</sub>SH<sup>+</sup> 306.0795).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>E</i>)-2′-Chloro-3′-(2-((2-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>6c</b>)</h3><div class="NLM_p last">Diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.43 mL, 0.85 mmol), and 2-chloropyridine-3-carboxaldehyde (0.12 g, 0.85 mmol) gave 0.16 g (68%) of <b>6c</b> as a white powder; <i>R</i><sub>f</sub> = 0.25 (<i>n</i>-hexane/EtOAc 1/1); mp: 154–155 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.40 (d, <i>J</i> = 1.2 Hz, Ar<b>H</b>), 7.98–8.02 (m, Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 7.87 (dd, <i>J</i> = 1.7, 7.7 Hz, Ar<b>H</b>), 7.59 (td, <i>J</i> = 1.6, 8.4 Hz, Ar<b>H</b>), 7.30 (m, Ar<b>H</b>), 7.08–7.16 (m, Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 7.02 (d, <i>J</i> = 8.4 Hz, Ar<b>H</b>), 3.97 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 157.6, 151.5, 151.2, 138.0, 136.9, 136.0, 131.9, 130.0, 128.3, 127.7, 123.0, 121.0, 112.6, 56.4; HPLC purity: 5.4 min, 99.8%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 310.0292 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>ClNO<sub>3</sub>SH<sup>+</sup> 310.0299).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>E</i>)-2′,6′-Dichloro-3′-(2-((2-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>6d</b>)</h3><div class="NLM_p last">Diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.43 mL, 0.85 mmol), and 2,6-dichloropyridine-3-carboxaldehyde (0.16 g, 0.83 mmol) gave 0.25 g (94%) of <b>6d</b> as a white solid; <i>R</i><sub>f</sub> = 0.45 (<i>n</i>-hexane/EtOAc 1/1); mp: 136–138 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.26 (d, <i>J</i> = 5.3 Hz, Ar<b>H</b>), 8.05 (dd, <i>J</i> = 1.5, 7.9 Hz, Ar<b>H</b>), 7.82 (d, <i>J</i> = 15.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.62 (m, Ar<b>H</b>), 7.47 (d, <i>J</i> = 15.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.37 (d, <i>J</i> = 5.3 Hz, Ar<b>H</b>), 7.13 (t, <i>J</i> = 7.6 Hz, Ar<b>H</b>), 7.04 (d, <i>J</i> = 8.4 Hz, Ar<b>H</b>), 3.98 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 157.6, 151.8, 149.5, 145.6, 136.8, 136.1, 134.3, 130.0, 127.6, 127.4, 124.7, 121.0, 112.5, 56.4; HPLC purity: 4.6 min, 99.0%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 343.9906 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>11</sub>Cl<sub>2</sub>NO<sub>3</sub>SH<sup>+</sup> 343.9909).</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>E</i>)-3′-(2-((3-Methoxyphenyl)sulfonyl)vinyl)pyridine (<b>6e</b>)</h3><div class="NLM_p last">Diethyl (((3-methoxyphenyl)sulfonyl)methyl)phosphonate (0.50 g, 1.55 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.85 mL, 1.71 mmol), and 3-pyridinecarboxaldehyde (0.18 g, 1.71 mmol) gave 0.42 g (85%) of <b>6e</b> as a pale yellow oil; <i>R</i><sub>f</sub> = 0.45 (<i>n</i>-hexane/EtOAc 1/3); mp: 52–53 °C; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.91 (d, <i>J</i> = 1.8 Hz, Ar<b>H</b>), 8.61 (d, <i>J</i> = 4.7 Hz, Ar<b>H</b>), 8.18 (d, <i>J</i> = 8.1 Hz, Ar<b>H</b>), 7.81 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.71 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.59 (m, Ar<b>H</b>), 7.45–7.51 (m, 2Ar<b>H</b>), 7.41 (m, Ar<b>H</b>), 7.31 (m, Ar<b>H</b>), 3.85 (s, C<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.2, 151.8, 150.0, 141.3, 138.7, 134.8, 130.6, 129.6, 128.3, 123.9, 120.2, 120.0, 112.2, 55.8; HPLC purity: 11.2 min, 96.4%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 276.0685 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>13</sub>NO<sub>3</sub>SH<sup>+</sup> 276.0689).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>E</i>)-2′-Chloro-3′-(2-((3-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>6f</b>)</h3><div class="NLM_p last">Diethyl (((3-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.43 mL, 0.85 mmol), and 2-chloropyridine-3-carboxaldehyde (0.12 g, 0.85 mmol) gave 0.19 g (78%) of <b>6f</b> as a pale yellow powder; <i>R</i><sub>f</sub> = 0.34 (<i>n</i>-hexane/EtOAc 1/1); mp: 101–103 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.49 (dd, <i>J</i> = 1.7, 4.7 Hz, Ar<b>H</b>), 8.35 (dd, <i>J</i> = 1.7, 8.0 Hz, Ar<b>H</b>), 7.88 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.78 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.61 (t, <i>J</i> = 7.9 Hz, Ar<b>H</b>), 7.51–7.54 (m, 2Ar<b>H</b>), 7.41–7.44 (m, Ar<b>H</b>), 7.33 (dd, <i>J</i> = 1.9, 8.0 Hz, Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.2, 152.2, 150.7, 141.4, 138.4, 136.2, 133.3, 131.6, 127.5, 124.2, 120.5, 119.9, 112.5, 56.3; HPLC purity: 5.0 min, 98.8%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 310.0294 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>ClNO<sub>3</sub>SH<sup>+</sup> 310.0299).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (<i>E</i>)-3′-(2-((4-Methoxyphenyl)sulfonyl)vinyl)pyridine (<b>6g</b>)</h3><div class="NLM_p last">Diethyl (((4-methoxyphenyl)sulfonyl)methyl)phosphonate (0.30 g, 0.93 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.51 mL, 1.02 mmol), and 3-pyridinecarboxaldehyde (0.11 g, 1.02 mmol) gave 0.23 g (89%) of <b>6g</b> as a white powder; <i>R</i><sub>f</sub> = 0.26 (<i>n</i>-hexane/EtOAc 1/3); mp: 111–112 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.90 (d, <i>J</i> = 1.7 Hz, Ar<b>H</b>), 8.61 (dd, <i>J</i> = 1.4, 4.7 Hz, Ar<b>H</b>), 8.16–8.18 (m, Ar<b>H</b>), 7.85 (d, <i>J</i> = 8.9 Hz, 2Ar<b>H</b>), 7.74 (d, <i>J</i> = 15.5 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.65 (d, <i>J</i> = 15.5 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.44–7.47 (m, Ar<b>H</b>), 7.19 (d, <i>J</i> = 8.9 Hz, 2Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.8, 151.9, 150.7, 138.2, 135.7, 132.2, 131.2, 130.1, 129.0, 124.4, 115.4, 56.3; HPLC purity: 4.6 min, 99.7%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 276.0687 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>13</sub>NO<sub>3</sub>SH<sup>+</sup> 276.0689).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>E</i>)-2′-Chloro-3′-(2-((4-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>6h</b>)</h3><div class="NLM_p last">Diethyl (((4-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.43 mL, 0.85 mmol), and 2-chloropyridine-3-carboxaldehyde (0.12 g, 0.85 mmol) gave 0.18 g (77%) of <b>6h</b> as a white solid; <i>R</i><sub>f</sub> = 0.28 (<i>n</i>-hexane/EtOAc 1/1); mp: 146–148 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (dd, <i>J</i> = 1.3, 4.4 Hz, Ar<b>H</b>), 8.33 (m, Ar<b>H</b>), 7.87 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 7.81 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.73 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.49–7.52 (m, Ar<b>H</b>), 7.19 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 3.87 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.0, 152.0, 150.7, 138.3, 134.9, 134.1, 131.5, 130.3, 127.6, 124.2, 115.5, 56.3; HPLC purity: 5.4 min, 99.2%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 310.0293 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>ClNO<sub>3</sub>SH<sup>+</sup> 310.0299).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>E</i>)-2′-Chloro-5′-(2-((4-methoxyphenyl)sulfonyl)vinyl)pyridine (<b>6i</b>)</h3><div class="NLM_p last">Diethyl (((4-methoxyphenyl)sulfonyl)methyl)phosphonate (0.50 g, 1.55 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.85 mL, 1.71 mmol), and 2-fluoropyridine-5-carboxaldehyde (0.21 g, 1.71 mmol) gave 0.32 g (71%) of <b>6i</b> as a white solid; <i>R</i><sub>f</sub> = 0.24 (<i>n</i>-hexane/EtOAc 3/1); mp: 124–125 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.62 (d, <i>J</i> = 1.8 Hz, Ar<b>H</b>), 8.40 (td, <i>J</i> = 2.3, 8.3 Hz, Ar<b>H</b>), 7.84 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 7.71 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.67 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.28–7.30 (m, Ar<b>H</b>), 7.19 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.5 (d, <i>J</i><sub>C–F</sub> = 243.5 Hz), 163.9, 148.5 (d, <i>J</i><sub>C–F</sub> = 15.6 Hz), 139.7 (d, <i>J</i><sub>C–F</sub> = 8.7 Hz), 136.1, 131.4, 130.1, 130.0, 126.7 (d, <i>J</i><sub>C–F</sub> = 4.8 Hz), 114.8, 110.3 (d, <i>J</i><sub>C–F</sub> = 37.6 Hz), 55.8; HPLC purity: 4.9 min, 99.1%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 294.0593 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>12</sub>FNO<sub>3</sub>SH<sup>+</sup> 294.0595).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>E</i>)-4′-(2-((2-Methoxyphenyl)sulfonyl)vinyl)pyridine (<b>7a</b>)</h3><div class="NLM_p last">Diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.43 mL, 0.85 mmol), and 4-pyridinecarboxaldehyde (0.09 g, 0.85 mmol) gave 0.23 g (99%) of <b>7a</b> as a pale gray solid; <i>R</i><sub>f</sub> = 0.20 (<i>n</i>-hexane/EtOAc 1/3); mp: 107–108 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.67 (d, <i>J</i> = 6.0 Hz, 2Ar<b>H</b>), 8.02 (dd, <i>J</i> = 1.5, 7.8 Hz, Ar<b>H</b>), 7.58–7.64 (m, 2Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 7.34 (d, <i>J</i> = 6.0 Hz, 2Ar<b>H</b>), 7.31 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.13 (t, <i>J</i> = 7.7 Hz, Ar<b>H</b>), 7.03 (d, <i>J</i> = 8.3 Hz, Ar<b>H</b>), 3.98 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 157.6, 150.9, 140.3, 140.2, 136.0, 132.0, 129.9, 127.9, 122.2, 121.0, 112.6, 56.5; HPLC purity: 4.8 min, 98.8%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 276.0687 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>13</sub>NO<sub>3</sub>SH<sup>+</sup> 276.0689).</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>E</i>)-4′-(2-((3-Methoxyphenyl)sulfonyl)vinyl)pyridine (<b>7b</b>)</h3><div class="NLM_p last">Diethyl (((3-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.43 mL, 0.85 mmol), and 4-pyridinecarboxaldehyde (0.09 g, 0.85 mmol) gave 0.12 g (56%) of <b>7b</b> as a black oil; <i>R</i><sub>f</sub> = 0.31 (<i>n</i>-hexane/EtOAc 1/1); <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66 (dd, <i>J</i> = 1.6, 4.5 Hz, Ar<b>H</b>), 7.94 (d, <i>J</i> = 15.5 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.58–7.71 (m, 4Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 7.49–7.53 (m, Ar<b>H</b>), 7.41–7.43 (m, Ar<b>H</b>), 7.30–7.34 (m, Ar<b>H</b>), 3.86 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.2, 150.8, 140.9, 139.6, 139.3, 132.2, 130.7, 122.1, 120.3, 120.1, 112.4, 55.8; HPLC purity: 4.6 min, 99.0%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 276.0687 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>13</sub>NO<sub>3</sub>SH<sup>+</sup> 276.0689).</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (<i>E</i>)-4′-(2-((4-Methoxyphenyl)sulfonyl)vinyl)-3-fluorobenzene (<b>7c</b>)</h3><div class="NLM_p last">Diethyl (((4-methoxyphenyl)sulfonyl)methyl)phosphonate (0.25 g, 0.77 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.43 mL, 0.85 mmol), and 4-pyridinecarboxaldehyde (0.09 g, 0.85 mmol) gave 0.12 g (56%) of <b>7c</b> as a orange solid; <i>R</i><sub>f</sub> = 0.32 (<i>n</i>-hexane/EtOAc 1/3); mp: 97–99 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.65 (d, <i>J</i> = 4.8 Hz, 2Ar<b>H</b>), 7.86–7.90 (m, 2Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 7.70 (d, <i>J</i> = 4.9 Hz, 2Ar<b>H</b>), 7.60 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.20 (d, <i>J</i> = 8.4 Hz, 2Ar<b>H</b>), 3.87 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.9, 150.9, 140.2, 138.7, 133.9, 131.7, 130.3, 123.0, 115.5, 56.3; HPLC purity: 4.6 min, 98.7%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 276.0687 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>13</sub>NO<sub>3</sub>SH<sup>+</sup> 276.0689).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>E</i>)-5′-(2-((2-Methoxyphenyl)sulfonyl)vinyl)pyrimidine (<b>8a</b>)</h3><div class="NLM_p last">Diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate (0.70 g, 2.17 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (1.20 mL, 2.39 mmol), and pyrimidine-5-carboxaldehyde (0.26 g, 2.39 mmol) gave 0.43 g (72%) of <b>8a</b> as a white powder; <i>R</i><sub>f</sub> = 0.24 (<i>n</i>-hexane/EtOAc 1/2); mp: 170–171 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.22 (s, Ar<b>H</b>), 8.87 (s, 2Ar<b>H</b>), 8.03 (dd, <i>J</i> = 1.6, 7.8 Hz, Ar<b>H</b>), 7.65 (d, <i>J</i> = 15.7 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.60–7.64 (m, Ar<b>H</b>), 7.34 (d, <i>J</i> = 15.7 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.14 (t, <i>J</i> = 7.8 Hz, Ar<b>H</b>), 7.05 (d, <i>J</i> = 8.3 Hz, Ar<b>H</b>), 3.99 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.7, 157.4, 155.9, 136.0, 135.7, 131.3, 129.8, 127.6, 127.1, 121.0, 112.5, 56.4; HPLC purity: 4.3 min, 99.3%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 277.0642 [M + H]<sup>+</sup> (calcd for C<sub>13</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub>SH<sup>+</sup> 277.0641).</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>E</i>)-4′,6′-Dichloro-5′-(2-((2-methoxyphenyl)sulfonyl)vinyl)pyrimidine (<b>8b</b>)</h3><div class="NLM_p last">Diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate (0.35 g, 1.03 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.57 mL, 1.13 mmol), and 4,6-dichloropyrimidine-5-carboxaldehyde (0.20 g, 1.13 mmol) gave 0.21 g (68%) of <b>8b</b> as a white powder; <i>R</i><sub>f</sub> = 0.34 (<i>n</i>-hexane/EtOAc 1/2); mp: 150–151 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (s, Ar<b>H</b>), 8.04 (dd, <i>J</i> = 1.6, 7.8 Hz, Ar<b>H</b>), 7.78 (d, <i>J</i> = 15.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.61–7.65 (m, Ar<b>H</b>), 7.55 (d, <i>J</i> = 15.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.15 (t, <i>J</i> = 7.6 Hz, Ar<b>H</b>), 7.05 (d, <i>J</i> = 8.3 Hz, Ar<b>H</b>), 3.98 (s,OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.2, 157.6, 157.2, 138.1, 136.3, 132.1, 130.1, 127.2, 126.1, 121.1, 112.5, 56.5 (O<b>C</b>H<sub>3</sub>); HPLC purity: 5.0 min, 98.3%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 344.9867 [M + H]<sup>+</sup> (calcd for C<sub>13</sub>H<sub>10</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub>SH<sup>+</sup> 344.9862).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>E</i>)-5′-(2-((3-Methoxyphenyl)sulfonyl)vinyl)pyrimidine (<b>8c</b>)</h3><div class="NLM_p last">Diethyl (((3-methoxyphenyl)sulfonyl)methyl)phosphonate (0.30 g, 0.93 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.51 mL, 1.02 mmol), and pyrimidine-5-carboxaldehyde (0.11 g, 1.02 mmol) gave 0.10 g (37%) of <b>8c</b> as a white powder; <i>R</i><sub>f</sub> = 0.46 (<i>n</i>-hexane/EtOAc 1/2); mp: 123–125 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.21 (s, Ar<b>H</b>), 8.89 (s, 2Ar<b>H</b>), 7.88 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 7.58 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.02–7.06 (m, 2Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 3.89 (OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.3, 159.9, 156.0, 140.7, 134.9, 131.6, 130.7, 126.7, 120.4, 120.1, 112.4, 55.8; HPLC purity: 4.5 min, 97.2%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 277.0640 [M + H]<sup>+</sup> (calcd for C<sub>13</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub>SH<sup>+</sup> 277.0641).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>E</i>)-5′-(2-((4-Methoxyphenyl)sulfonyl)vinyl)pyrimidine (<b>8d</b>)</h3><div class="NLM_p last">Diethyl (((4-methoxyphenyl)sulfonyl)methyl)phosphonate (0.50 g, 1.55 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.85 mL, 1.71 mmol), and pyrimidine-5-carboxaldehyde (0.18 mL, 1.71 mmol) gave 0.37 g (86%) of <b>8d</b> as a white powder; <i>R</i><sub>f</sub> = 0.36 (<i>n</i>-hexane/EtOAc 1/2); mp: 194–195 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.21 (s, Ar<b>H</b>), 8.89 (s, 2Ar<b>H</b>), 7.88 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 7.58 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.04 (m, 2Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 3.89 (OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.1, 159.7, 155.9, 133.8, 132.3, 130.9, 130.3, 126.8, 114.9, 55.8; HPLC purity: 4.3 min, 99.3%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 277.0640 [M + H]<sup>+</sup> (calcd for C<sub>13</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub>SH<sup>+</sup> 277.0641).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>E</i>)-2-((2′-Methoxystyryl)sulfonyl)pyridine (<b>11a</b>)</h3><div class="NLM_p last">Diethyl ((pyridine-2-ylsulfonyl)methyl)phosphonate (0.30 g, 1.02 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.56 mL, 1.12 mmol), and 2-methoxybenzaldehyde (0.15 g, 1.12 mmol) gave 0.22 g (75%) of <b>11a</b> as a white powder; <i>R</i><sub>f</sub> = 0.40 (<i>n</i>-hexane/EtOAc 1/1); mp: 74–75 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (d, <i>J</i> = 4.4 Hz, Ar<b>H</b>), 7.12–8.19 (m, 2Ar<b>H</b>), 7.90 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.72–7.78 (m, 2Ar<b>H</b>), 7.54 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.48 (m, Ar<b>H</b>), 7.13 (d, <i>J</i> = 8.4 Hz, Ar<b>H</b>), 7.01 (t, <i>J</i> = 7.5 Hz, Ar<b>H</b>), 3.90 (s, OC<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.0, 158.9, 150.4, 141.1, 138.1, 132.7, 131.1, 126.9, 125.3, 121.9, 121.3, 120.8, 111.3, 55.5; HPLC purity: 4.6 min, 99.8%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 276.0685 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>13</sub>NO<sub>3</sub>SH<sup>+</sup> 276.0689).</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>E</i>)-2-((2′-Fluorostyryl)sulfonyl)pyridine (<b>11b</b>)</h3><div class="NLM_p last">Diethyl ((pyridine-2-ylsulfonyl)methyl)phosphonate (0.30 g, 1.02 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.56 mL, 1.12 mmol), and 2-fluorobenzaldehyde (0.14 g, 1.12 mmol) gave 0.25 g (92%) of <b>11b</b> as a white powder; <i>R</i><sub>f</sub> = 0.30 (<i>n</i>-hexane/EtOAc 3/2); mp: 95–96 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.80 (d, <i>J</i> = 4.5 Hz, Ar<b>H</b>), 8.15–8.21 (m, 2Ar<b>H</b>), 7.95 (t, <i>J</i> = 7.4 Hz, Ar<b>H</b>), 7.78 (d, <i>J</i> = 15.5 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.74–7.78 (m, Ar<b>H</b>), 7.69 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.56 (m, Ar<b>H</b>), 7.28–7.38 (m, 2Ar<b>H</b>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.6 (d, <i>J</i><sub>C–F</sub> = 254.4 Hz), 158.4, 150.4, 138.3, 138.1 (d, <i>J</i><sub>C–F</sub> = 2.0 Hz), 133.0 (d, <i>J</i><sub>C–F</sub> = 8.9 Hz), 130.5 (d, <i>J</i><sub>C–F</sub> = 2.5 Hz), 127.5 (d, <i>J</i><sub>C–F</sub> = 8.6 Hz), 127.2, 124.7 (d, <i>J</i><sub>C–F</sub> = 3.6 Hz), 120.0, 120.6 (d, <i>J</i><sub>C–F</sub> = 11.4 Hz), 116.4 (d, <i>J</i><sub>C–F</sub> = 21.4 Hz); HPLC purity: 11.2 min, 96.8%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 264.0486 [M + H]<sup>+</sup> (calcd for C<sub>13</sub>H<sub>10</sub>FNO<sub>2</sub>SH<sup>+</sup> 264.0489).</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>E</i>)-2-((2′-Fluorostyryl)sulfonyl)-3-(trifluoromethyl)pyridine (<b>11c</b>)</h3><div class="NLM_p last">Diethyl (((3-(trifluoromethyl)pyridin-2-yl)sulfonyl)methyl)phosphonate (0.40 g, 1.11 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.61 mL, 1.22 mmol), and 2-fluorobenzaldehyde (0.15 g, 1.12 mmol) gave 0.28 g (70%) of <b>11c</b> as a white powder; <i>R</i><sub>f</sub> = 0.39 (<i>n</i>-hexane/EtOAc 1/1); mp: 130–131 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.99 (d, <i>J</i> = 4.2 Hz, Ar<b>H</b>), 8.57 (d, <i>J</i> = 7.0 Hz, Ar<b>H</b>), 7.96–8.03 (m, 2Ar<b>H</b>), 7.90 (d, <i>J</i> = 15.7 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.74 (d, <i>J</i> = 15.7 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.56–7.62 (m, Ar<b>H</b>), 7.32–7.40 (m, 2Ar<b>H</b>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.2 (d, <i>J</i><sub>C–F</sub> = 251.3 Hz), 156.8, 152.7, 138.6 (q, <i>J</i><sub>C–F</sub> = 5.4, 10.9 Hz), 136.1 (d, <i>J</i><sub>C–F</sub> = 4.0 Hz), 134.2 (d, <i>J</i><sub>C–F</sub> = 9.1 Hz), 130.6 (d, <i>J</i><sub>C–F</sub> = 1.6 Hz), 129.2 (d, <i>J</i><sub>C–F</sub> = 5.8 Hz), 128.4, 125.7 (d, <i>J</i><sub>C–F</sub> = 3.4 Hz), 123.2 (q, <i>J</i><sub>C–F</sub> = 35.2 Hz), 122.6 (q, <i>J</i><sub>C–F</sub> = 272.1 Hz), 120.4 (q, <i>J</i><sub>C–F</sub> = 43.6 Hz), 116.7 (d, <i>J</i><sub>C–F</sub> = 21.3 Hz); HPLC purity: 16.4 min, 98.1%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 332.0359 [M + H]<sup>+</sup> (calcd for C<sub>14</sub>H<sub>9</sub>F<sub>4</sub>NO<sub>2</sub>SH<sup>+</sup> 332.0363).</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>E</i>)-4-((2′-Fluorostyryl)sulfonyl)pyridine (<b>11d</b>)</h3><div class="NLM_p last">Diethyl ((pyridine-4-ylsulfonyl)methyl)phosphonate (0.30 g, 0.83 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.46 mL, 0.91 mmol), and 2-fluorobenzaldehyde (0.12 g, 0.91 mmol) gave 0.23 g (71%) of <b>11d</b> as a white powder; <i>R</i><sub>f</sub> = 0.35 (<i>n</i>-hexane/EtOAc 1/1); mp: 68–69 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.93 (d, <i>J</i> = 6.0 Hz, 2Ar<b>H</b>), 7.88–7.93 (m, 3Ar<b>H</b>), 7.80 (d, <i>J</i> = 15.5 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.73 (d, <i>J</i> = 15.5 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.55–7.60 (m, Ar<b>H</b>), 7.29–7.38 (m, 2Ar<b>H</b>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.7 (d, <i>J</i><sub>C–F</sub> = 254.6 Hz), 151.3, 148.7, 138.2, 133.4 (d, <i>J</i><sub>C–F</sub> = 8.9 Hz), 130.7 (d, <i>J</i><sub>C–F</sub> = 2.2 Hz), 128.6 (d, <i>J</i><sub>C–F</sub> = 9.0 Hz), 124.8 (d, <i>J</i> = 3.5 Hz), 120.7, 120.1 (d, <i>J</i><sub>C–F</sub> = 11.3 Hz), 116.5 (d, <i>J</i><sub>C–F</sub> = 21.6 Hz); HPLC purity: 9.8 min, 97.5%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 264.0484 [M + H]<sup>+</sup> (calcd for C<sub>13</sub>H<sub>10</sub>FNO<sub>2</sub>SH<sup>+</sup> 264.0489).</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>E</i>)-3′-(Fluoro-2-(2-((3-trifluoromethyl)pyridin-2-yl)sulfonyl)vinyl)pyridine (<b>12</b>)</h3><div class="NLM_p last">Diethyl (((3-(trifluoromethyl)pyridin-2-yl)sulfonyl)methyl)phosphonate (0.30 g, 0.83 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.46 mL, 0.91 mmol), and 3-fluoropyridine-2-carboxaldehyde (0.11 g, 0.91 mmol) gave 0.26 g (75%) of <b>12</b> as a white powder; <i>R</i><sub>f</sub> = 0.40 (<i>n</i>-hexane/EtOAc 1/1); mp: 126–127 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.99 (d, <i>J</i> = 4.5 Hz, Ar<b>H</b>), 8.58–8.60 (m, 2Ar<b>H</b>), 7.90–8.03 (m, 2Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 7.79 (d, <i>J</i> = 15.2 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.64–7.68 (m, Ar<b>H</b>); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.8 (d, <i>J</i><sub>C–F</sub> = 261.9 Hz), 156.0, 152.3, 146.5 (d, <i>J</i><sub>C–F</sub> = 4.7 Hz), 138.3, 138.2 (d, <i>J</i><sub>C–F</sub> = 21.9 Hz), 134.1, 131.3 (d, <i>J</i><sub>C–F</sub> = 4.1 Hz), 128.2 (d, <i>J</i><sub>C–F</sub> = 4.7 Hz), 128.0, 127.5, 124.9 (d, <i>J</i><sub>C–F</sub> = 18.8 Hz), 122.7 (d, <i>J</i><sub>C–F</sub> = 35.2 Hz); HPLC purity: 13.3 min, 98.0%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 333.0310 [M + H]<sup>+</sup> (calcd for C<sub>13</sub>H<sub>8</sub>F<sub>4</sub>N<sub>2</sub>O<sub>2</sub>SH<sup>+</sup> 333.0315).</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>E</i>)-4-(3-(4-((2-(Pyridin-2′-yl)vinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>17a</b>)</h3><div class="NLM_p last">Diethyl (((2-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (1.10 g, 2.66 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (1.46 mL, 2.93 mmol), 2-pyridinecarboxaldehyde (0.31 g, 2.93 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.91 g (87%) of <b>17a</b> as a white powder; <i>R</i><sub>f</sub> = 0.29 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 19/1); mp: 227–229 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.19 (s, <b>H</b>Cl), 8.67 (d, <i>J</i> = 4.6 Hz, Ar<b>H</b>), 7.89–7.98 (m, 3Ar<b>H</b>), 7.70–7.74 (m, Ar<b>H</b>, (<i>E</i>)-isomeric 2<b>H</b>), 7.49 (t, <i>J</i> = 5.0 Hz, Ar<b>H</b>), 7.28 (d, <i>J</i> = 8.4 Hz, Ar<b>H</b>), 7.21 (t, <i>J</i> = 7.6 Hz, Ar<b>H</b>), 4.27 (t, <i>J</i> = 5.8 Hz, 2Ar<b>H</b>), 3.95–4.05 (m, 2C<b>H</b><sub><b>2</b></sub>), 3.80–3.86 (m, C<b>H</b><sub><b>2</b></sub>), 3.41 (d, <i>J</i> = 12.2 Hz, C<b>H</b><sub><b>2</b></sub>), 3.28 (s, C<b>H</b><sub><b>2</b></sub>), 2.23–2.27 (m, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.0, 151.5, 150.3, 141.3, 136.9, 135.4, 131.8, 129.7, 128.1, 125.3, 124.8, 120.5, 113.1, 67.2, 67.0, 55.2, 53.7, 26.2; HPLC purity: 4.3 min, 98.2%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 389.1523 [M + H]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>24</sub>N<sub>2</sub>O<sub>4</sub>SH<sup>+</sup> 389.1530).</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>E</i>)-4-(3-(2-((2-(3′-Fluoropyridin-2′-yl)vinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>17b</b>)</h3><div class="NLM_p last">Diethyl (((2-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.70 g, 1.60 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.88 mL, 1.76 mmol), 3-fluoropyridine-2-carboxaldehyde (0.22 g, 1.76 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.64 g (98%) of <b>17b</b> as a white powder; <i>R</i><sub>f</sub> = 0.31 (EtOAc/MeOH 9/1); mp: 86–88 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.94 (s, <b>H</b>Cl), 8.37 (d, <i>J</i> = 4.0 Hz, Ar<b>H</b>), 7.91 (d, <i>J</i> = 7.7 Hz, Ar<b>H</b>), 7.75 (d, <i>J</i> = 15.2 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.64 (d, <i>J</i> = 15.2 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.50 (t, <i>J</i> = 7.4 Hz, Ar<b>H</b>), 7.43 (t, <i>J</i> = 9.2 Hz, Ar<b>H</b>), 7.30–7.34 (m, Ar<b>H</b>), 7.05 (t, <i>J</i> = 7.6 Hz, Ar<b>H</b>), 6.90 (d, <i>J</i> = 8.3 Hz, Ar<b>H</b>), 4.20–4.23 (m, 2C<b>H</b><sub><b>2</b></sub>), 3.90 (d, <i>J</i> = 12.5 Hz, C<b>H</b><sub><b>2</b></sub>), 3.33–3.43 (m, 2C<b>H</b><sub><b>2</b></sub>), 2.92–2.95 (m, C<b>H</b><sub><b>2</b></sub>), 2.52 (s, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.6 (d, <i>J</i><sub>C–F</sub> = 263.3 Hz), 156.7, 143.7, 138.3 (d, d, <i>J</i><sub>C–F</sub> = 14.5 Hz), 136.7 (d, <i>J</i><sub>C–F</sub> = 4.7 Hz), 136.5, 130.2, 129.9, 127.8 (d, <i>J</i><sub>C–F</sub> = 5.1 Hz), 127.2, 121.6, 113.6, 67.2, 66.5, 63.7, 55.4, 52.3, 23.6; HPLC purity: 4.4 min, 97.5%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 407.1430 [M + H]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>4</sub>SH<sup>+</sup> 407.1435).</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>E</i>)-4-(3-(3-((2-(3′-Fluoropyridin-2′-yl)vinyl)sulfonyl)phenoxy)propyl)morpholine (<b>17c</b>)</h3><div class="NLM_p last">Diethyl (((3-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.98 g, 2.27 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (1.25 mL, 2.50 mmol), 3-fluoropyridine-2-carboxaldehyde (0.31 g, 2.50 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.57 g (46%) of <b>17c</b> as a pale yellow oil; salt is not formed because salt free <b>17c</b> is oil form; <i>R</i><sub>f</sub> = 0.50 (EtOAc/MeOH 4/1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.42 (d, <i>J</i> = 4.4 Hz, Ar<b>H</b>), 7.91 (d, <i>J</i> = 15.0 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.42–7.55 (m, 4Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 7.33–7.37 (m, Ar<b>H</b>), 7.14 (dd, <i>J</i> = 2.1, 8.2 Hz, Ar<b>H</b>), 4.08 (t, <i>J</i> = 6.3 Hz, C<b>H</b><sub><b>2</b></sub>), 3.71–3.73 (m, 2C<b>H</b><sub><b>2</b></sub>), 2.46–2.54 (m, 3C<b>H</b><sub><b>2</b></sub>), 1.95–2.02 (m, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.8, 158.4 (d, <i>J</i><sub>C–F</sub> = 245.9 Hz), 145.9 (d, <i>J</i><sub>C–F</sub> = 5.1 Hz), 141.1, 139.7 (d, <i>J</i><sub>C–F</sub> = 44.8 Hz), 133.3 (d, <i>J</i><sub>C–F</sub> = 4.4 Hz), 132.9, 130.5, 126.7 (d, <i>J</i><sub>C–F</sub> = 4.4 Hz), 124.1 (d, <i>J</i><sub>C–F</sub> = 18.9 Hz), 120.6, 120.1, 112.8, 66.9, 66.7, 55.3, 53.7, 26.2; HPLC purity: 4.3 min, 97.3%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 407.1431 [M + H]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>4</sub>SH<sup>+</sup> 407.1435).</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (<i>E</i>)-4-(3-(4-((2-(3′-Fluoropyridin-2′-yl)vinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>17d</b>)</h3><div class="NLM_p last">Diethyl (((4-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.50 g, 1.53 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.84 mL, 1.68 mmol), 3-fluoropyridine-2-carboxaldehyde (0.21 g, 1.68 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.57 g (92%) of <b>17d</b> as a white powder; <i>R</i><sub>f</sub> = 0.35 (EtOAc/MeOH 4/1); mp: 218–219 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.19 (s, <b>H</b>Cl), 8.63 (d, <i>J</i> = 4.3 Hz, Ar<b>H</b>), 7.81–7.93 (m, 4Ar<b>H</b>), 7.67 (d, <i>J</i> = 15.1 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.61 (d, <i>J</i> = 15.1 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.45–7.48 (m, Ar<b>H</b>), 7.18 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 4.19 (t, <i>J</i> = 5.9 Hz, C<b>H</b><sub><b>2</b></sub>), 3.79–4.05 (m, 2C<b>H</b><sub><b>2</b></sub>), 3.44 (d, <i>J</i> = 12.2 Hz, C<b>H</b><sub><b>2</b></sub>), 3.05–3.26 (m, 2C<b>H</b><sub><b>2</b></sub>), 2.20–2.26 (m, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.9, 150.7, 149.9, 139.6, 138.8, 133.2, 132.1, 130.3, 126.1, 126.0, 115.9, 66.2, 63.6, 53.7, 51.5, 23.2; HPLC purity: 4.2 min, 98.3%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 389.1526 [M + H]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>24</sub>N<sub>2</sub>O<sub>4</sub>SH<sup>+</sup> 389.1530).</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (<i>E</i>)-4-(3-(4-((2-(3′-Fluoropyridin-2′-yl)vinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>17e</b>)</h3><div class="NLM_p last">Diethyl (((4-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.50 g, 1.53 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.84 mL, 1.68 mmol), 3-fluoropyridine-2-carboxaldehyde (0.21 g, 1.68 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.57 g (92%) of <b>17e</b> as a white powder; <i>R</i><sub>f</sub> = 0.35 (EtOAc/MeOH 4/1); mp: 229–230 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.98 (s, <b>H</b>Cl), 8.50 (d, <i>J</i> = 3.8 Hz, Ar<b>H</b>), 7.93 (d, <i>J</i> = 8.6 Hz, 2Ar<b>H</b>), 7.85–7.90 (m, Ar<b>H</b>), 7.67 (s, (<i>E</i>)-isomeric 2<b>H</b>), 7.58–7.62 (m, Ar<b>H</b>), 7.19 (d, <i>J</i> = 8.7 Hz, 2Ar<b>H</b>), 4.20 (t, <i>J</i> = 5.8 Hz, C<b>H</b><sub><b>2</b></sub>), 3.95–3.98 (m, C<b>H</b><sub><b>2</b></sub>), 3.77–3.83 (m, C<b>H</b><sub><b>2</b></sub>), 3.43–3.47 (m, C<b>H</b><sub><b>2</b></sub>), 3.24 (s, C<b>H</b><sub><b>2</b></sub>), 3.03–3.11 (m, C<b>H</b><sub><b>2</b></sub>), 2.20–3.24 (m, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 164.6, 160.2 (d, <i>J</i><sub>C–F</sub> = 261.9 Hz), 147.5 (d, <i>J</i><sub>C–F</sub> = 4.8 Hz), 140.0 (d, <i>J</i><sub>C–F</sub> = 11.7 Hz), 134.3, 134.2 (d, <i>J</i><sub>C–F</sub> = 4.9 Hz), 131.9, 131.4, 129.4 (d, <i>J</i><sub>C–F</sub> = 5.1 Hz), 126.6 (d, <i>J</i><sub>C–F</sub> = 19.2 Hz), 116.9, 66.8, 65.2, 56.1. 53.3, 24.6; HPLC purity: 4.4 min, 98.6%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 407.1431 [M + H]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>4</sub>SH<sup>+</sup> 407.1435).</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (<i>E</i>)-4-(3-(4-((2-(3′-Chloropyridin-2′-yl)vinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>17f</b>)</h3><div class="NLM_p last">Diethyl (((4-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.36 g, 0.83 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.46 mL, 0.91 mmol), 3-chloropyridine-2-carboxaldehyde (0.13 g, 0.91 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.35 g (98%) of <b>17f</b> as a pale yellow powder; <i>R</i><sub>f</sub> = 0.31 (EtOAc/MeOH 9/1); mp: 210–211 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.40 (s, <b>H</b>Cl), 8.59 (dd, <i>J</i> = 1.3, 4.5 Hz, Ar<b>H</b>), 8.06 (dd, <i>J</i> = 1.4, 8.2 Hz, Ar<b>H</b>), 7.93 (d, <i>J</i> = 8.9 Hz, 2Ar<b>H</b>), 7.87 (d, <i>J</i> = 14.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.70 (d, <i>J</i> = 14.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.51–7.54 (m, Ar<b>H</b>), 7.19 (d, <i>J</i> = 8.9 Hz, 2Ar<b>H</b>), 4.20 (t, <i>J</i> = 6.0 Hz, C<b>H</b><sub><b>2</b></sub>), 3.82–3.97 (m, 2C<b>H</b><sub><b>2</b></sub>), 3.44 (d, <i>J</i> = 12.2 Hz, C<b>H</b><sub><b>2</b></sub>), 3.21–3.26 (m, C<b>H</b><sub><b>2</b></sub>), 3.02–3.11 (m, C<b>H</b><sub><b>2</b></sub>), 2.21–2.28 (m, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.4, 148.5, 147.0, 138.3, 134.6, 133.8, 132.0, 131.0, 130.0, 126.9, 115.4, 65.6, 63.0, 53.1, 50.9, 22.6; HPLC purity: 4.4 min, 98.2%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 423.1136 [M + H]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>4</sub>SH<sup>+</sup> 423.1140).</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (<i>E</i>)-4-(3-(4-((2-(2′-Chloropyridine-3′-yl)vinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>18a</b>)</h3><div class="NLM_p last">Diethyl (((4-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.96 g, 2.20 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (1.21 mL, 2.43 mmol), 2-chloropyridine-3-carboxaldehyde (0.34 g, 2.43 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.71 g (76%) of <b>18a</b> as a pale pink powder; <i>R</i><sub>f</sub> = 0.35 (EtOAc/Acetone 4/1); mp: 221–223 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.09 (s, <b>H</b>Cl), 8.48 (d, <i>J</i> = 4.7 Hz, Ar<b>H</b>), 8.34 (d, <i>J</i> = 7.8 Hz, Ar<b>H</b>), 7.88 (d, <i>J</i> = 8.6 Hz, 2Ar<b>H</b>), 7.83 (d, <i>J</i> = 15.2 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.73 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.48–7.54 (m, Ar<b>H</b>), 7.21 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 4.21 (t, <i>J</i> = 5.9 Hz, C<b>H</b><sub><b>2</b></sub>), 3.97 (d, <i>J</i> = 11.7 Hz, C<b>H</b><sub><b>2</b></sub>), 3.82 (t, <i>J</i> = 11.9 Hz, C<b>H</b><sub><b>2</b></sub>), 3.44–3.47 (m, C<b>H</b><sub><b>2</b></sub>), 3.23–3.28 (m, C<b>H</b><sub><b>2</b></sub>), 3.04–2.11 (m, C<b>H</b><sub><b>2</b></sub>), 2.22–2.25 (m, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO) δ 163.0, 152.0, 150.7, 138.3, 135.0, 134.1, 131.7, 130.4, 127.6, 124.3, 116.0, 66.2, 64.0, 53.7, 51.5, 23.2; HPLC purity: 4.0 min, 97.8%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 423.1136 [M + H]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>4</sub>SH<sup>+</sup> 423.1140).</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (<i>E</i>)-4-(3-(4-((2-(6′-Fluoropyridine-3′-yl)vinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>18b</b>)</h3><div class="NLM_p last">Diethyl (((4-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.50 g, 1.14 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.63 mL, 1.25 mmol), 6-fluoropyridine-3-carboxaldehyde (0.16 g, 1.25 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.42 g (79%) of <b>18b</b> as a white powder; <i>R</i><sub>f</sub> = 0.35 (EtOAc/MeOH 99/1); mp: 187–188 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.97 (s, <b>H</b>Cl), 8.61 (s, Ar<b>H</b>), 8.38–8.42 (m, Ar<b>H</b>), 7.85 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 7.72 (d, <i>J</i> = 15.5 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.67 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.28–7.30 (m, Ar<b>H</b>), 7.19 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 4.19 (t, <i>J</i> = 5.8 Hz, C<b>H</b><sub><b>2</b></sub>), 3.96 (d, <i>J</i> = 12.3 Hz, C<b>H</b><sub><b>2</b></sub>), 3.79 (t, <i>J</i> = 12.0 Hz, C<b>H</b><sub><b>2</b></sub>), 3.2 (s, C<b>H</b><sub><b>2</b></sub>), 3.03–3.11 (m, C<b>H</b><sub><b>2</b></sub>), 2.21 (s, C<b>H</b><sub><b>2</b></sub>), 2.22–2.25 (m, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 165.9 (d, <i>J</i><sub>C–F</sub> = 240.9 Hz), 164.2, 149.8 (d, <i>J</i><sub>C–F</sub> = 15.1 Hz), 142.0 (d, <i>J</i><sub>C–F</sub> = 8.9 Hz), 137.8, 133.7, 131.7, 131.2, 128.8 (d, <i>J</i><sub>C–F</sub> = 4.7 Hz), 116.4, 111.3 (d, <i>J</i><sub>C–F</sub> = 37.7 Hz), 66.6, 65.1, 55.9, 53.3, 24.7; HPLC purity: 4.4 min, 97.1%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 407.1433 [M + H]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>4</sub>SH<sup>+</sup> 407.1435).</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (<i>E</i>)-4-(3-(4-((2′-Chlorostyrylvinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>19a</b>)</h3><div class="NLM_p last">Diethyl (((4-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.96 g, 2.20 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (1.21 mL, 2.42 mmol), 2-chlorobenzaldehyde (0.34 g, 2.42 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.71 g (72%) of <b>19a</b> as a white powder; <i>R</i><sub>f</sub> = 0.38 (EtOAc/MeOH 19/1); mp: 242–243 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.30 (s, <b>H</b>Cl), 7.82–7.92 (m, 3Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 7.72 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.58 (dd, <i>J</i> = 1.2, 8.0 Hz, Ar<b>H</b>), 7.48 (td, <i>J</i> =1.6, 7.4 Hz, Ar<b>H</b>), 7.18–7.42 (m, 2Ar<b>H</b>), 4.20 (t, <i>J</i> = 6.0 Hz, C<b>H</b><sub><b>2</b></sub>), 3.97 (d, <i>J</i> = 10.7 Hz, C<b>H</b><sub><b>2</b></sub>), 3.80–3.97 (m, C<b>H</b><sub><b>2</b></sub>), 3.45 (d, <i>J</i> = 12.1 Hz, C<b>H</b><sub><b>2</b></sub>), 3.22–3.25 (m, C<b>H</b><sub><b>2</b></sub>), 3.03–3.10 (m, C<b>H</b><sub><b>2</b></sub>), 2.22–2.26 (m, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.3, 135.4, 134.0, 132.5, 131.7, 130.6, 130.1, 130.0, 129.7, 128.8, 127.8, 115.4, 65.7, 63.1, 53.2, 51.0, 22.7; HPLC purity: 4.5 min, 97.8%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 422.1181 [M + H]<sup>+</sup> (calcd for C<sub>21</sub>H<sub>24</sub>ClNO<sub>4</sub>SH<sup>+</sup> 422.1187).</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (<i>E</i>)-4-(3-(4-((3′-Chlorostyrylvinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>19b</b>)</h3><div class="NLM_p last">Diethyl (((4-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.96 g, 2.20 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (1.21 mL, 2.42 mmol), 3-chlorobenzaldehyde (0.34 g, 2.42 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.91 g (89%) of <b>19b</b> as a white powder; <i>R</i><sub>f</sub> = 0.35 (EtOAc/MeOH 19/1); mp: 225–227 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.13 (s, <b>H</b>Cl), 7.84–7.89 (m, 2Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 7.68–7.73 (m, 2Ar<b>H</b>), 7.58 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.43–7.52 (m, 2Ar<b>H</b>), 7.19 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 4.20 (t, <i>J</i> = 5.8 Hz, C<b>H</b><sub><b>2</b></sub>), 3.95 (d, <i>J</i> = 11.7 Hz, C<b>H</b><sub><b>2</b></sub>), 3.81 (t, <i>J</i> = 11.8 Hz, C<b>H</b><sub><b>2</b></sub>), 3.45 (d, <i>J</i> = 11.9 Hz, C<b>H</b><sub><b>2</b></sub>), 3.24 (s, C<b>H</b><sub><b>2</b></sub>), 3.03–3.11 (m, C<b>H</b><sub><b>2</b></sub>), 2.21–2.25 (m, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.2, 139.2, 134.7, 133.8, 132.1, 130.7, 130.5, 130.4, 129.6, 128.2, 127.7, 115.3, 65.7, 63.1, 53.2, 51.0, 22.7; HPLC purity: 4.3 min, 98.9%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 422.1180 [M + H]<sup>+</sup> (calcd for C<sub>21</sub>H<sub>24</sub>ClNO<sub>4</sub>SH<sup>+</sup> 422.1187).</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>E</i>)-4-(3-(4-((4′-Chlorostyrylvinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>19c</b>)</h3><div class="NLM_p last">Diethyl (((4-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.96 g, 2.20 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (1.21 mL, 2.42 mmol), 4-chlorobenzaldehyde (0.34 g, 2.42 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.94 g (90%) of <b>19c</b> as a white powder; <i>R</i><sub>f</sub> = 0.33 (EtOAc/MeOH 19/1); mp: 241–242 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.10 (s, <b>H</b>Cl), 7.85 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 7.77 (d, <i>J</i> = 8.5 Hz, 2Ar<b>H</b>), 7.63 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.58 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.50 (d, <i>J</i> = 8.5 Hz, 2Ar<b>H</b>), 7.18 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 4.18 (t, <i>J</i> = 5.9 Hz, C<b>H</b><sub><b>2</b></sub>), 3.95 (d, <i>J</i> = 11.6 Hz, C<b>H</b><sub><b>2</b></sub>), 3.81 (t, <i>J</i> = 11.8 Hz, C<b>H</b><sub><b>2</b></sub>), 3.44 (d, <i>J</i> = 11.3 Hz, C<b>H</b><sub><b>2</b></sub>), 3.23 (s, C<b>H</b><sub><b>2</b></sub>), 3.06–3.08 (m, C<b>H</b><sub><b>2</b></sub>), 2.22 (s, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.2, 139.5, 135.5, 132.2, 131.4, 130.6, 129.5, 129.0, 115.3, 65.7, 63.1, 53.2, 51.0, 22.7; one signal was not detected and is believed to overlap with a nearby peak; HPLC purity: 4.2 min, 99.7%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 422.1183 [M + H]<sup>+</sup> (calcd for C<sub>21</sub>H<sub>24</sub>ClNO<sub>4</sub>SH<sup>+</sup> 422.1187).</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (<i>E</i>)-4-(3-(4-((2′-Fluorostyrylvinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>19d</b>)</h3><div class="NLM_p last">Diethyl (((4-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.96 g, 2.20 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (1.21 mL, 2.42 mmol), 2-fluorobenzaldehyde (0.34 g, 2.42 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.81 g (82%) of <b>19d</b> as a white powder; <i>R</i><sub>f</sub> = 0.38 (EtOAc/MeOH 19/1); mp: 247–248 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.54 (s, <b>H</b>Cl), 7.83–7.89 (m, 3Ar<b>H</b>), 7.64 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.59 (d, <i>J</i> = 15.6 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.49–7.55 (m, Ar<b>H</b>), 7.17–7.35 (m, 2Ar<b>H</b>), 7.18 (d, <i>J</i> = 8.9 Hz, 2Ar<b>H</b>), 4.19 (t, <i>J</i> = 5.9 Hz, C<b>H</b><sub><b>2</b></sub>), 3.97 (d, <i>J</i> = 12.2 Hz, C<b>H</b><sub><b>2</b></sub>), 3.74 (t, <i>J</i> = 12.1 Hz, C<b>H</b><sub><b>2</b></sub>), 3.46 (d, <i>J</i> = 11.6 Hz, C<b>H</b><sub><b>2</b></sub>), 3.23–3.28 (m, C<b>H</b><sub><b>2</b></sub>), 3.04–3.12 (m, C<b>H</b><sub><b>2</b></sub>), 2.20 (s, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.1, 160.4 (d, <i>J</i><sub>C–F</sub> = 250.1 Hz), 133.3 (d, <i>J</i><sub>C–F</sub> = 8.9 Hz), 132.5 (d, <i>J</i><sub>C–F</sub> = 4.4 Hz), 131.8, 131.1 (d, <i>J</i><sub>C–F</sub> = 4.6 Hz), 129.6 (d, <i>J</i><sub>C–F</sub> = 7.0 Hz), 125.1, 120.1 (d, <i>J</i><sub>C–F</sub> = 11.2 Hz), 116.2 (d, <i>J</i><sub>C–F</sub> = 21.4 Hz), 115.4, 65.6, 63.2, 53.2, 51.0, 22.8; one signal was not detected and is believed to overlap with a nearby peak; HPLC purity: 4.7 min, 98.4%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 406.1479 [M + H]<sup>+</sup> (calcd for C<sub>21</sub>H<sub>24</sub>FNO<sub>4</sub>SH<sup>+</sup> 406.1483).</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (<i>E</i>)-4-(3-(4-((3′-Fluorostyrylvinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>19e</b>)</h3><div class="NLM_p last">Diethyl (((4-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.96 g, 2.20 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (1.21 mL, 2.42 mmol), 3-fluorobenzaldehyde (0.34 g, 2.42 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.89 g (89%) of <b>19e</b> as a white powder; <i>R</i><sub>f</sub> = 0.35 (EtOAc/MeOH 19/1); mp: 220–221 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.77 (s, <b>H</b>Cl), 7.85 (d, <i>J</i> = 8.9 Hz, 2Ar<b>H</b>), 7.57–7.78 (m, 2Ar<b>H</b>, (<i>E</i>)-isomeric 2<b>H</b>), 7.31–7.50 (m, Ar<b>H</b>), 7.27–7.31 (m, Ar<b>H</b>), 7.18 (d, <i>J</i> = 8.9 Hz, 2Ar<b>H</b>), 4.19 (t, <i>J</i> = 5.8 Hz, C<b>H</b><sub><b>2</b></sub>), 3.96 (d, <i>J</i> = 12.1 Hz, C<b>H</b><sub><b>2</b></sub>), 3.77 (t, <i>J</i> = 11.8 Hz, C<b>H</b><sub><b>2</b></sub>), 3.45 (d, <i>J</i> = 11.9 Hz, C<b>H</b><sub><b>2</b></sub>), 3.25 (s, C<b>H</b><sub><b>2</b></sub>), 3.06–3.09 (m, C<b>H</b><sub><b>2</b></sub>), 2.20 (s, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>6</sub>) δ 162.3 (d, <i>J</i><sub>C–F</sub> = 242.4 Hz), 162.1, 139.4 (d, <i>J</i><sub>C–F</sub> = 2.6 Hz), 134.9 (d, <i>J</i><sub>C–F</sub> = 8.1 Hz), 133.2, 132.1, 131.0 (d, <i>J</i><sub>C–F</sub> = 8.4 Hz), 130.7, 130.2, 129.5, 125.3 (d, <i>J</i><sub>C–F</sub> = 2.6 Hz), 117.6 (d, <i>J</i><sub>C–F</sub> = 21.2 Hz), 115.3, 114.9 (d, <i>J</i><sub>C–F</sub> = 22.1 Hz), 65.6, 63.1, 53.1, 51.0, 22.7; HPLC purity: 4.7 min, 96.6%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 406.1479 [M + H]<sup>+</sup> (calcd for C<sub>21</sub>H<sub>24</sub>FNO<sub>4</sub>SH<sup>+</sup> 406.1483).</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (<i>E</i>)-4-(3-(4-((4′-Fluorostyrylvinyl)sulfonyl)phenoxy)propyl)morpholine Hydrochloride (<b>19f</b>)</h3><div class="NLM_p last">Diethyl (((4-(3-morpholinopropoxy)phenyl)sulfonyl)methyl)phosphonate (0.96 g, 2.20 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (1.21 mL, 2.42 mmol), 4-fluorobenzaldehyde (0.34 g, 2.42 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.79 g (78%) of <b>19f</b> as a white powder; <i>R</i><sub>f</sub> = 0.33 (EtOAc/MeOH 19/1); mp: 221–223 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.89 (s, <b>H</b>Cl), 7.76–7.87 (m, 4Ar<b>H</b>), 7.60 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.53 (d, <i>J</i> = 15.4 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.25–7.30 (m, 2Ar<b>H</b>), 7.16–7.20 (m, 2Ar<b>H</b>), 4.18 (t, <i>J</i> = 6.0 Hz, C<b>H</b><sub><b>2</b></sub>), 3.96 (d, <i>J</i> = 12.7 Hz, C<b>H</b><sub><b>2</b></sub>), 3.78–3.82 (m, C<b>H</b><sub><b>2</b></sub>), 3.45 (d, <i>J</i> = 12.4 Hz, C<b>H</b><sub><b>2</b></sub>), 3.24 (s, C<b>H</b><sub><b>2</b></sub>), 3.06–3.08 (m, C<b>H</b><sub><b>2</b></sub>), 2.19–2.23 (m, C<b>H</b><sub><b>2</b></sub>); <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>6</sub>) δ 163.8 (d, <i>J</i><sub>C–F</sub> = 249.5 Hz), 162.1, 139.7, 132.4, 131.3 (d, <i>J</i><sub>C–F</sub> = 8.8 Hz), 129.4, 129.1, 128.5, 116.0 (d, <i>J</i><sub>C–F</sub> = 21.9 Hz), 115.3, 115.2, 65.6, 63.2, 53.2, 51.0, 22.8; one signal was not detected and is believed to overlap with a nearby peak; HPLC purity: 4.3 min, 96.4%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 406.1480 [M + H]<sup>+</sup> (calcd for C<sub>21</sub>H<sub>24</sub>FNO<sub>4</sub>SH<sup>+</sup> 406.1483).</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (<i>E</i>)-2-(4-((2-(3′-Fluoropyridin-2′-yl)vinyl)sulfonyl)phenoxy)-1-(4-methylpiperazin-1-yl)ethan-1-one Hydrochloride (<b>23a</b>)</h3><div class="NLM_p last">Diethyl (((4-(2-(4-methylpiperazine-1-yl)2-oxoethoxy)phenyl)sulfonyl)methyl)phosphonate (0.50 g, 1.11 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.61 mL, 1.22 mmol), 3-fluoropyridine-2-carboxaldehyde (0.15 g, 1.22 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.51 g (91%) of <b>23a</b> as a white powder; <i>R</i><sub>f</sub> = 0.35 (EtOAc/acetone 4/1); mp: 153–154 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.72 (s, <b>H</b>Cl), 8.49 (d, <i>J</i> = 3.7 Hz, Ar<b>H</b>), 7.84–7.90 (m, 3Ar<b>H</b>), 7.74 (s, (<i>E</i>)-isomeric 2<b>H</b>), 7.57–7.60 (m, Ar<b>H</b>), 7.19 (d, <i>J</i> = 8.6 Hz, 2Ar<b>H</b>), 5.04–5.17 (m, C<b>H</b><sub><b>2</b></sub>), 4.36 (d, <i>J</i> = 13.1 Hz, C<b>H</b>), 4.00 (d, <i>J</i> = 13.4 Hz, C<b>H</b>), 3.60–3.63 (m, C<b>H</b>), 3.42 (s, C<b>H</b><sub><b>2</b></sub>), 3.13–3.16 (m, C<b>H</b><sub><b>2</b></sub>), 2.97 (s, C<b>H</b>), 2.76 (s, C<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.9, 162.8, 158.5 (d, <i>J</i><sub>C–F</sub> = 261.4 Hz), 146.8 (d, <i>J</i><sub>C–F</sub> = 4.8 Hz), 139.1 (d, <i>J</i><sub>C–F</sub> = 11.0 Hz), 134.0 (d, <i>J</i><sub>C–F</sub> = 4.0 Hz), 132.1, 131.7, 130.3, 128.2 (d, <i>J</i><sub>C–F</sub> = 4.5 Hz), 125.2 (d, <i>J</i><sub>C–F</sub> = 18.8 Hz), 116.2, 66.8, 66.1, 52.3 (d, <i>J</i><sub>C–F</sub> = 15.6 Hz), 42.4, 41.4, 38.6; HPLC purity: 4.5 min, 98.7%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 420.1384 [M + H]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>4</sub>SH<sup>+</sup> 420.1388).</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (<i>E</i>)-2-(4-((2-(3′-Chloropyridin-2′-yl)vinyl)sulfonyl)phenoxy)-1-(4-methylpiperazin-1-yl)ethan-1-one Hydrochloride (<b>23b</b>)</h3><div class="NLM_p last">Diethyl (((4-(2-(4-methylpiperazine-1-yl)2-oxoethoxy)phenyl)sulfonyl)methyl)phosphonate (0.50 g, 1.11 mmol), 2.0 M <i>n</i>-BuLi solution in cyclohexane (0.61 mL, 1.22 mmol), 3-chloropyridine-2-carboxaldehyde (0.17 g, 1.22 mmol), and 4.0 M hydrogen chloride solution in dioxane (2.0 equiv) gave 0.45 g (85%) of <b>23b</b> as a white powder; <i>R</i><sub>f</sub> = 0.38 (EtOAc/acetone 4/1); mp: 148–149 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.28 (s, <b>H</b>Cl), 8.59 (d, <i>J</i> = 4.0 Hz, Ar<b>H</b>), 8.06 (d, <i>J</i> = 8.1 Hz, Ar<b>H</b>), 7.86–7.91 (m, 2Ar<b>H</b>, (<i>E</i>)-isomeric <b>H</b>), 7.72 (d, <i>J</i> = 14.8 Hz, (<i>E</i>)-isomeric <b>H</b>), 7.51–7.54 (m, Ar<b>H</b>), 7.18 (d, <i>J</i> = 8.8 Hz, 2Ar<b>H</b>), 5.03–5.15 (m, C<b>H</b><sub><b>2</b></sub>), 4.37 (d, <i>J</i> = 13.4 Hz, C<b>H</b>), 4.40 (d, <i>J</i> = 13.6 Hz, C<b>H</b>), 3.43–3.57 (m, C<b>H</b>, C<b>H</b><sub><b>2</b></sub>), 3.09–3.12 (m, C<b>H</b><sub><b>2</b></sub>), 2.96 (s, C<b>H</b>), 2.77 (s, C<b>H</b><sub><b>3</b></sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.9, 162.9, 149.1, 147.6, 138.9, 135.2, 134.4, 132.5, 131.6, 130.3, 127.4, 116.2, 99.1, 66.0, 52.5, 42.5; two signals were not detected and believed to overlap with a nearby solvent peak; HPLC purity: 4.5 min, 98.3%; HRMS (M + H)<sup>+</sup> (ESI<sup>+</sup>) 436.1087 [M + H]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>4</sub>SH<sup>+</sup> 436.1092).</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Cell Culture</h3><div class="NLM_p last">Engineered U2OS Keap1–Nrf2 nuclear translocation cell lines (93-0821C3, DiscoveRX, Fremont, CA) were grown with an AssayComplete cell culture kit (92-3103G, DiscoveRx) at 37 °C in a humidified atmosphere containing 5% CO<sub>2</sub>. BV2 cells were grown in RPMI-1640 (Gibco, Carlsbad, CA) supplemented with 10% (v/v) fetal bovine serum (Atlas Biologicals, Fort Collins, CO), 100 U/mL penicillin, 10 μg/mL streptomycin, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Gibco) at 37 °C in a humidified atmosphere containing 5% CO<sub>2</sub>.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Keap1–Nrf2 Functional Assay</h3><div class="NLM_p last">The Keap1–Nrf2 functional assay was performed using a PathHunter U2OS Keap1–Nrf2 nuclear translocation cell line (93-0821C3, DiscoveRx) according to the manufacturer’s instructions. Briefly, this Nrf2 activation system was designed to measure a nontranscriptional response of activation-dependent Nrf2 translocation to the nucleus using a principal enzyme fragment complementation (EFC) technology. This EFC technology utilized a genetically engineered β-galactosidase enzyme consisting of two fragments: (a) an Nrf2-tagged enzyme donor and (b) an enzyme acceptor, which is localized to the nucleus. The activation of the Keap1–Nrf2 protein complex resulted in the formation of the functional β-galactosidase in the nucleus, the activity of which can be quantitatively detected using a chemiluminescent substrate. The engineered U2OS cells (1.5 × 10<sup>4</sup> cells/well) were seeded on a white 96-well plate and incubated overnight at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>. The cells were then incubated with test compounds in the dark at room temperature for 6 h. Subsequently, the cells were incubated for 1 h in the same environment with working detection reagent solution. Then, luminescence was detected using a SpectraMax i3 microplate reader (Molecular Devices, Sunnyvale, CA).</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Cell Viability Assay</h3><div class="NLM_p last">Cell viability was assessed using an Ez-Cytox cell viability assay kit (DoGenBio, Cheongju, South Korea) according to the manufacturer’s protocol. This assay is based on a water-soluble tetrazolium salt method. BV2 cells (1.0 × 10<sup>4</sup> cells/well) were seeded on a 96-well plate in 100 μL of medium and incubated overnight at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>. The cells were then treated with various concentrations of the synthesized compounds for 24 h at 37 °C. Then, 10 μL of Ez-Cytox reagent was added to the wells and incubated for 1 h at 37 °C. Cell viability was then determined by measuring the absorbance at 450 nm using a SpectraMax i3 microplate reader.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> CYP Inhibition Assay</h3><div class="NLM_p last">CYP inhibition was measured using a P450-Glo screening system (Promega Corp.) according to the manufacturer’s protocols (Promega Technical Bulletin, P450-Glo Assays, 2009). Briefly, the CYP enzyme and substrate were mixed in KH<sub>2</sub>PO<sub>4</sub> buffer (100 mM, pH 7.4) with or without test compounds, and the reaction was initiated by addition of the NADPH regeneration system (containing NADP<sup>+</sup>, MgCl<sub>2</sub>, glucose-6-phosphate, and glucose-6-phosphate dehydrogenase). After incubation for 10–30 min at 37 °C (different incubation times depending on the CYP isotype), the reconstituted luciferin detection reagent was added to stop the reaction and generate the luminescent signal. After incubation for 20 min to stabilize the luminescence, signals were detected using a SpectraMax i3 microplate reader; inhibition of each CYP isotype by test compounds was expressed as the percentage of activity versus control.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Microsomal Stability</h3><div class="NLM_p last">Human liver microsomes (0.5 mg/mL) were preincubated with compounds (1 μM) in 0.1 M phosphate buffer (pH 7.4) at 37 °C for 5 min before adding the NADPH regeneration buffer (containing NADP<sup>+</sup>, MgCl<sub>2</sub>, glucose-6-phosphate, and glucose-6-phosphate dehydrogenase). The incubation was started by treating the NADPH regeneration buffer and terminated with chlorpropamide in acetonitrile after 30 min at 37 °C. Precipitated proteins were removed by centrifugation for 5 min at 14 000<i>g</i> at 4 °C. The supernatant was injected into a liquid chromatography-MS/MS system and analyzed using a Shimadzu Nexera XR system and TSQ vantage (Thermo). The HPLC column was a Luna C18 column (2.0 × 50 mm<sup>2</sup>, 3 μm particle size; Phenomenex), and the mobile phase was distilled water (A) containing 0.1% formic acid and acetonitrile (B) containing 0.1% formic acid. Data analysis was performed using Xcalibur (version 1.6.1). Percentage of remaining compound was calculated by comparing the peak area.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> RT-qPCR</h3><div class="NLM_p last">Total RNA was extracted with Trizol (Invitrogen, Carlsbad, CA) and converted to cDNA using an iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). RT-qPCR was performed using 50 ng of cDNA and the iQ-SYBR Green Supermix (Bio-Rad). Nrf2-dependent antioxidant genes were amplified using the following primers: GCLC (forward: 5′-TGTGGTATTCGTGGTACTGCTC-3′, reverse: 5′-GGGCCACTTTCATGTTCTCG-3′); GCLM (forward: 5′-GGAGCTTCGGGACTGTATCC-3′, reverse: 5′-TCGGGATTTATCTTC TCCACTGC-3′); HO-1 (forward: 5′-CAGCCACACAGCACTATG-3′, reverse: 5′-GCAATC TTCTTCAGGACCT-3′); hypoxanthine-guanine phosphoribosyltransferase (forward: 5′-CAGGAGAGAAAGATGTGATTGA TA-3′, reverse: 5′-GCCAACACTGCTGAAACA-3′); hypoxanthine-guanine phosphoribosyltransferase was used as an internal control. All RT-qPCR reactions were performed on a Bio-Rad CFX Connect Real-Time PCR Detection system. The 2ΔΔCt method was used to calculate fold changes in gene expression.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Western Blot</h3><div id="sec4_61_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Nuclear Lysate Extraction</h4><div class="NLM_p last">Nuclear lysates were extracted by a previously described method.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> BV2 cells (3 × 10<sup>6</sup> cells/plate) were seeded onto a culture dish and treated with various concentrations of <b>17e</b> for 6 h. Then, the cells were harvested in ice-cold phosphate-buffered saline (PBS) and resuspended in 400 μL of cytoplasmic extract buffer containing 10 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid (HEPES, pH 7.9), 10 mM KCl, 0.1 mM ethylenediaminetetraacetic acid (EDTA), 0.1 mM ethylene glycol-bis(β-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid (EGTA), 1 mM dithiothreitol, and 0.5 mM phenylmethylsulfonyl fluoride. The resuspended cells were incubated at 4 °C for 20 min. Then, 28 μL of 10% NP40 was added and the cells were vortexed vigorously for 15 s. After centrifuging for 2 min at 17 800<i>g</i> and 4 °C, the cytoplasmic supernatant was transferred to a new tube. This process was repeated to wash the nuclear pellet; the supernatant was discarded. The nuclear pellet was subsequently resuspended in 100 μL of nuclear extract buffer containing 20 mM HEPES (pH 7.9), 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride and incubated at 4 °C for 20 min. During this incubation, the pellet was vortexed for 10 s in 5 min intervals. The lysates were then centrifuged for 10 min at 17 800<i>g</i> and 4 °C, and the nuclear supernatant was transferred to a new tube. The lysates were stored at −80 °C until used for analysis.</div></div><div id="sec4_61_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Whole Cell Lysate Extraction</h4><div class="NLM_p">To extract the whole cell lysate, the cells (5 × 10<sup>5</sup> cells/well) were seeded onto a six-well plate and treated with various concentrations of <b>17e</b> for 24 h. Then, the cells were harvested in radioimmunoprecipitation assay buffer (Sigma-Aldrich, St. Louis, MO) containing a protease inhibitor cocktail and incubated at 4 °C for 30 min. The lysates were then centrifuged for 20 min at 15 814<i>g</i> and 4 °C before being transferred to a new tube. The lysates were stored at −80 °C until used for analysis.</div><div class="NLM_p last">Lysate concentrations were determined by bicinchoninic acid method, and equal amounts of protein (10–20 μg) diluted in 5× sample buffer were separated on a 10% sodium dodecyl sulfate-polyacrylamide gel, followed by transfer onto a poly(vinylidene difluoride) membrane (Millipore, Billerica, MA). Membranes were incubated with blocking solution containing 4% nonfat dried milk in Tris-buffered saline with 0.1% Tween-20 (TBS-T) for 1 h at room temperature. The membranes were then rinsed three times with TBS-T and immunoblotted overnight at 4 °C with primary antibodies specific for Nrf2 (1:500; Cell Signaling Technology, Inc., Danvers, MA), GCLC (1:1000; Novus Biologicals, Littleton, CO), GCLM (1:2000; Santa Cruz Biotechnology, Santa Cruz, CA), β-actin (1:2000; Santa Cruz Biotechnology), HO-1 (1:1000; Enzo Life Science, Ann Arbor, MI), and lamin B1 (1:4000; Bioworld Technology, St. Louis Park, MN). Then, membranes were rinsed three times with TBS-T and treated with the appropriate horseradish peroxidase-conjugated secondary antibody (1:10000; GeneTex, Irvine, CA) for 1 h at room temperature. Subsequently, the membranes were rinsed three times with TBS-T and treated with the D-Plus enhanced chemiluminescence Pico system (Dongin Biotech, Seoul, South Korea) for 3 min. Immunoblotted proteins were detected with an Amersham Imager 600 (GE Healthcare, Arlington Heights, IL). Densitometric analyses were performed using ImageJ software (National Institutes of Health), and the data were normalized to lamin B1 or β-actin as loading controls.</div></div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> PD Animal Model and Treatment</h3><div class="NLM_p last">All animal experiments were carried out in accordance with the National Institutes of Health guide for the care and use of laboratory animals (Publication No. 8023, revised 1978) and the guidelines of the Institutional Animal Care and Use Committee of the Korea Institute of Science and Technology (Seoul, South Korea). Male 10 week old C57BL/6 mice (weight, 23–26 g) were purchased from Daehan Biolink (Eumseong, South Korea). Food and water were given ad libitum, and mice were housed in the animal facility of the Korea Institute of Science and Technology on a standard 12 h light/12 h dark cycle. Vehicle for oral administration was used as a solution containing 10% <i>N</i>-methyl-2-pyrrolidone and 20% Tween-80 in distilled water. Vehicle or <b>17e</b> (20 mg/(kg day)) dissolved in the same vehicle solution was orally administered for 3 days; on the second day, MPTP-HCl (20 mg/kg) or saline was intraperitoneally injected four times at 2 h intervals to create the MPTP-induced PD mouse models (<i>n</i> = 10 per group). Six days after MPTP injection, the mice were sacrificed for further study.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Behavioral Tests</h3><div id="sec4_63_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Vertical Grid Test</h4><div class="NLM_p last">All of the mice were handled daily and trained on the vertical grid apparatus for 3 days before oral drug administration. The mice were allowed to move freely on the apparatus for acclimation and trained to turn around and climb down within 15 s when placed on the top position of the apparatus with their head facing up. After 6 days of MPTP injection, vertical grid testing was conducted to evaluate motor function. The test was conducted twice and videotaped to measure the time to turn, total time, and time to climb down after turn.</div></div><div id="sec4_63_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Coat-Hanger Test</h4><div class="NLM_p last">The mice were placed on the center of the coat-hanger and allowed to climb into the safety zone for 3 min. The position of the mouse on the hanger was scored: 0, falling off the hanger within 20 s; 1, hanging on and moving from the starting position of the hanger; 2, reaching the side of the hanger; 3, climbing the top of one side of the hanger; 4, moving toward the top of the hanger; and 5, reaching the safety zone by climbing the hook of the hanger. The mice did not receive a score if they immediately fell off the hanger. The test was conducted twice.</div></div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Immunohistochemistry</h3><div class="NLM_p last">After anesthetized, the mice were transcardially perfused using cold saline and 4% paraformaldehyde. The brains were removed and subsequently postfixed in paraformaldehyde at 4 °C overnight, followed by transfer to 30% sucrose solution for 48 h for cryoprotection. Then, the brains were mounted onto optimum cutting temperature embedding solution. The striatum and SNpc were serially cut in 35 or 30 μm sections in an HM525 NX Cryostat (Thermo Shandon Ltd., Cambridge, U.K.) and then stored in a cryoprotectant containing 30% glycerol, 30% ethylene glycol, and 10% 0.2 M phosphate buffer at 4 °C. Immunostaining was performed by the free-floating method. The brain sections were rinsed in PBS and then incubated in 3% H<sub>2</sub>O<sub>2</sub> for 15 min at room temperature. Subsequently, the sections were treated with serum-free protein-blocking buffer (Agilent, Santa Clara, CA) for 15 min, followed by incubation with a primary anti-TH antibody (1:1000; Pel-Freez Biologicals, Rogers, AZ) overnight at 4 °C. On the next day, the sections were washed three times with PBS and treated with a Polink-2 Plus Horseradish Peroxidase Broad secondary antibody for mouse and rabbit (GBI Labs, Mukilteo, WA) in accordance with the manufacturer’s instructions. Immunoreactivity was visualized by application of 3,3′-diaminobenzidine. The striatum and SNpc were imaged using an Olympus IX51 microscope (Olympus, Tokyo, Japan) to measure the optical density and count the number of TH-positive cells.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Double Immunofluorescent Staining</h3><div class="NLM_p last">SNpc sections were rinsed in PBS with 0.3% Triton X-100 (PBS-T) and incubated in a blocking solution (1% bovine serum albumin in PBS-T) for 2 h. Then, the sections were cotreated at 4 °C (16 h) with Iba-1 (1:800; Wako, Osaka, Japan) and TH (1:800; Millipore, Burlington, MA) primary antibodies. Then, the sections were washed three times with PBS-T before coincubating with antirabbit Alexa Fluor 594 IgG (1:1000) and antimouse Alexa Fluor 488 IgG (1:1000) for 2 h at room temperature. Finally, all sections were washed three times with PBS-T and mounted on slides using fluorescent mounting medium (Agilent). Fluorescent images were obtained with a CELENAS Digital Imaging System microscope (Logos Biosystems, Anyang, South Korea).</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Statistical Analysis</h3><div class="NLM_p last">All experimental results are presented as the mean ± standard error of the mean. Statistical analyses were computed by GraphPad Prism 7.0 software (San Diego, CA). Differences between groups were measured using an unpaired two-tailed Student’s <i>t</i>-test or one-way analysis of variance, followed by Tukey’s or Dunnett’s multiple comparison test. <i>P</i> < 0.05 was considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01527" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01527" class="ext-link">10.1021/acs.jmedchem.8b01527</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional ADME/Tox results of compound <b>17e</b>; result graph of <i>hERG</i> fluorescence polarization assay for <b>17e</b> (Figure S1); result graph of Ames test for <b>17e</b> (Figure S2); the ability to induce HO-1 by ELISA assay for compound <b>5f</b>, <b>5n</b>, <b>6b</b>, <b>7a</b>, <b>7b</b>, <b>17d</b>, <b>17e</b>, <b>18b</b>, <b>19a</b>, <b>19b</b>, <b>19c</b>, <b>19d</b>, <b>19e</b>, and <b>19f</b> (Table S1); plasma stability of <b>17e</b> (Table S2); PAMPA-BBB data for <b>17e</b> (Table S3); synthetic methods and data for the intermediates <b>2</b>, <b>3</b>, <b>4</b>, <b>9</b>, <b>10</b>, <b>13</b>, <b>14</b>, <b>15</b>, <b>16</b>, <b>20</b>, <b>21</b>, <b>22</b>, supporting methods, and <sup>1</sup>H and <sup>13</sup>C NMR spectra of the final compounds <b>5</b>, <b>6</b>, <b>7</b>, <b>8</b>, <b>11</b>, <b>12</b>, <b>17</b>, <b>18</b>, <b>19</b>, <b>23</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_001.pdf">jm8b01527_si_001.pdf (8.57 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_002.csv">jm8b01527_si_002.csv (5.29 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01527" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ki Duk Park</span> - <span class="hlFld-Affiliation affiliation">Convergence
Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Bio-Med Science & Technology, KIST School, Korea University of Science and Technology, Seoul 02792, Republic of
Korea</span>; 
    <span class="hlFld-Affiliation affiliation">KHU-KIST
Department of Converging Science and Technology, Kyung Hee University, Seoul 02447, Republic of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7753-214X" title="Orcid link">http://orcid.org/0000-0002-7753-214X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1279766273607952797b61663c60773c7960"><span class="__cf_email__" data-cfemail="59323d29382b321932302a2d772b3c77322b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ji Won Choi</span> - <span class="hlFld-Affiliation affiliation">Convergence
Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Siwon Kim</span> - <span class="hlFld-Affiliation affiliation">Convergence
Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Bio-Med Science & Technology, KIST School, Korea University of Science and Technology, Seoul 02792, Republic of
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jong-Hyun Park</span> - <span class="hlFld-Affiliation affiliation">Convergence
Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyeon Jeong Kim</span> - <span class="hlFld-Affiliation affiliation">Convergence
Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Yonsei University, Seoul 03722, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Su Jeong Shin</span> - <span class="hlFld-Affiliation affiliation">Convergence
Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin Woo Kim</span> - <span class="hlFld-Affiliation affiliation">Convergence
Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seo Yeon Woo</span> - <span class="hlFld-Affiliation affiliation">Convergence
Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Changho Lee</span> - <span class="hlFld-Affiliation affiliation">Division
of Functional Food Research, Korea Food
Research Institute, Wanju-gun, Jeollabuk-do 55365, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sang Moon Han</span> - <span class="hlFld-Affiliation affiliation">Doping
Control Center, KIST, Seoul 02792, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jaeick Lee</span> - <span class="hlFld-Affiliation affiliation">Doping
Control Center, KIST, Seoul 02792, Republic
of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7548-0297" title="Orcid link">http://orcid.org/0000-0001-7548-0297</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ae Nim Pae</span> - <span class="hlFld-Affiliation affiliation">Convergence
Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology (KIST), Seoul 02792, Republic of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Bio-Med Science & Technology, KIST School, Korea University of Science and Technology, Seoul 02792, Republic of
Korea</span>; 
    <span class="hlFld-Affiliation affiliation">KHU-KIST
Department of Converging Science and Technology, Kyung Hee University, Seoul 02447, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gyoonhee Han</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Yonsei University, Seoul 03722, Republic of Korea</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.W.C and S.K. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e10486-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07330" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07330" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by a National Research Council of Science & Technology grant by the South Korean government (MSIP, No. CRC-15-04-KIST), the National Research Foundation of Korea (NRF-2018M3A9C8016849), and Main Research Program (E0164503-01) of the Korea Food Research Institute.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ADME/Tox</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion/toxicity</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P</p></td></tr><tr><td class="NLM_term">DAergic</td><td class="NLM_def"><p class="first last">dopaminergic</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal effective concentration</p></td></tr><tr><td class="NLM_term">GCL</td><td class="NLM_def"><p class="first last">glutamate–cysteine ligase</p></td></tr><tr><td class="NLM_term">GCLC</td><td class="NLM_def"><p class="first last">glutamate–cysteine ligase catalytic subunit</p></td></tr><tr><td class="NLM_term">GCLM</td><td class="NLM_def"><p class="first last">glutamate–cysteine ligase modifier subunit</p></td></tr><tr><td class="NLM_term">HO-1</td><td class="NLM_def"><p class="first last">heme oxygenase 1</p></td></tr><tr><td class="NLM_term"><i>hERG</i></td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatogtraphy</p></td></tr><tr><td class="NLM_term">Iba-1</td><td class="NLM_def"><p class="first last">ionized calcium-binding adapter molecule 1</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">Keap1</td><td class="NLM_def"><p class="first last">Kelch-like ECH-associated protein 1</p></td></tr><tr><td class="NLM_term"><span class="smallcaps smallerCapital">l</span>-DOPA</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-3,4-dihydroxyphenylalanine</p></td></tr><tr><td class="NLM_term">MPTP</td><td class="NLM_def"><p class="first last">1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectrometry</p></td></tr><tr><td class="NLM_term">Nrf2</td><td class="NLM_def"><p class="first last">nuclear factor (erythroid-derived 2)-like 2</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate-buffered saline</p></td></tr><tr><td class="NLM_term">PBS-T</td><td class="NLM_def"><p class="first last">phosphate-buffered saline-Triton X-100</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>e</sub></td><td class="NLM_def"><p class="first last">permeability (cm/s)</p></td></tr><tr><td class="NLM_term">RT-qPCR</td><td class="NLM_def"><p class="first last">real-time quantitative polymerase chain reaction</p></td></tr><tr><td class="NLM_term">SNpc</td><td class="NLM_def"><p class="first last">substantia nigra pars compacta</p></td></tr><tr><td class="NLM_term">TBS-T</td><td class="NLM_def"><p class="first last">Tris-buffered saline-Tween-20</p></td></tr><tr><td class="NLM_term">TH</td><td class="NLM_def"><p class="first last">tyrosine hydroxylase</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76534" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76534" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reeve, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simcox, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, D.</span></span> <span> </span><span class="NLM_article-title">Ageing and Parkinson’s Disease: Why Is Advancing Age the Biggest Risk Factor?</span>. <i>Ageing Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/j.arr.2014.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1016%2Fj.arr.2014.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=24503004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltl2ntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=19-30&author=A.+Reeveauthor=E.+Simcoxauthor=D.+Turnbull&title=Ageing+and+Parkinson%E2%80%99s+Disease%3A+Why+Is+Advancing+Age+the+Biggest+Risk+Factor%3F&doi=10.1016%2Fj.arr.2014.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?</span></div><div class="casAuthors">Reeve, Amy; Simcox, Eve; Turnbull, Doug</div><div class="citationInfo"><span class="NLM_cas:title">Ageing Research Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19-30</span>CODEN:
                <span class="NLM_cas:coden">ARRGAK</span>;
        ISSN:<span class="NLM_cas:issn">1568-1637</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  As the second most common age related neurodegenerative disease after Alzheimer's disease, the health, social and economic impact resulting from Parkinson's disease will continue to increase alongside the longevity of the population.  Ageing remains the biggest risk factor for developing idiopathic Parkinson's disease.  Although research into the mechanisms leading to cell death in Parkinson's disease has shed light on many aspects of the pathogenesis of this disorder, we still cannot answer the fundamental question, what specific age related factors predispose some individuals to develop this common neurodegenerative disease.  In this review we focus specifically on the neuronal population assocd. with the motor symptoms of Parkinson's disease, the dopaminergic neurons of the substantia nigra, and try to understand how ageing puts these neurons at risk to the extent that a slight change in protein metab. or mitochondrial function can push the cells over the edge leading to catastrophic cell death and many of the symptoms seen in Parkinson's disease.  We review the evidence that ageing is important for the development of Parkinson's disease and how age related decline leads to the loss of neurons within this disease, before describing exactly how advancing age may lead to substantia nigra neuronal loss and Parkinson's disease in some individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreiLPwxZJJ6bVg90H21EOLACvtfcHk0ligh533LwuvAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltl2ntbc%253D&md5=2ed35c35b3da7ad23b93a08e06b2905f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.arr.2014.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arr.2014.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DReeve%26aufirst%3DA.%26aulast%3DSimcox%26aufirst%3DE.%26aulast%3DTurnbull%26aufirst%3DD.%26atitle%3DAgeing%2520and%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520Why%2520Is%2520Advancing%2520Age%2520the%2520Biggest%2520Risk%2520Factor%253F%26jtitle%3DAgeing%2520Res.%2520Rev.%26date%3D2014%26volume%3D14%26spage%3D19%26epage%3D30%26doi%3D10.1016%2Fj.arr.2014.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, G. L.</span></span> <span> </span><span class="NLM_article-title">Current Understanding of the Molecular Mechanisms in Parkinson’s Disease: Targets for Potential Treatments</span>. <i>Transl. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">28</span>, <span class="refDoi"> DOI: 10.1186/s40035-017-0099-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1186%2Fs40035-017-0099-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=29090092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlOrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=28&author=P.+Maitiauthor=J.+Mannaauthor=G.+L.+Dunbar&title=Current+Understanding+of+the+Molecular+Mechanisms+in+Parkinson%E2%80%99s+Disease%3A+Targets+for+Potential+Treatments&doi=10.1186%2Fs40035-017-0099-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Current understanding of the molecular mechanisms in parkinson's disease: targets for potential treatments</span></div><div class="casAuthors">Maiti, Panchanan; Manna, Jayeeta; Dunbar, Gary L.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Neurodegeneration</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28/1-28/35</span>CODEN:
                <span class="NLM_cas:coden">TNREAP</span>;
        ISSN:<span class="NLM_cas:issn">2047-9158</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Gradual degeneration and loss of dopaminergic neurons in the substantia nigra, pars compacta and subsequent redn. of dopamine levels in striatum are assocd. with motor deficits that characterize Parkinson's disease (PD).  In addn., half of the PD patients also exhibit frontostriatal-mediated executive dysfunction, including deficits in attention, short-term working memory, speed of mental processing, and impulsivity.  The most commonly used treatments for PD are only partially or transiently effective and are available or applicable to a minority of patients.  Because, these therapies neither restore the lost or degenerated dopaminergic neurons, nor prevent or delay the disease progression, the need for more effective therapeutics is crit.  In this review, we provide a comprehensive overview of the current understanding of the mol. signaling pathways involved in PD, particularly within the context of how genetic and environmental factors contribute to the initiation and progression of this disease.  The involvement of mol. chaperones, autophagy-lysosomal pathways, and proteasome systems in PD are also highlighted.  In addn., emerging therapies, including pharmacol. manipulations, surgical procedures, stem cell transplantation, gene therapy, as well as complementary, supportive and rehabilitation therapies to prevent or delay the progression of this complex disease are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl88QaNqVjT7Vg90H21EOLACvtfcHk0ligh533LwuvAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlOrtb4%253D&md5=a97bb4699019a09d98b2ba4d43618dd2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2Fs40035-017-0099-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40035-017-0099-z%26sid%3Dliteratum%253Aachs%26aulast%3DMaiti%26aufirst%3DP.%26aulast%3DManna%26aufirst%3DJ.%26aulast%3DDunbar%26aufirst%3DG.%2BL.%26atitle%3DCurrent%2520Understanding%2520of%2520the%2520Molecular%2520Mechanisms%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520Targets%2520for%2520Potential%2520Treatments%26jtitle%3DTransl.%2520Neurodegener.%26date%3D2017%26volume%3D6%26spage%3D28%26doi%3D10.1186%2Fs40035-017-0099-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imam, S.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>, <span class="NLM_elocation-id">904</span> <span class="refDoi"> DOI: 10.3390/ijms17060904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.3390%2Fijms17060904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKktb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&author=S.+Sarkarauthor=J.+Raymickauthor=S.+Imam&title=Neuroprotective+and+Therapeutic+Strategies+against+Parkinson%E2%80%99s+Disease%3A+Recent+Perspectives&doi=10.3390%2Fijms17060904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective and therapeutic strategies against Parkinson's disease: recent perspectives</span></div><div class="casAuthors">Sarkar, Sumit; Raymick, James; Imam, Syed</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">904/1-904/31</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Parkinsonism is a progressive motor disease that affects 1.5 million Americans and is the second most common neurodegenerative disease after Alzheimer's.  Typical neuropathol. features of Parkinson's disease (PD) include degeneration of dopaminergic neurons located in the pars compacta of the substantia nigra that project to the striatum (nigro-striatal pathway) and depositions of cytoplasmic fibrillary inclusions (Lewy bodies) which contain ubiquitin and α-synuclein.  The cardinal motor signs of PD are tremors, rigidity, slow movement (bradykinesia), poor balance, and difficulty in walking (Parkinsonian gait).  In addn. to motor symptoms, non-motor symptoms that include autonomic and psychiatric as well as cognitive impairments are pressing issues that need to be addressed.  Several different mechanisms play an important role in generation of Lewy bodies; endoplasmic reticulum (ER) stress induced unfolded proteins, neuroinflammation and eventual loss of dopaminergic neurons in the substantia nigra of mid brain in PD.  Moreover, these diverse processes that result in PD make modeling of the disease and evaluation of therapeutics against this devastating disease difficult.  Here, we will discuss diverse mechanisms that are involved in PD, neuroprotective and therapeutic strategies currently in clin. trial or in preclin. stages, and impart views about strategies that are promising to mitigate PD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFw5yjGJ5dSrVg90H21EOLACvtfcHk0lh_ZTriESDWBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKktb3P&md5=7b71b202aad876c50bdaaf11d497e1e8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fijms17060904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms17060904%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DRaymick%26aufirst%3DJ.%26aulast%3DImam%26aufirst%3DS.%26atitle%3DNeuroprotective%2520and%2520Therapeutic%2520Strategies%2520against%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520Recent%2520Perspectives%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D17%26doi%3D10.3390%2Fijms17060904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">AlDakheel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalia, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, A. E.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">6</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1007/s13311-013-0218-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1007%2Fs13311-013-0218-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=6-23&author=A.+AlDakheelauthor=L.+V.+Kaliaauthor=A.+E.+Lang&title=Pathogenesis-Targeted%2C+Disease-Modifying+Therapies+in+Parkinson+Disease&doi=10.1007%2Fs13311-013-0218-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs13311-013-0218-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-013-0218-1%26sid%3Dliteratum%253Aachs%26aulast%3DAlDakheel%26aufirst%3DA.%26aulast%3DKalia%26aufirst%3DL.%2BV.%26aulast%3DLang%26aufirst%3DA.%2BE.%26atitle%3DPathogenesis-Targeted%252C%2520Disease-Modifying%2520Therapies%2520in%2520Parkinson%2520Disease%26jtitle%3DNeurotherapeutics%26date%3D2014%26volume%3D11%26spage%3D6%26epage%3D23%26doi%3D10.1007%2Fs13311-013-0218-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Factor, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLong, M. R.</span></span> <span> </span><span class="NLM_article-title">Parkinson’s Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1038/npp.2011.212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1038%2Fnpp.2011.212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=21956442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=213-246&author=Y.+Smithauthor=T.+Wichmannauthor=S.+A.+Factorauthor=M.+R.+DeLong&title=Parkinson%E2%80%99s+Disease+Therapeutics%3A+New+Developments+and+Challenges+Since+the+Introduction+of+Levodopa&doi=10.1038%2Fnpp.2011.212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa</span></div><div class="casAuthors">Smith, Yoland; Wichmann, Thomas; Factor, Stewart A.; DeLong, Mahlon R.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">213-246</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The demonstration that dopamine loss is the key pathol. feature of Parkinson's disease (PD), and the subsequent introduction of levodopa have revolutionalized the field of PD therapeutics.  This review will discuss the significant progress that has been made in the development of new pharmacol. and surgical tools to treat PD motor symptoms since this major breakthrough in the 1960s.  However, we will also highlight some of the challenges the field of PD therapeutics has been struggling with during the past decades.  The lack of neuroprotective therapies and the limited treatment strategies for the nonmotor symptoms of the disease (ie, cognitive impairments, autonomic dysfunctions, psychiatric disorders, etc.) are among the most pressing issues to be addressed in the years to come.  It appears that the combination of early PD nonmotor symptoms with imaging of the nigrostriatal dopaminergic system offers a promising path toward the identification of PD biomarkers, which, once characterized, will set the stage for efficient use of neuroprotective agents that could slow down and alter the course of the disease.  Neuropsychopharmacol. Reviews (2012) 37, 213-246; doi:10.1038/npp.2011.212; published online 28 Sept. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKGa2hNY5gcbVg90H21EOLACvtfcHk0lh_ZTriESDWBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejsrbF&md5=d1e259530039c7e35aae30f77a939fe6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.212%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DY.%26aulast%3DWichmann%26aufirst%3DT.%26aulast%3DFactor%26aufirst%3DS.%2BA.%26aulast%3DDeLong%26aufirst%3DM.%2BR.%26atitle%3DParkinson%25E2%2580%2599s%2520Disease%2520Therapeutics%253A%2520New%2520Developments%2520and%2520Challenges%2520Since%2520the%2520Introduction%2520of%2520Levodopa%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D213%26epage%3D246%26doi%3D10.1038%2Fnpp.2011.212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rizek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jog, M. S.</span></span> <span> </span><span class="NLM_article-title">An Update on the Diagnosis and Treatment of Parkinson Disease</span>. <i>Can. Med. Assoc. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>188</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1165</span>, <span class="refDoi"> DOI: 10.1503/cmaj.151179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1503%2Fcmaj.151179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FjtVKrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2016&pages=1157-1165&author=P.+Rizekauthor=N.+Kumarauthor=M.+S.+Jog&title=An+Update+on+the+Diagnosis+and+Treatment+of+Parkinson+Disease&doi=10.1503%2Fcmaj.151179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An update on the diagnosis and treatment of Parkinson disease</span></div><div class="casAuthors">Rizek Philippe; Kumar Niraj; Jog Mandar S</div><div class="citationInfo"><span class="NLM_cas:title">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1157-1165</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJwnJGQ9n_whwLZxei1HN8fW6udTcc2ebsujcDDCXgiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FjtVKrsQ%253D%253D&md5=965c7ad9631f880d1d91dde7bed09cd3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1503%2Fcmaj.151179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1503%252Fcmaj.151179%26sid%3Dliteratum%253Aachs%26aulast%3DRizek%26aufirst%3DP.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DJog%26aufirst%3DM.%2BS.%26atitle%3DAn%2520Update%2520on%2520the%2520Diagnosis%2520and%2520Treatment%2520of%2520Parkinson%2520Disease%26jtitle%3DCan.%2520Med.%2520Assoc.%2520J.%26date%3D2016%26volume%3D188%26spage%3D1157%26epage%3D1165%26doi%3D10.1503%2Fcmaj.151179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pahwa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacson, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nausieda, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hull, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stempien, M. J.</span></span> <span> </span><span class="NLM_article-title">ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial</span>. <i>JAMA Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">949</span>, <span class="refDoi"> DOI: 10.1001/jamaneurol.2017.0943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1001%2Fjamaneurol.2017.0943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=28604926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A280%3ADC%252BC1cnntlGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2017&pages=941-949&author=R.+Pahwaauthor=C.+M.+Tannerauthor=R.+A.+Hauserauthor=S.+H.+Isaacsonauthor=P.+A.+Nausiedaauthor=D.+D.+Truongauthor=P.+Agarwalauthor=K.+L.+Hullauthor=K.+E.+Lyonsauthor=R.+Johnsonauthor=M.+J.+Stempien&title=ADS-5102+%28Amantadine%29+Extended-Release+Capsules+for+Levodopa-Induced+Dyskinesia+in+Parkinson+Disease+%28EASE+LID+Study%29%3A+A+Randomized+Clinical+Trial&doi=10.1001%2Fjamaneurol.2017.0943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial</span></div><div class="casAuthors">Pahwa Rajesh; Lyons Kelly E; Tanner Caroline M; Tanner Caroline M; Hauser Robert A; Isaacson Stuart H; Nausieda Paul A; Truong Daniel D; Agarwal Pinky; Hull Keith L; Johnson Reed; Stempien Mary Jean</div><div class="citationInfo"><span class="NLM_cas:title">JAMA neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">941-949</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Importance:  Medical treatment of levodopa-induced dyskinesia (LID) in Parkinson disease (PD) is an unmet need.  Objective:  To evaluate the efficacy and safety of ADS-5102 (amantadine) extended-release 274-mg capsules for treatment of LID in patients with PD.  Design, Setting, and Participants:  A randomized, double-blind, placebo-controlled clinical trial was conducted between May 7, 2014, and July 22, 2015, at 44 North American sites among patients with PD treated with levodopa who experienced at least 1 hour of troublesome dyskinesia per day with at least mild functional impact.  Interventions:  Patients were randomized to receive placebo or 274 mg of ADS-5102 administered orally at bedtime for up to 25 weeks.  Main Outcomes and Measures:  The primary efficacy analysis was the change from baseline to week 12 in the Unified Dyskinesia Rating Scale total score for ADS-5102 vs placebo in the modified intent-to-treat population.  OFF time (amount of time the PD medication is not controlling motor symptoms) was a key secondary end point.  Safety analyses included all patients who received the study drug (ADS-5102 or placebo).  Results:  A total of 189 patients were screened, and 126 were randomized; the modified intent-to-treat population included 121 patients (51 women and 70 men; mean [SD] age, 64.7 [9.1] years).  At week 12, the least-squares mean (SE) change in the Unified Dyskinesia Rating Scale score was -15.9 (1.6) for ADS-5102 (n = 63) and -8.0 (1.6) for placebo (n = 58) (treatment difference, -7.9; 95% CI, -12.5 to -3.3; P < .001).  OFF time decreased by a mean (SE) of 0.6 (0.3) hours for ADS-5102 and increased by 0.3 (0.3) hours for placebo (treatment difference, -0.9 hours; 95% CI, -1.6 to -0.2; P = .02).  Common adverse events for ADS-5102 vs placebo included visual hallucinations (15 [23.8%] vs 1 [1.7%]), peripheral edema (15 [23.8%] vs 0), and dizziness (14 [22.2%] vs 0).  Adverse events led to treatment discontinuation for 13 patients receiving ADS-5102 (20.6%) vs 4 patients receiving placebo (6.9%).  Conclusions and Relevance:  ADS-5102, 274 mg at bedtime, may be an effective treatment for LID.  An additional benefit is reduced OFF time.  To our knowledge, this is the first demonstration of an oral treatment reducing both LID and OFF time in patients with PD with dyskinesia.  Trial Registration:  clinicaltrials.gov Identifier: NCT02136914.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBUNsJZAeUhbesJRIHUP1ofW6udTcc2ebsujcDDCXgiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnntlGhtg%253D%253D&md5=90caa8d3c82cb96280c497501565b129</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1001%2Fjamaneurol.2017.0943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaneurol.2017.0943%26sid%3Dliteratum%253Aachs%26aulast%3DPahwa%26aufirst%3DR.%26aulast%3DTanner%26aufirst%3DC.%2BM.%26aulast%3DHauser%26aufirst%3DR.%2BA.%26aulast%3DIsaacson%26aufirst%3DS.%2BH.%26aulast%3DNausieda%26aufirst%3DP.%2BA.%26aulast%3DTruong%26aufirst%3DD.%2BD.%26aulast%3DAgarwal%26aufirst%3DP.%26aulast%3DHull%26aufirst%3DK.%2BL.%26aulast%3DLyons%26aufirst%3DK.%2BE.%26aulast%3DJohnson%26aufirst%3DR.%26aulast%3DStempien%26aufirst%3DM.%2BJ.%26atitle%3DADS-5102%2520%2528Amantadine%2529%2520Extended-Release%2520Capsules%2520for%2520Levodopa-Induced%2520Dyskinesia%2520in%2520Parkinson%2520Disease%2520%2528EASE%2520LID%2520Study%2529%253A%2520A%2520Randomized%2520Clinical%2520Trial%26jtitle%3DJAMA%2520Neurol.%26date%3D2017%26volume%3D74%26spage%3D941%26epage%3D949%26doi%3D10.1001%2Fjamaneurol.2017.0943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. S.</span></span> <span> </span><span class="NLM_article-title">Toward Neuroprotective Treatments of Parkinson’s Disease</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">3795</span>– <span class="NLM_lpage">3797</span>, <span class="refDoi"> DOI: 10.1073/pnas.1703362114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1073%2Fpnas.1703362114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=3795-3797&author=K.+S.+Kim&title=Toward+Neuroprotective+Treatments+of+Parkinson%E2%80%99s+Disease&doi=10.1073%2Fpnas.1703362114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1703362114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1703362114%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BS.%26atitle%3DToward%2520Neuroprotective%2520Treatments%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D3795%26epage%3D3797%26doi%3D10.1073%2Fpnas.1703362114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, W.</span></span> <span> </span><span class="NLM_article-title">Current Pharmaceutical Treatments and Alternative Therapies of Parkinson’s Disease</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.2174/1570159X14666151120123025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.2174%2F1570159X14666151120123025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=26585523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVOqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=339-355&author=J.+Dongauthor=Y.+Cuiauthor=S.+Liauthor=W.+Le&title=Current+Pharmaceutical+Treatments+and+Alternative+Therapies+of+Parkinson%E2%80%99s+Disease&doi=10.2174%2F1570159X14666151120123025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease</span></div><div class="casAuthors">Dong, Jie; Cui, Yanhua; Li, Song; Le, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">339-355</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Over the decades, pharmaceutical treatments, particularly dopaminergic (DAergic) drugs have been considered as the main therapy against motor symptoms of Parkinson's disease (PD).  It is proposed that DAergic drugs in combination with other medications, such as monoamine oxidase type B inhibitors, catechol-O-Me transferase inhibitors, anticholinergics and other newly developed non-DAergic drugs can make a better control of motor symptoms or alleviate levodopa-induced motor complications.  Moreover, non-motor symptoms of PD, such as cognitive, neuropsychiatric, sleep, autonomic and sensory disturbances caused by intrinsic PD pathol. or drug-induced side effects, are gaining increasing attention and urgently need to be taken care of due to their impact on quality of life.  Currently, neuroprotective therapies have been investigated extensively in pre-clin. studies, and some of them have been subjected to clin. trials.  Furthermore, non-pharmaceutical treatments, including deep brain stimulation (DBS), gene therapy, cell replacement therapy and some complementary managements, such as Tai chi, Yoga, traditional herbs and mol. targeted therapies have also been considered as effective alternative therapies to classical pharmaceutics.  This review will provide us updated information regarding the current drugs and non-drugs therapies for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5zCGF-keur7Vg90H21EOLACvtfcHk0ljvYIRFyBbWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVOqt7w%253D&md5=8cc305e81e3126a87967b2488e97b42c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F1570159X14666151120123025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X14666151120123025%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLe%26aufirst%3DW.%26atitle%3DCurrent%2520Pharmaceutical%2520Treatments%2520and%2520Alternative%2520Therapies%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2016%26volume%3D14%26spage%3D339%26epage%3D355%26doi%3D10.2174%2F1570159X14666151120123025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michel, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunot, S.</span></span> <span> </span><span class="NLM_article-title">Understanding Dopaminergic Cell Death Pathways in Parkinson Disease</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2016.03.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1016%2Fj.neuron.2016.03.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=27196972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC28Xotlehsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=675-691&author=P.+P.+Michelauthor=E.+C.+Hirschauthor=S.+Hunot&title=Understanding+Dopaminergic+Cell+Death+Pathways+in+Parkinson+Disease&doi=10.1016%2Fj.neuron.2016.03.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding Dopaminergic Cell Death Pathways in Parkinson Disease</span></div><div class="casAuthors">Michel, Patrick P.; Hirsch, Etienne C.; Hunot, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">675-691</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Parkinson disease (PD) is a multifactorial neurodegenerative disorder, the etiol. of which remains largely unknown.  Progressive impairment of voluntary motor control, which represents the primary clin. feature of the disease, is caused by a loss of midbrain substantia nigra dopamine (DA) neurons.  We present here a synthetic overview of cell-autonomous mechanisms that are likely to participate in DA cell death in both sporadic and inherited forms of the disease.  In particular, we describe how damage to vulnerable DA neurons may arise from cellular disturbances produced by protein misfolding and aggregation, disruption of autophagic catabolism, endoplasmic reticulum (ER) stress, mitochondrial dysfunction, or loss of calcium homeostasis.  Where pertinent, we show how these mechanisms may mutually cooperate to promote neuronal death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvlzkQ3un99bVg90H21EOLACvtfcHk0ljvYIRFyBbWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xotlehsbc%253D&md5=82b13858c9daff03ba1fcdf74d2e16e9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.03.038%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DHunot%26aufirst%3DS.%26atitle%3DUnderstanding%2520Dopaminergic%2520Cell%2520Death%2520Pathways%2520in%2520Parkinson%2520Disease%26jtitle%3DNeuron%26date%3D2016%26volume%3D90%26spage%3D675%26epage%3D691%26doi%3D10.1016%2Fj.neuron.2016.03.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puspita, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, J. W.</span></span> <span> </span><span class="NLM_article-title">Oxidative Stress and Cellular Pathologies in Parkinson’s Disease</span>. <i>Mol. Brain</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">53</span>, <span class="refDoi"> DOI: 10.1186/s13041-017-0340-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1186%2Fs13041-017-0340-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=29183391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFWmtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=53&author=L.+Puspitaauthor=S.+Y.+Chungauthor=J.+W.+Shim&title=Oxidative+Stress+and+Cellular+Pathologies+in+Parkinson%E2%80%99s+Disease&doi=10.1186%2Fs13041-017-0340-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and cellular pathologies in Parkinson's disease</span></div><div class="casAuthors">Puspita, Lesly; Chung, Sun Young; Shim, Jae-Won</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53/1-53/12</span>CODEN:
                <span class="NLM_cas:coden">MBORAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-6606</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is a chronic and progressive neurodegeneration of dopamine neurons in the substantia nigra.  The reason for the death of these neurons is unclear; however, studies have demonstrated the potential involvement of mitochondria, endoplasmic reticulum, α-synuclein or dopamine levels in contributing to cellular oxidative stress as well as PD symptoms.  Even though those papers had sep. described the individual roles of each element leading to neurodegeneration, recent publications suggest that neurodegeneration is the product of various cellular interactions.  This review discusses the role of oxidative stress in mediating sep. pathol. events that together, ultimately result in cell death in PD.  Understanding the multi-faceted relationships between these events, with oxidative stress as a common denominator underlying these processes, is needed for developing better therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgYX_i8fchLbVg90H21EOLACvtfcHk0ljvYIRFyBbWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFWmtb%252FO&md5=fba063f39209bb90e72a69bf52292d50</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1186%2Fs13041-017-0340-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13041-017-0340-9%26sid%3Dliteratum%253Aachs%26aulast%3DPuspita%26aufirst%3DL.%26aulast%3DChung%26aufirst%3DS.%2BY.%26aulast%3DShim%26aufirst%3DJ.%2BW.%26atitle%3DOxidative%2520Stress%2520and%2520Cellular%2520Pathologies%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DMol.%2520Brain%26date%3D2017%26volume%3D10%26spage%3D53%26doi%3D10.1186%2Fs13041-017-0340-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dallé, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mabandla, M. V.</span></span> <span> </span><span class="NLM_article-title">Early Life Stress, Depression and Parkinson’s Disease: A New Approach</span>. <i>Mol. Brain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">18</span>, <span class="refDoi"> DOI: 10.1186/s13041-018-0356-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1186%2Fs13041-018-0356-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=29551090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1enu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=18&author=E.+Dall%C3%A9author=M.+V.+Mabandla&title=Early+Life+Stress%2C+Depression+and+Parkinson%E2%80%99s+Disease%3A+A+New+Approach&doi=10.1186%2Fs13041-018-0356-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Early life stress, depression and parkinson's disease: a new approach</span></div><div class="casAuthors">Dalle, Ernest; Mabandla, Musa V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18/1-18/13</span>CODEN:
                <span class="NLM_cas:coden">MBORAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-6606</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">This review aims to shed light on the relationship that involves exposure to early life stress, depression and Parkinson's disease (PD).  A systematic literature search was conducted in Pubmed, MEDLINE, EBSCOHost and Google Scholar and relevant data were submitted to a meta-anal.  Early life stress may contribute to the development of depression and patients with depression are at risk of developing PD later in life.  Depression is a common non-motor symptom preceding motor symptoms in PD.  Stimulation of regions contiguous to the substantia nigra as well as dopamine (DA) agonists have been shown to be able to attenuate depression.  Therefore, since PD causes depletion of dopaminergic neurons in the substantia nigra, depression, rather than being just a simple mood disorder, may be part of the pathophysiol. process that leads to PD.  It is plausible that the mesocortical and mesolimbic dopaminergic pathways that mediate mood, emotion, and/or cognitive function may also play a key role in depression assocd. with PD.  Here, we propose that a medication designed to address a deficiency in serotonin is more likely to influence motor symptoms of PD assocd. with depression.  This review highlights the effects of an antidepressant, Fluvoxamine maleate, in an animal model that combines depressive-like symptoms and Parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI2eKfCZ4oZbVg90H21EOLACvtfcHk0lhvTi9aNickEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1enu7fE&md5=ff5d57076fa3ded8bece2dd95c7e4131</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2Fs13041-018-0356-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13041-018-0356-9%26sid%3Dliteratum%253Aachs%26aulast%3DDall%25C3%25A9%26aufirst%3DE.%26aulast%3DMabandla%26aufirst%3DM.%2BV.%26atitle%3DEarly%2520Life%2520Stress%252C%2520Depression%2520and%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520A%2520New%2520Approach%26jtitle%3DMol.%2520Brain%26date%3D2018%26volume%3D11%26spage%3D18%26doi%3D10.1186%2Fs13041-018-0356-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dias, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouradian, M. M.</span></span> <span> </span><span class="NLM_article-title">The Role of Oxidative Stress in Parkinson’s Disease</span>. <i>J. Parkinson’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.3233/JPD-130230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.3233%2FJPD-130230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=24252804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2iur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=461-491&author=V.+Diasauthor=E.+Junnauthor=M.+M.+Mouradian&title=The+Role+of+Oxidative+Stress+in+Parkinson%E2%80%99s+Disease&doi=10.3233%2FJPD-130230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Oxidative Stress in Parkinson's Disease</span></div><div class="casAuthors">Dias, Vera; Junn, Eunsung; Mouradian, M. Maral</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Parkinson's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">461-491</span>CODEN:
                <span class="NLM_cas:coden">JPDOAP</span>;
        ISSN:<span class="NLM_cas:issn">1877-7171</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Oxidative stress plays an important role in the degeneration of dopaminergic neurons in Parkinson's disease (PD).  Disruptions in the physiol. maintenance of the redox potential in neurons interfere with several biol. processes, ultimately leading to cell death.  Evidence has been developed for oxidative and nitrative damage to key cellular components in the PD substantia nigra.  A no. of sources and mechanisms for the generation of reactive oxygen species (ROS) are recognized including the metab. of dopamine itself, mitochondrial dysfunction, iron, neuroinflammatory cells, calcium, and aging.  PD causing gene products including DJ-1, PINK1, parkin, alpha-synuclein and LRRK2 also impact in complex ways mitochondrial function leading to exacerbation of ROS generation and susceptibility to oxidative stress.  Addnl., cellular homeostatic processes including the ubiquitin-proteasome system and mitophagy are impacted by oxidative stress.  It is apparent that the interplay between these various mechanisms contributes to neurodegeneration in PD as a feed forward scenario where primary insults lead to oxidative stress, which damages key cellular pathogenetic proteins that in turn cause more ROS prodn.  Animal models of PD have yielded some insights into the mol. pathways of neuronal degeneration and highlighted previously unknown mechanisms by which oxidative stress contributes to PD.  However, therapeutic attempts to target the general state of oxidative stress in clin. trials have failed to demonstrate an impact on disease progression.  Recent knowledge gained about the specific mechanisms related to PD gene products that modulate ROS prodn. and the response of neurons to stress may provide targeted new approaches towards neuroprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyB_eTkTn3e7Vg90H21EOLACvtfcHk0lhvTi9aNickEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2iur%252FM&md5=f7fb58575347af0b3221675e8f71631d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3233%2FJPD-130230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJPD-130230%26sid%3Dliteratum%253Aachs%26aulast%3DDias%26aufirst%3DV.%26aulast%3DJunn%26aufirst%3DE.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26atitle%3DThe%2520Role%2520of%2520Oxidative%2520Stress%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Parkinson%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D3%26spage%3D461%26epage%3D491%26doi%3D10.3233%2FJPD-130230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavala-Flores, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Rocha, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span> <span> </span><span class="NLM_article-title">Thiol-Redox Signaling, Dopaminergic Cell Death, and Parkinson’s Disease</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1764</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1089/ars.2011.4501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1089%2Fars.2011.4501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=22369136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFagtb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1764-1784&author=A.+Garcia-Garciaauthor=L.+Zavala-Floresauthor=H.+Rodriguez-Rochaauthor=R.+Franco&title=Thiol-Redox+Signaling%2C+Dopaminergic+Cell+Death%2C+and+Parkinson%E2%80%99s+Disease&doi=10.1089%2Fars.2011.4501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Thiol-Redox Signaling, Dopaminergic Cell Death, and Parkinson's Disease</span></div><div class="casAuthors">Garcia-Garcia, Aracely; Zavala-Flores, Laura; Rodriguez-Rocha, Humberto; Franco, Rodrigo</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1764-1784</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Significance: Parkinson's disease (PD) is characterized by the selective loss of dopaminergic neurons of the substantia nigra pars compacta, which has been widely assocd. with oxidative stress.  However, the mechanisms by which redox signaling regulates cell death progression remain elusive.  Recent Advances: Early studies demonstrated that depletion of glutathione (GSH), the most abundant low-mol.-wt. thiol and major antioxidant defense in cells, is one of the earliest biochem. events assocd. with PD, prompting researchers to det. the role of oxidative stress in dopaminergic cell death.  Since then, the concept of oxidative stress has evolved into redox signaling, and its complexity is highlighted by the discovery of a variety of thiol-based redox-dependent processes regulating not only oxidative damage, but also the activation of a myriad of signaling/enzymic mechanisms.  Crit. Issues: GSH and GSH-based antioxidant systems are important regulators of neurodegeneration assocd. with PD.  In addn., thiol-based redox systems, such as peroxiredoxins, thioredoxins, metallothioneins, methionine sulfoxide reductases, transcription factors, as well as oxidative modifications in protein thiols (cysteines), including cysteine hydroxylation, glutathionylation, and nitrosylation, have been demonstrated to regulate dopaminergic cell loss.  Future Directions: In this review, we summarize major advances in the understanding of the role of thiol-redox signaling in dopaminergic cell death in exptl. PD.  Future research is still required to clearly understand how integrated thiol-redox signaling regulates the activation of the cell death machinery, and the knowledge generated should open new avenues for the design of novel therapeutic approaches against PD.  Antioxid. Redox Signal. 17, 1764-1784.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwVBqRQzDPOrVg90H21EOLACvtfcHk0lh6sfOcWBxn_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFagtb%252FE&md5=95fc98ad0be27fa11022f356a5bebd2b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1089%2Fars.2011.4501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2011.4501%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Garcia%26aufirst%3DA.%26aulast%3DZavala-Flores%26aufirst%3DL.%26aulast%3DRodriguez-Rocha%26aufirst%3DH.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DThiol-Redox%2520Signaling%252C%2520Dopaminergic%2520Cell%2520Death%252C%2520and%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2012%26volume%3D17%26spage%3D1764%26epage%3D1784%26doi%3D10.1089%2Fars.2011.4501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristóvão, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guhathakurta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joh, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidase 1-Mediated Oxidative Stress Leads to Dopamine Neuron Death in Parkinson’s Disease</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1045</span>, <span class="refDoi"> DOI: 10.1089/ars.2011.3960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1089%2Fars.2011.3960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=22098189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVSqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=1033-1045&author=D.+H.+Choiauthor=A.+C.+Crist%C3%B3v%C3%A3oauthor=S.+Guhathakurtaauthor=J.+Leeauthor=T.+H.+Johauthor=M.+F.+Bealauthor=Y.+S.+Kim&title=NADPH+Oxidase+1-Mediated+Oxidative+Stress+Leads+to+Dopamine+Neuron+Death+in+Parkinson%E2%80%99s+Disease&doi=10.1089%2Fars.2011.3960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">NADPH Oxidase 1-Mediated Oxidative Stress Leads to Dopamine Neuron Death in Parkinson's Disease</span></div><div class="casAuthors">Choi, Dong-Hee; Cristovao, Ana Clara; Guhathakurta, Subhrangshu; Lee, Jongmin; Joh, Tong H.; Beal, M. Flint; Kim, Yoon-Seong</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1033-1045, S1033/1-S1033/4</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aim: Oxidative stress has long been considered as a major contributing factor in the pathogenesis of Parkinson's disease.  However, mol. sources for reactive oxygen species in Parkinson's disease have not been clearly elucidated.  Herein, we sought to investigate whether a superoxide-producing NADPH oxidases (NOXs) are implicated in oxidative stress-mediated dopaminergic neuronal degeneration.  Results: Expression of various Nox isoforms and cytoplasmic components were investigated in N27, rat dopaminergic cells.  While most of Nox isoforms were constitutively expressed, Nox1 expression was significantly increased after treatment with 6-hydroxydopamine.  Rac1, a key regulator in the Nox1 system, was also activated.  Striatal injection of 6-hydroxydopamine increased Nox1 expression in dopaminergic neurons in the rat substantia nigra.  Interestingly, it was localized into the nucleus, and immunostaining for DNA oxidative stress marker, 8-oxo-dG, was increased.  Nox1expression was also found in the nucleus of dopaminergic neurons in the substantia nigra of Parkinson's disease patients.  Adeno-assocd. virus-mediated Nox1 knockdown or Rac1 inhibition reduced 6-hydroxydopamine-induced oxidative DNA damage and dopaminergic neuronal degeneration significantly.  Innovation: Nox1/Rac1 could serve as a potential therapeutic target for Parkinson's disease.  Conclusion: We provide evidence that dopaminergic neurons are equipped with the Nox1/Rac1 superoxide-generating system.  Stress-induced Nox1/Rac1 activation causes oxidative DNA damage and neurodegeneration.  Reduced dopaminergic neuronal death achieved by targeting Nox1/Rac1, emphasizes the impact of oxidative stress caused by this system on the pathogenesis and therapy in Parkinson's disease.  Antioxid. Redox Signal. 16, 1033-1045.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoke7Gavp_GZrVg90H21EOLACvtfcHk0lh6sfOcWBxn_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVSqsrg%253D&md5=633e2c7369bdb87dbe1fa7a8d633f516</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1089%2Fars.2011.3960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2011.3960%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DD.%2BH.%26aulast%3DCrist%25C3%25B3v%25C3%25A3o%26aufirst%3DA.%2BC.%26aulast%3DGuhathakurta%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJoh%26aufirst%3DT.%2BH.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DNADPH%2520Oxidase%25201-Mediated%2520Oxidative%2520Stress%2520Leads%2520to%2520Dopamine%2520Neuron%2520Death%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2012%26volume%3D16%26spage%3D1033%26epage%3D1045%26doi%3D10.1089%2Fars.2011.3960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, O.</span></span> <span> </span><span class="NLM_article-title">Activation of the Nrf2 Signaling Pathway and Neuroprotection of Nigral Dopaminergic Neurons by a Novel Synthetic Compound KMS99220</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2017.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1016%2Fj.neuint.2017.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=29158022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOiur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2018&pages=96-107&author=J.+A.+Leeauthor=H.+J.+Sonauthor=J.+W.+Choiauthor=J.+Kimauthor=S.+H.+Hanauthor=N.+Shinauthor=J.+H.+Kimauthor=S.+J.+Kimauthor=J.+Y.+Heoauthor=D.+J.+Kimauthor=K.+D.+Parkauthor=O.+Hwang&title=Activation+of+the+Nrf2+Signaling+Pathway+and+Neuroprotection+of+Nigral+Dopaminergic+Neurons+by+a+Novel+Synthetic+Compound+KMS99220&doi=10.1016%2Fj.neuint.2017.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220</span></div><div class="casAuthors">Lee, Ji Ae; Son, Hyo Jin; Choi, Ji Won; Kim, Jinwoo; Han, Se Hee; Shin, Nari; Kim, Ji Hyun; Kim, Soo Jeong; Heo, Jun Young; Kim, Dong Jin; Park, Ki Duk; Hwang, Onyou</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96-107</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 is known to induce gene expression of antioxidant enzymes and proteasome subunits.  Because both oxidative stress and protein aggregation have damaging effects on neurons, activation of the Nrf2 signaling should be beneficial against neurodegeneration.  In this study, we report a novel synthetic morpholine-contg. chalcone KMS99220 that confers neuroprotection.  It showed high binding affinity to the Nrf2 inhibitory protein Keap-1 and increased nuclear translocation of Nrf2 and gene expression of the antioxidant enzymes heme oxygenase-1, NAD(P)H:quinone oxidoreductase-1, and the catalytic and modifier subunits of glutamate-cysteine ligase in dopaminergic CATH.a cells.  KMS99220 also increased expression of the proteasome subunits PSMB5, PSMB7, PSMB8 and PSMA1, and the resp. chymotrypsin and trypsin-like proteasomal enzyme activities, and reduced α-synuclein aggregate in GFP-α-syn A53T-overexpressing cells.  KMS99220 exhibited a favorable pharmacokinetic profile with excellent bioavailability and metabolic stability, did not interfere with activities of the cytochrome P 450 isotypes, and showed no apparent in vivo toxicity when administered up to 2000 mg/kg.  In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, oral administration of KMS99220 prevented degeneration of the nigral dopaminergic neurons, induced the Nrf2 target genes, and effectively prevented the assocd. motor deficits.  These results suggest KMS99220 as a potential candidate for therapy against Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD447oQRdnILVg90H21EOLACvtfcHk0lh6sfOcWBxn_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOiur3K&md5=1d50ff474c77fe5d59fdce862754d1ed</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2017.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2017.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DSon%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DS.%2BH.%26aulast%3DShin%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DHeo%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DPark%26aufirst%3DK.%2BD.%26aulast%3DHwang%26aufirst%3DO.%26atitle%3DActivation%2520of%2520the%2520Nrf2%2520Signaling%2520Pathway%2520and%2520Neuroprotection%2520of%2520Nigral%2520Dopaminergic%2520Neurons%2520by%2520a%2520Novel%2520Synthetic%2520Compound%2520KMS99220%26jtitle%3DNeurochem.%2520Int.%26date%3D2018%26volume%3D112%26spage%3D96%26epage%3D107%26doi%3D10.1016%2Fj.neuint.2017.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caporaso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Racchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer’s Disease: A Rational Approach</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1618</span>– <span class="NLM_lpage">1627</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00100</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00100" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt1amu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1618-1627&author=E.+Simoniauthor=M.+M.+Serafiniauthor=R.+Caporasoauthor=C.+Marchettiauthor=M.+Racchiauthor=A.+Minariniauthor=M.+Bartoliniauthor=C.+Lanniauthor=M.+Rosini&title=Targeting+the+Nrf2%2FAmyloid-Beta+Liaison+in+Alzheimer%E2%80%99s+Disease%3A+A+Rational+Approach&doi=10.1021%2Facschemneuro.7b00100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational Approach</span></div><div class="casAuthors">Simoni, Elena; Serafini, Melania M.; Caporaso, Roberta; Marchetti, Chiara; Racchi, Marco; Minarini, Anna; Bartolini, Manuela; Lanni, Cristina; Rosini, Michela</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1618-1627</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amyloid is a prominent feature of Alzheimer's disease (AD).  Yet, a linear linkage between amyloid-β peptide (Aβ) and the disease onset and progression has recently been questioned.  In this context, the crucial partnership between Aβ and Nrf2 pathways is acquiring paramount importance, offering prospects for deciphering the Aβ-centered disease network.  Here, we report on a new class of antiaggregating agents rationally designed to simultaneously activate transcription-based antioxidant responses, whose lead 1 showed interesting properties in a preliminary investigation.  Relying on the requirements of Aβ recognition, we identified the catechol deriv. 12.  In SH-SY5Y neuroblastoma cells, 12 combined remarkable free radical scavenger properties to the ability to trigger the Nrf2 pathway and induce the Nrf2-dependent defensive gene NQO1 by means of electrophilic activation of the transcriptional response.  Moreover, 12 prevented the formation of cytotoxic stable oligomeric intermediates, being significantly more effective, and per se less toxic, than prototype 1.  More importantly, as different chem. features were exploited to regulate Nrf2 and Aβ activities, the two pathways could be tuned independently.  These findings point to compd. 12 and its derivs. as promising tools for investigating the therapeutic potential of the Nrf2/Aβ cellular network, laying foundation for generating new drug leads to confront AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkXBQ0LGYZrLVg90H21EOLACvtfcHk0ljY9tzGrx8EsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt1amu7o%253D&md5=29a4aee2a516521ef138729b55665ff9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00100%26sid%3Dliteratum%253Aachs%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DSerafini%26aufirst%3DM.%2BM.%26aulast%3DCaporaso%26aufirst%3DR.%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DLanni%26aufirst%3DC.%26aulast%3DRosini%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520Nrf2%252FAmyloid-Beta%2520Liaison%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Rational%2520Approach%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D1618%26epage%3D1627%26doi%3D10.1021%2Facschemneuro.7b00100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shekh-Ahmad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidu, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovac, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramov, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M. C.</span></span> <span> </span><span class="NLM_article-title">KEAP1 Inhibition Is Neuroprotective and Suppresses the Development of Epilepsy</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">1390</span>– <span class="NLM_lpage">1403</span>, <span class="refDoi"> DOI: 10.1093/brain/awy071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1093%2Fbrain%2Fawy071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2018&pages=1390-1403&author=T.+Shekh-Ahmadauthor=R.+Eckelauthor=S.+D.+Naiduauthor=M.+Higginsauthor=M.+Yamamotoauthor=A.+T.+Dinkova-Kostovaauthor=S.+Kovacauthor=A.+Y.+Abramovauthor=M.+C.+Walker&title=KEAP1+Inhibition+Is+Neuroprotective+and+Suppresses+the+Development+of+Epilepsy&doi=10.1093%2Fbrain%2Fawy071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawy071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawy071%26sid%3Dliteratum%253Aachs%26aulast%3DShekh-Ahmad%26aufirst%3DT.%26aulast%3DEckel%26aufirst%3DR.%26aulast%3DNaidu%26aufirst%3DS.%2BD.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DKovac%26aufirst%3DS.%26aulast%3DAbramov%26aufirst%3DA.%2BY.%26aulast%3DWalker%26aufirst%3DM.%2BC.%26atitle%3DKEAP1%2520Inhibition%2520Is%2520Neuroprotective%2520and%2520Suppresses%2520the%2520Development%2520of%2520Epilepsy%26jtitle%3DBrain%26date%3D2018%26volume%3D141%26spage%3D1390%26epage%3D1403%26doi%3D10.1093%2Fbrain%2Fawy071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lastres-Becker, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Yagüe, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casarejos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kügler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rábano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy against Synucleinopathy in Parkinson’s Disease</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1089/ars.2015.6549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1089%2Fars.2015.6549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=27009601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFegtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=61-77&author=I.+Lastres-Beckerauthor=A.+J.+Garc%C3%ADa-Yag%C3%BCeauthor=R.+H.+Scannevinauthor=M.+J.+Casarejosauthor=S.+K%C3%BCglerauthor=A.+R%C3%A1banoauthor=A.+Cuadrado&title=Repurposing+the+NRF2+Activator+Dimethyl+Fumarate+as+Therapy+against+Synucleinopathy+in+Parkinson%E2%80%99s+Disease&doi=10.1089%2Fars.2015.6549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease</span></div><div class="casAuthors">Lastres-Becker, Isabel; Garcia-Yaguee, Angel J.; Scannevin, Robert H.; Casarejos, Maria J.; Kuegler, Sebastian; Rabano, Alberto; Cuadrado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">61-77</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: This preclin. study was aimed at detg. whether pharmacol. targeting of transcription factor NRF2, a master controller of many homeostatic genes, might provide a disease-modifying therapy in the animal model of Parkinson's disease (PD) that best reproduces the main hallmark of this pathol., i.e., α-synucleinopathy, and assocd. events, including nigral dopaminergic cell death, oxidative stress, and neuroinflammation.  Results: Pharmacol. activation of NRF2 was achieved at the basal ganglia by repurposing di-Me fumarate (DMF), a drug already in use for the treatment of multiple sclerosis.  Daily oral gavage of DMF protected nigral dopaminergic neurons against α-SYN toxicity and decreased astrocytosis and microgliosis after 1, 3, and 8 wk from stereotaxic delivery to the ventral midbrain of recombinant adeno-assocd. viral vector expressing human α-synuclein.  This protective effect was not obsd. in Nrf2-knockout mice.  In vitro studies indicated that this neuroprotective effect was correlated with altered regulation of autophagy markers SQTSM1/p62 and LC3 in MN9D, BV2, and IMA 2.1 and with a shift in microglial dynamics toward a less pro-inflammatory and a more wound-healing phenotype.  In postmortem samples of PD patients, the cytoprotective proteins assocd. with NRF2 expression, NQO1 and p62, were partly sequestered in Lewy bodies, suggesting impaired neuroprotective capacity of the NRF2 signature.  Innovation: These expts. provide a compelling rationale for targeting NRF2 with DMF as a therapeutic strategy to reinforce endogenous brain defense mechanisms against PD-assocd. synucleinopathy.  Conclusion: DMF is ready for clin. validation in PD.  Antioxid. Redox Signal. 25, 61-77.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoATK_XdXYVVbVg90H21EOLACvtfcHk0ljY9tzGrx8EsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFegtrzP&md5=b060eaf4f4030f742054f906cbe09676</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1089%2Fars.2015.6549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2015.6549%26sid%3Dliteratum%253Aachs%26aulast%3DLastres-Becker%26aufirst%3DI.%26aulast%3DGarc%25C3%25ADa-Yag%25C3%25BCe%26aufirst%3DA.%2BJ.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DCasarejos%26aufirst%3DM.%2BJ.%26aulast%3DK%25C3%25BCgler%26aufirst%3DS.%26aulast%3DR%25C3%25A1bano%26aufirst%3DA.%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DRepurposing%2520the%2520NRF2%2520Activator%2520Dimethyl%2520Fumarate%2520as%2520Therapy%2520against%2520Synucleinopathy%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2016%26volume%3D25%26spage%3D61%26epage%3D77%26doi%3D10.1089%2Fars.2015.6549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lastres-Becker, I.</span></span> <span> </span><span class="NLM_article-title">Role of the Transcription Factor Nrf2 in Parkinson’s Disease: New Insights</span>. <i>J. Alzheimer’s Dis. Parkinsonism</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">340</span> <span class="refDoi"> DOI: 10.4172/2161-0460.1000340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.4172%2F2161-0460.1000340" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&author=I.+Lastres-Becker&title=Role+of+the+Transcription+Factor+Nrf2+in+Parkinson%E2%80%99s+Disease%3A+New+Insights&doi=10.4172%2F2161-0460.1000340"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4172%2F2161-0460.1000340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2161-0460.1000340%26sid%3Dliteratum%253Aachs%26aulast%3DLastres-Becker%26aufirst%3DI.%26atitle%3DRole%2520of%2520the%2520Transcription%2520Factor%2520Nrf2%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520New%2520Insights%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%2520Parkinsonism%26date%3D2017%26volume%3D7%26doi%3D10.4172%2F2161-0460.1000340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vomund, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parnham, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Knethen, A.</span></span> <span> </span><span class="NLM_article-title">Nrf2, the Master Regulator of Anti-Oxidative Responses</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>, <span class="NLM_elocation-id">2772</span> <span class="refDoi"> DOI: 10.3390/ijms18122772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.3390%2Fijms18122772" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&author=S.+Vomundauthor=A.+Sch%C3%A4ferauthor=M.+J.+Parnhamauthor=B.+Br%C3%BCneauthor=A.+von+Knethen&title=Nrf2%2C+the+Master+Regulator+of+Anti-Oxidative+Responses&doi=10.3390%2Fijms18122772"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3390%2Fijms18122772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18122772%26sid%3Dliteratum%253Aachs%26aulast%3DVomund%26aufirst%3DS.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DA.%26aulast%3DParnham%26aufirst%3DM.%2BJ.%26aulast%3DBr%25C3%25BCne%26aufirst%3DB.%26aulast%3Dvon%2BKnethen%26aufirst%3DA.%26atitle%3DNrf2%252C%2520the%2520Master%2520Regulator%2520of%2520Anti-Oxidative%2520Responses%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26doi%3D10.3390%2Fijms18122772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pant, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.-W.</span></span> <span> </span><span class="NLM_article-title">The Nrf2 Signaling in Retinal Ganglion Cells under Oxidative Stress in Ocular Neurodegenerative Diseases</span>. <i>Int. J. Biol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1090</span>– <span class="NLM_lpage">1098</span>, <span class="refDoi"> DOI: 10.7150/ijbs.25996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.7150%2Fijbs.25996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=29989056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Kgs7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=1090-1098&author=X.-F.+Liuauthor=D.-D.+Zhouauthor=T.+Xieauthor=J.-L.+Haoauthor=T.+H.+Malikauthor=C.-B.+Luauthor=J.+Qiauthor=O.+P.+Pantauthor=C.-W.+Lu&title=The+Nrf2+Signaling+in+Retinal+Ganglion+Cells+under+Oxidative+Stress+in+Ocular+Neurodegenerative+Diseases&doi=10.7150%2Fijbs.25996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The Nrf2 signaling in retinal ganglion cells under oxidative stress in ocular neurodegenerative diseases</span></div><div class="casAuthors">Liu, Xiu-Fen; Zhou, Dan-Dan; Xie, Tian; Hao, Ji-Long; Malik, Tayyab Hamid; Lu, Cheng-Bo; Qi, Jing; Pant, Om Prakash; Lu, Cheng-Wei</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1090-1098</span>CODEN:
                <span class="NLM_cas:coden">IJBSB9</span>;
        ISSN:<span class="NLM_cas:issn">1449-2288</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Retinal ganglion cells (RGCs) are one of the important cell types affected in many ocular neurodegenerative diseases.  Oxidative stress is considered to be involved in retinal RGCs death in ocular neurodegenerative diseases.  More and more attention has been focused on studying the agents that may have neuroprotective effects.  Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a key nuclear transcription factor for the systemic antioxidant defense system.  This review elucidates the underlying mechanism of the Nrf2-mediated neuroprotective effects on RGCs in ocular neurodegenerative diseases, such as diabetic retinopathy and retinal ischemia-reperfusion injury.  Several Nrf2 inducers that shield RGCs from oxidative stress-induced neurodegeneration via regulating Nrf2 signaling are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOOl0UoA0NN7Vg90H21EOLACvtfcHk0lhf4b8AAePIbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Kgs7zE&md5=facbc7e11a93617f30e9c251594a5b29</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.7150%2Fijbs.25996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fijbs.25996%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.-F.%26aulast%3DZhou%26aufirst%3DD.-D.%26aulast%3DXie%26aufirst%3DT.%26aulast%3DHao%26aufirst%3DJ.-L.%26aulast%3DMalik%26aufirst%3DT.%2BH.%26aulast%3DLu%26aufirst%3DC.-B.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DPant%26aufirst%3DO.%2BP.%26aulast%3DLu%26aufirst%3DC.-W.%26atitle%3DThe%2520Nrf2%2520Signaling%2520in%2520Retinal%2520Ganglion%2520Cells%2520under%2520Oxidative%2520Stress%2520in%2520Ocular%2520Neurodegenerative%2520Diseases%26jtitle%3DInt.%2520J.%2520Biol.%2520Sci.%26date%3D2018%26volume%3D14%26spage%3D1090%26epage%3D1098%26doi%3D10.7150%2Fijbs.25996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeon, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of Vinyl Sulfones as a Novel Class of Neuroprotective Agents toward Parkinson’s Disease Therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1473</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi"> DOI: 10.1021/jm401788m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401788m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCnu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1473-1487&author=S.+Y.+Wooauthor=J.+H.+Kimauthor=M.+K.+Moonauthor=S.+H.+Hanauthor=S.+K.+Yeonauthor=J.+W.+Choiauthor=B.+K.+Jangauthor=H.+J.+Songauthor=Y.+G.+Kangauthor=J.+W.+Kimauthor=J.+Leeauthor=D.+J.+Kimauthor=O.+Hwangauthor=K.+D.+Park&title=Discovery+of+Vinyl+Sulfones+as+a+Novel+Class+of+Neuroprotective+Agents+toward+Parkinson%E2%80%99s+Disease+Therapy&doi=10.1021%2Fjm401788m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Vinyl Sulfones as a Novel Class of Neuroprotective Agents toward Parkinson's Disease Therapy</span></div><div class="casAuthors">Woo, Seo Yeon; Kim, Ji Hyun; Moon, Mi Kyeong; Han, Se-Hee; Yeon, Seul Ki; Choi, Ji Won; Jang, Bo Ko; Song, Hyo Jung; Kang, Yong Gu; Kim, Jin Woo; Lee, Jaeick; Kim, Dong Jin; Hwang, Onyou; Park, Ki Duk</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1473-1487</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although the etiol. of Parkinson's disease (PD) remains elusive, recent studies suggest that oxidative stress contributes to the cascade leading to dopaminergic (DAergic) neurodegeneration.  The nuclear factor E2-related factor 2 (Nrf2) signaling is the main pathway responsible for cellular defense system against oxidative stress.  Nrf2 is a transcription factor that regulates environmental stress response by inducing expression of antioxidant enzyme genes.  We have synthesized novel vinyl sulfone derivs.  They exhibited a broad range of activities in inducing HO-1, whose gene expression is under the control of Nrf2.  Among them, compd. I was confirmed to activate Nrf2 and induce expression of the Nrf2-dependent antioxidant enzymes NQO1, GCLC, GLCM, and HO-1, at both mRNA and protein levels in DAergic neuronal cells.  This was accompanied by protection of DAergic neurons in both in vitro and MPTP-induced in vivo models of PD.  In addn., compd. I effectively resulted in attenuation of the PD-assocd. behavioral deficits in the mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptlXVsw_3ZfbVg90H21EOLACvtfcHk0lhf4b8AAePIbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCnu7c%253D&md5=1b6da05ff9b10771abff6ab2fd5e708a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm401788m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401788m%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DMoon%26aufirst%3DM.%2BK.%26aulast%3DHan%26aufirst%3DS.%2BH.%26aulast%3DYeon%26aufirst%3DS.%2BK.%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DJang%26aufirst%3DB.%2BK.%26aulast%3DSong%26aufirst%3DH.%2BJ.%26aulast%3DKang%26aufirst%3DY.%2BG.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DHwang%26aufirst%3DO.%26aulast%3DPark%26aufirst%3DK.%2BD.%26atitle%3DDiscovery%2520of%2520Vinyl%2520Sulfones%2520as%2520a%2520Novel%2520Class%2520of%2520Neuroprotective%2520Agents%2520toward%2520Parkinson%25E2%2580%2599s%2520Disease%2520Therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1473%26epage%3D1487%26doi%3D10.1021%2Fjm401788m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, O.</span></span> <span> </span><span class="NLM_article-title">A Novel Compound VSC2 Has Anti-Inflammatory and Antioxidant Properties in Microglia and in Parkinson’s Disease Animal Model</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1100</span>, <span class="refDoi"> DOI: 10.1111/bph.12973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1111%2Fbph.12973" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=25297649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=1087-1100&author=J.+A.+Leeauthor=J.+H.+Kimauthor=S.+Y.+Wooauthor=H.+J.+Sonauthor=S.+H.+Hanauthor=B.+K.+Jangauthor=J.+W.+Choiauthor=D.+J.+Kimauthor=K.+D.+Parkauthor=O.+Hwang&title=A+Novel+Compound+VSC2+Has+Anti-Inflammatory+and+Antioxidant+Properties+in+Microglia+and+in+Parkinson%E2%80%99s+Disease+Animal+Model&doi=10.1111%2Fbph.12973"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model</span></div><div class="casAuthors">Lee, Ji Ae; Kim, Ji Hyun; Woo, Seo Yeon; Son, Hyo Jin; Han, Se Hee; Jang, Bo Ko; Choi, Ji Won; Kim, Dong Jin; Park, Ki Duk; Hwang, Onyou</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1087-1100</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Neuroinflammation through microglial activation is involved in the pathogenesis of neurodegenerative diseases including Parkinson's disease (PD), a major neurodegenerative disorder characterized by dopaminergic neuronal death in the substantia nigra.  We examd. our novel synthetic compd. VSC2 for its anti-inflammatory properties towards development of a PD therapy.  Exptl. Approach : We tested the effects of VSC2 on prodn. of various NF-κB-dependent proinflammatory mols. and Nrf2-dependent antioxidant enzymes in BV-2 microglia and in vivo.  Key Results : The vinyl sulfone compd., VSC2, most effectively suppressed the prodn. of NO in LPS-activated microglia.  It also down-regulated expression of inducible NOS (iNOS), COX-2, IL-1β and TNF-α and inhibited nuclear translocalization and transcriptional activity of NF-κB.  VSC2 increased total and nuclear Nrf2 levels, induced Nrf2 transcriptional activity and was bound to Keap1 with high affinity.  Expression of the Nrf2-regulated antioxidant enzyme genes NAD(P)H quinone oxidoreducase-1 (NQO-1), haem oxygenase-1 (HO-1) and glutamylcysteine ligase (GCL) were up-regulated by VSC2.  In the MPTP mouse model of PD, oral administration of VSC2 decreased the no. of activated microglia in the substantia nigra, lowered the levels of iNOS, COX-2 and IL-1β, and protected the dopaminergic neurons.  VSC2 also elevated the levels of NQO1, HO-1, GCL and Nrf2 in the nigrostriatal area.  Conclusions and Implications : VSC2 has both anti-inflammatory and antioxidant properties and prevented neuroinflammation in microglia and in an animal model of PD.  This suggests VSC2 as a potential candidate for PD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkO-es2O8AkLVg90H21EOLACvtfcHk0lhf4b8AAePIbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWntro%253D&md5=8112f952e44d1b38cba09c3f473c9aa9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fbph.12973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12973%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DWoo%26aufirst%3DS.%2BY.%26aulast%3DSon%26aufirst%3DH.%2BJ.%26aulast%3DHan%26aufirst%3DS.%2BH.%26aulast%3DJang%26aufirst%3DB.%2BK.%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DPark%26aufirst%3DK.%2BD.%26aulast%3DHwang%26aufirst%3DO.%26atitle%3DA%2520Novel%2520Compound%2520VSC2%2520Has%2520Anti-Inflammatory%2520and%2520Antioxidant%2520Properties%2520in%2520Microglia%2520and%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%2520Animal%2520Model%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D1087%26epage%3D1100%26doi%3D10.1111%2Fbph.12973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vitaku, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njardarson, J. T.</span></span> <span> </span><span class="NLM_article-title">Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10257</span>– <span class="NLM_lpage">10274</span>, <span class="refDoi"> DOI: 10.1021/jm501100b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501100b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Wlu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10257-10274&author=E.+Vitakuauthor=D.+T.+Smithauthor=J.+T.+Njardarson&title=Analysis+of+the+Structural+Diversity%2C+Substitution+Patterns%2C+and+Frequency+of+Nitrogen+Heterocycles+among+U.S.+FDA+Approved+Pharmaceuticals&doi=10.1021%2Fjm501100b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals</span></div><div class="casAuthors">Vitaku, Edon; Smith, David T.; Njardarson, Jon T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10257-10274</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Nitrogen heterocycles are among the most significant structural components of pharmaceuticals.  Anal. of our database of U.S. FDA approved drugs reveals that 59% of unique small-mol. drugs contain a nitrogen heterocycle.  In this review we report on the top 25 most commonly utilized nitrogen heterocycles found in pharmaceuticals.  The main part of our anal. is divided into seven sections: (1) three- and four-membered heterocycles, (2) five-, (3) six-, and (4) seven- and eight-membered heterocycles, as well as (5) fused, (6) bridged bicyclic, and (7) macrocyclic nitrogen heterocycles.  Each section reveals the top nitrogen heterocyclic structures and their relative impact for that ring type.  For the most commonly used nitrogen heterocycles, we report detailed substitution patterns, highlight common architectural cores, and discuss unusual or rare structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5cUk9KxUSkbVg90H21EOLACvtfcHk0liRODWiUXm7KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Wlu7%252FP&md5=7065b3b2fc6f69cede0f87479c7cf472</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm501100b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501100b%26sid%3Dliteratum%253Aachs%26aulast%3DVitaku%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DD.%2BT.%26aulast%3DNjardarson%26aufirst%3DJ.%2BT.%26atitle%3DAnalysis%2520of%2520the%2520Structural%2520Diversity%252C%2520Substitution%2520Patterns%252C%2520and%2520Frequency%2520of%2520Nitrogen%2520Heterocycles%2520among%2520U.S.%2520FDA%2520Approved%2520Pharmaceuticals%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10257%26epage%3D10274%26doi%3D10.1021%2Fjm501100b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, D. T.</span></span> <span> </span><span class="NLM_article-title">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3552</span>– <span class="NLM_lpage">3579</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3552-3579&author=L.+D.+Penningtonauthor=D.+T.+Moustakas&title=The+Necessary+Nitrogen+Atom%3A+A+Versatile+High-Impact+Design+Element+for+Multiparameter+Optimization&doi=10.1021%2Facs.jmedchem.6b01807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span></div><div class="casAuthors">Pennington, Lewis D.; Moustakas, Demetri T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3552-3579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is a continued desire in biomedical research to reduce the no. and duration of design cycles required to optimize lead compds. into high-quality chem. probes or safe and efficacious drug candidates.  The insightful application of impactful mol. design elements is one approach toward achieving this goal.  The replacement of a CH group with a N atom in arom. and heteroarom. ring systems can have many important effects on mol. and physicochem. properties and intra- and intermol. interactions that can translate to improved pharmacol. profiles.  In this Perspective, the "necessary nitrogen atom" is shown to be a versatile high-impact design element for multiparameter optimization, wherein ≥10-, 100-, or 1000-fold improvement in a variety of key pharmacol. parameters can be realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ZLKZMgt6IbVg90H21EOLACvtfcHk0liRODWiUXm7KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D&md5=002aaee48995e7954647a1f75183db4d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMoustakas%26aufirst%3DD.%2BT.%26atitle%3DThe%2520Necessary%2520Nitrogen%2520Atom%253A%2520A%2520Versatile%2520High-Impact%2520Design%2520Element%2520for%2520Multiparameter%2520Optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3552%26epage%3D3579%26doi%3D10.1021%2Facs.jmedchem.6b01807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patil, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavachary, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurpiewska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowska-Tłuścik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dömling, A.</span></span> <span> </span><span class="NLM_article-title">De Novo Assembly of Highly Substituted Morpholines and Piperazines</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">642</span>– <span class="NLM_lpage">645</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.6b03807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b03807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=642-645&author=P.+Patilauthor=R.+Madhavacharyauthor=K.+Kurpiewskaauthor=J.+Kalinowska-T%C5%82u%C5%9Bcikauthor=A.+D%C3%B6mling&title=De+Novo+Assembly+of+Highly+Substituted+Morpholines+and+Piperazines&doi=10.1021%2Facs.orglett.6b03807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">De Novo Assembly of Highly Substituted Morpholines and Piperazines</span></div><div class="casAuthors">Patil, Pravin; Madhavachary, Rudrakshula; Kurpiewska, Katarzyna; Kalinowska-Tluscik, Justyna; Doemling, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">642-645</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The morpholine and piperazine with their remarkable phys. and biochem. properties are popular heterocycles in org. and medicinal chem. used in rational property design.  However, in the majority of cases these rings are added to an existing mol. in a building block approach thus limiting their substitution pattern and diversity.  Here the authors introduce a versatile de novo synthesis of the morpholine and piperazine rings using multicomponent reaction chem.  The large scale amenable building blocks can be further substituted at up to four positions, making this a very versatile scaffold synthesis strategy.  The authors' methods thus fulfill the increasing demand for novel building block design and nontraditional scaffolds which previously were not accessible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9H3Uo_iqSD7Vg90H21EOLACvtfcHk0liRODWiUXm7KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yhsLk%253D&md5=9e1413c0d74e626f806916dbe50f22cc</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b03807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b03807%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DP.%26aulast%3DMadhavachary%26aufirst%3DR.%26aulast%3DKurpiewska%26aufirst%3DK.%26aulast%3DKalinowska-T%25C5%2582u%25C5%259Bcik%26aufirst%3DJ.%26aulast%3DD%25C3%25B6mling%26aufirst%3DA.%26atitle%3DDe%2520Novo%2520Assembly%2520of%2520Highly%2520Substituted%2520Morpholines%2520and%2520Piperazines%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D642%26epage%3D645%26doi%3D10.1021%2Facs.orglett.6b03807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rupak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulichi, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suman, K.</span></span> <span> </span><span class="NLM_article-title">Emphasizing Morpholine and its Derivatives (MAID): Typical Candidate of Pharmaceutical Importance</span>. <i>Int. J. Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1777</span>– <span class="NLM_lpage">1788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFantLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=1777-1788&author=K.+Rupakauthor=S.+R.+Vulichiauthor=K.+Suman&title=Emphasizing+Morpholine+and+its+Derivatives+%28MAID%29%3A+Typical+Candidate+of+Pharmaceutical+Importance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Emphasizing morpholine and its derivatives (MAID): typical candidate of pharmaceutical importance</span></div><div class="casAuthors">Rupak, Kumar; Vulichi, Srinivasa R.; Suman, Kapur</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Chemical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1777-1788</span>CODEN:
                <span class="NLM_cas:coden">IJCSIL</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Sadguru Publications</span>)
        </div><div class="casAbstract">The use of chems. (drugs) for both medical and recreational purposes is hardly new.  In fact, drug use seems to have been a part of human science prehistory.  Morpholine (C4H9NO, 1-oxa-4-azacyclohexane) is a synthetic simple heterocyclic org. compd. having characteristic functional groups of amine and ether and great industrial importance.  Chem. manipulations on morpholine based mols. through structure - activity relationship strategy could help developing many interesting candidates of therapeutic significance to tackle broad range of medical ailments.  Feasible physicochem. properties (polarity and soly.), low cost and wide availability make it a suitable candidate for the synthesis of many potent drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT0rs1eUYwRbVg90H21EOLACvtfcHk0li4lyxTdKqwyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFantLs%253D&md5=5ebc0d446a0813a9ff55edccb0ef62ee</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRupak%26aufirst%3DK.%26aulast%3DVulichi%26aufirst%3DS.%2BR.%26aulast%3DSuman%26aufirst%3DK.%26atitle%3DEmphasizing%2520Morpholine%2520and%2520its%2520Derivatives%2520%2528MAID%2529%253A%2520Typical%2520Candidate%2520of%2520Pharmaceutical%2520Importance%26jtitle%3DInt.%2520J.%2520Chem.%2520Sci.%26date%3D2016%26volume%3D14%26spage%3D1777%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span> <span> </span><span class="NLM_article-title">Antioxidant and Anti-Inflammatory Activities of a Natural Compound, Shizukahenriol, through Nrf2 Activation</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">15989</span>– <span class="NLM_lpage">16003</span>, <span class="refDoi"> DOI: 10.3390/molecules200915989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.3390%2Fmolecules200915989" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=15989-16003&author=J.+H.+Parkauthor=J.+W.+Choiauthor=E.+J.+Juauthor=A.+N.+Paeauthor=K.+D.+Park&title=Antioxidant+and+Anti-Inflammatory+Activities+of+a+Natural+Compound%2C+Shizukahenriol%2C+through+Nrf2+Activation&doi=10.3390%2Fmolecules200915989"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3390%2Fmolecules200915989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules200915989%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DJu%26aufirst%3DE.%2BJ.%26aulast%3DPae%26aufirst%3DA.%2BN.%26aulast%3DPark%26aufirst%3DK.%2BD.%26atitle%3DAntioxidant%2520and%2520Anti-Inflammatory%2520Activities%2520of%2520a%2520Natural%2520Compound%252C%2520Shizukahenriol%252C%2520through%2520Nrf2%2520Activation%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D15989%26epage%3D16003%26doi%3D10.3390%2Fmolecules200915989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzclaw, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Protection against Electrophile and Oxidant Stress by Induction of the Phase 2 Response: Fate of Cysteines of the Keap1 Sensor Modified by Inducers</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">2040</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1073/pnas.0307301101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1073%2Fpnas.0307301101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=14764894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Sku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=2040-2045&author=N.+Wakabayashiauthor=A.+T.+Dinkova-Kostovaauthor=W.+D.+Holtzclawauthor=M.+I.+Kangauthor=A.+Kobayashiauthor=M.+Yamamotoauthor=T.+W.+Kenslerauthor=P.+Talalay&title=Protection+against+Electrophile+and+Oxidant+Stress+by+Induction+of+the+Phase+2+Response%3A+Fate+of+Cysteines+of+the+Keap1+Sensor+Modified+by+Inducers&doi=10.1073%2Fpnas.0307301101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Protecti6on against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers</span></div><div class="casAuthors">Wakabayashi, Nobunao; Dinkova-Kostova, Albena T.; Holtzclaw, W. David; Kang, Moon-Il; Kobayashi, Akira; Yamamoto, Masayuki; Kensler, Thomas W.; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2040-2045</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Induction of a family of phase 2 genes encoding for proteins that protect against the damage of electrophiles and reactive oxygen intermediates is potentially a major strategy for reducing the risk of cancer and chronic degenerative diseases.  Many phase 2 genes are regulated by upstream antioxidant response elements (ARE) that are targets of the leucine zipper transcription factor Nrf2.  Under basal conditions, Nrf2 resides mainly in the cytoplasm bound to its cysteine-rich, Kelch domain-contg. partner Keap1, which is itself anchored to the actin cytoskeleton and represses Nrf2 activity.  Inducers disrupt the Keap1-Nrf2 complex by modifying two (C273 and C288) of the 25 cysteine residues of Keap1.  The crit. role of C273 and C288 was established by (i) their high reactivity when purified recombinant Keap1 was treated with dexamethasone mesylate and the dexamethasone-modified tryptic peptides were analyzed by mass spectrometry, and (ii) transfection of keap1 and nrf2 gene-deficient mouse embryonic fibroblasts with constructs expressing cysteine to alanine mutants of Keap1, and measurement of the ability of cotransfected Nrf2 to repress an ARE-luciferase reporter.  Reaction of Keap1 with inducers results in formation of intermol. disulfide bridges, probably between C273 of one Keap1 mol. and C288 of a second.  Evidence for formation of such dimers was obtained by 2D PAGE of exts. of cells treated with inducers, and by the demonstration that whereas C273A and C288A mutants of Keap1 alone could not repress Nrf2 activation of the ARE-luciferase reporter, an equal mixt. of these mutant constructs restored repressor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHr3yEhR167bVg90H21EOLACvtfcHk0li4lyxTdKqwyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Sku7k%253D&md5=c36f98ef6b4a30d855497dfaa52b607c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0307301101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0307301101%26sid%3Dliteratum%253Aachs%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHoltzclaw%26aufirst%3DW.%2BD.%26aulast%3DKang%26aufirst%3DM.%2BI.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DProtection%2520against%2520Electrophile%2520and%2520Oxidant%2520Stress%2520by%2520Induction%2520of%2520the%2520Phase%25202%2520Response%253A%2520Fate%2520of%2520Cysteines%2520of%2520the%2520Keap1%2520Sensor%2520Modified%2520by%2520Inducers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D2040%26epage%3D2045%26doi%3D10.1073%2Fpnas.0307301101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fourquet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerois, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledano, M. B.</span></span> <span> </span><span class="NLM_article-title">Activation of NRF2 by Nitrosative Agents and H<sub>2</sub>O<sub>2</sub> Involves KEAP1 Disulfide Formation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">8463</span>– <span class="NLM_lpage">8471</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.051714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1074%2Fjbc.M109.051714" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=8463-8471&author=S.+Fourquetauthor=R.+Gueroisauthor=D.+Biardauthor=M.+B.+Toledano&title=Activation+of+NRF2+by+Nitrosative+Agents+and+H2O2+Involves+KEAP1+Disulfide+Formation&doi=10.1074%2Fjbc.M109.051714"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.051714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.051714%26sid%3Dliteratum%253Aachs%26aulast%3DFourquet%26aufirst%3DS.%26aulast%3DGuerois%26aufirst%3DR.%26aulast%3DBiard%26aufirst%3DD.%26aulast%3DToledano%26aufirst%3DM.%2BB.%26atitle%3DActivation%2520of%2520NRF2%2520by%2520Nitrosative%2520Agents%2520and%2520H2O2%2520Involves%2520KEAP1%2520Disulfide%2520Formation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D8463%26epage%3D8471%26doi%3D10.1074%2Fjbc.M109.051714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jazwa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Targeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1517</span>– <span class="NLM_lpage">1531</span>, <span class="refDoi"> DOI: 10.2174/1389450111009011517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.2174%2F1389450111009011517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=20704549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKrtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1517-1531&author=A.+Jazwaauthor=A.+Cuadrado&title=Targeting+Heme+Oxygenase-1+for+Neuroprotection+and+Neuroinflammation+in+Neurodegenerative+Diseases&doi=10.2174%2F1389450111009011517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases</span></div><div class="casAuthors">Jazwa, Agnieszka; Cuadrado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1517-1531</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Heme oxygenase-1 (HO-1), an enzyme degrading heme to carbon monoxide, free iron, and biliverdin, participates in the cell defense against oxidative stress and it has been speculated that it might be a new therapeutic target for neuroprotection.  In this review, we discuss recent findings on the regulation of the HO-1 gene, Hmox1, in the brain with particular focus on the transcription factors Nrf2 and HIF-1.  Functional polymorphisms in Hmox1 have been assocd. with high risk for Alzheimer's and Parkinson's disease.  Hence, we review the current knowledge on the role of HO-1 and its enzymic products on these two pathologies as well as ischemic brain injury.  HO-1 modulates the inflammatory response in several scenarios, and therefore we discuss its role in modulation of the innate immune cell of the brain, microglia.  From the therapeutic side, the blood brain barrier represents an obstacle to directly modulate heme oxygenase activity, but drugs activating the transcription actor Nrf2, which have a very diverse mol. structure, may be good candidates to induce HO-1 in concert with other antioxidant and detoxification enzymes.  A more complete understanding on the mechanisms regulating HO-1 expression in brain cells and how these mechanisms are involved in neuropathol. changes will be essential to develop these new therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0wq64mTDHb7Vg90H21EOLACvtfcHk0ljA_llvOE0kJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKrtrbP&md5=a72bf259d5dba4e1cbcca4bba33d9f73</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F1389450111009011517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450111009011517%26sid%3Dliteratum%253Aachs%26aulast%3DJazwa%26aufirst%3DA.%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DTargeting%2520Heme%2520Oxygenase-1%2520for%2520Neuroprotection%2520and%2520Neuroinflammation%2520in%2520Neurodegenerative%2520Diseases%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2010%26volume%3D11%26spage%3D1517%26epage%3D1531%26doi%3D10.2174%2F1389450111009011517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 24 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yanan Hou, Jie Li, Jun-Chen Wu, Quan-Xiang Wu, <span class="NLM_string-name hlFld-ContribAuthor">Jianguo Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of Cellular Antioxidant Defense System by Naturally Occurring Dibenzopyrone Derivatives Confers Neuroprotection against Oxidative Insults. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (15)
                                     , 2798-2809. <a href="https://doi.org/10.1021/acschemneuro.1c00023" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00023%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DActivation%252Bof%252BCellular%252BAntioxidant%252BDefense%252BSystem%252Bby%252BNaturally%252BOccurring%252BDibenzopyrone%252BDerivatives%252BConfers%252BNeuroprotection%252Bagainst%252BOxidative%252BInsults%26aulast%3DHou%26aufirst%3DYanan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D13012021%26date%3D13072021%26date%3D23072021%26volume%3D12%26issue%3D15%26spage%3D2798%26epage%3D2809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elena Lenci, Lorenzo Calugi, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Trabocchi</span>. </span><span class="cited-content_cbyCitation_article-title">Occurrence of Morpholine in Central Nervous System Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 378-390. <a href="https://doi.org/10.1021/acschemneuro.0c00729" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00729%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DOccurrence%252Bof%252BMorpholine%252Bin%252BCentral%252BNervous%252BSystem%252BDrug%252BDiscovery%26aulast%3DLenci%26aufirst%3DElena%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D13112020%26date%3D11012021%26date%3D18012021%26volume%3D12%26issue%3D3%26spage%3D378%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Claudio Zambaldo, Ekaterina V. Vinogradova, Xiaotian Qi, Jonathan Iaconelli, Radu M. Suciu, Minseob Koh, Kristine Senkane, Stormi R. Chadwick, Brittany B. Sanchez, Jason S. Chen, Arnab K. Chatterjee, Peng Liu, Peter G. Schultz, Benjamin F. Cravatt, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Bollong</span>. </span><span class="cited-content_cbyCitation_article-title">2-Sulfonylpyridines as Tunable, Cysteine-Reactive Electrophiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (19)
                                     , 8972-8979. <a href="https://doi.org/10.1021/jacs.0c02721" title="DOI URL">https://doi.org/10.1021/jacs.0c02721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c02721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c02721%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3D2-Sulfonylpyridines%252Bas%252BTunable%25252C%252BCysteine-Reactive%252BElectrophiles%26aulast%3DZambaldo%26aufirst%3DClaudio%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09032020%26date%3D29042020%26date%3D17042020%26volume%3D142%26issue%3D19%26spage%3D8972%26epage%3D8979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ji Won Choi, Su Jeong Shin, Hyeon Ji Kim, Jong-Hyun Park, Hyeon Jeong Kim, Elijah Hwejin Lee, Ae Nim Pae, Yong Sun Bahn, <span class="NLM_string-name hlFld-ContribAuthor">Ki Duk Park</span>. </span><span class="cited-content_cbyCitation_article-title">Antioxidant, Anti-inflammatory, and Neuroprotective Effects of Novel Vinyl Sulfonate Compounds as Nrf2 Activator. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (7)
                                     , 1061-1067. <a href="https://doi.org/10.1021/acsmedchemlett.9b00163" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00163%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAntioxidant%25252C%252BAnti-inflammatory%25252C%252Band%252BNeuroprotective%252BEffects%252Bof%252BNovel%252BVinyl%252BSulfonate%252BCompounds%252Bas%252BNrf2%252BActivator%26aulast%3DChoi%26aufirst%3DJi%2BWon%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D09042019%26date%3D03062019%26date%3D10062019%26date%3D03062019%26volume%3D10%26issue%3D7%26spage%3D1061%26epage%3D1067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruchi  Chawla</span>, <span class="hlFld-ContribAuthor ">Shefali  Jaiswal</span>, <span class="hlFld-ContribAuthor ">P. K.  Dutta</span>, <span class="hlFld-ContribAuthor ">Lal Dhar S.  Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">A photocatalyst-free visible-light-mediated solvent-switchable route to stilbenes/vinyl sulfones from β-nitrostyrenes and arylazo sulfones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (29)
                                     , 6487-6492. <a href="https://doi.org/10.1039/D1OB01028J" title="DOI URL">https://doi.org/10.1039/D1OB01028J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB01028J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB01028J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Bphotocatalyst-free%252Bvisible-light-mediated%252Bsolvent-switchable%252Broute%252Bto%252Bstilbenes%25252Fvinyl%252Bsulfones%252Bfrom%252B%2525CE%2525B2-nitrostyrenes%252Band%252Barylazo%252Bsulfones%26aulast%3DChawla%26aufirst%3DRuchi%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D29%26spage%3D6487%26epage%3D6492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hailong  Xu</span>, <span class="hlFld-ContribAuthor ">Ruyi  Ye</span>, <span class="hlFld-ContribAuthor ">Ziyang  Li</span>, <span class="hlFld-ContribAuthor ">Man‐Yi  Han</span>, <span class="hlFld-ContribAuthor ">Ling‐Guo  Meng</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent Assembly of α,α‐Bis‐Sulfonyl Arylketones and Multiple Substituted Conjugated Dienes Induced by Visible‐Light Irradiation without Additives and Photocatalysts. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (10)
                                     , 2670-2675. <a href="https://doi.org/10.1002/adsc.202100106" title="DOI URL">https://doi.org/10.1002/adsc.202100106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202100106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202100106%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DMulticomponent%252BAssembly%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B1%2525E2%252580%252590Bis%2525E2%252580%252590Sulfonyl%252BArylketones%252Band%252BMultiple%252BSubstituted%252BConjugated%252BDienes%252BInduced%252Bby%252BVisible%2525E2%252580%252590Light%252BIrradiation%252Bwithout%252BAdditives%252Band%252BPhotocatalysts%26aulast%3DXu%26aufirst%3DHailong%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D10%26spage%3D2670%26epage%3D2675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Barbosa</span>, <span class="hlFld-ContribAuthor ">Cátia  Gomes</span>, <span class="hlFld-ContribAuthor ">Catarina  Sequeira</span>, <span class="hlFld-ContribAuthor ">Joana  Gonçalves-Ribeiro</span>, <span class="hlFld-ContribAuthor ">Carolina Campos  Pina</span>, <span class="hlFld-ContribAuthor ">Luís A.  Carvalho</span>, <span class="hlFld-ContribAuthor ">Rui  Moreira</span>, <span class="hlFld-ContribAuthor ">Sandra H.  Vaz</span>, <span class="hlFld-ContribAuthor ">Ana Rita  Vaz</span>, <span class="hlFld-ContribAuthor ">Dora  Brites</span>. </span><span class="cited-content_cbyCitation_article-title">Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fcell.2021.634355" title="DOI URL">https://doi.org/10.3389/fcell.2021.634355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2021.634355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2021.634355%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DRecovery%252Bof%252BDepleted%252BmiR-146a%252Bin%252BALS%252BCortical%252BAstrocytes%252BReverts%252BCell%252BAberrancies%252Band%252BPrevents%252BParacrine%252BPathogenicity%252Bon%252BMicroglia%252Band%252BMotor%252BNeurons%26aulast%3DBarbosa%26aufirst%3DMarta%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zi-Long  Song</span>, <span class="hlFld-ContribAuthor ">Yanan  Hou</span>, <span class="hlFld-ContribAuthor ">Feifei  Bai</span>, <span class="hlFld-ContribAuthor ">Jianguo  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of potent Nrf2 activators via tuning the electrophilicity and steric hindrance of vinyl sulfones for neuroprotection. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>107 </em>, 104520. <a href="https://doi.org/10.1016/j.bioorg.2020.104520" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104520%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DGeneration%252Bof%252Bpotent%252BNrf2%252Bactivators%252Bvia%252Btuning%252Bthe%252Belectrophilicity%252Band%252Bsteric%252Bhindrance%252Bof%252Bvinyl%252Bsulfones%252Bfor%252Bneuroprotection%26aulast%3DSong%26aufirst%3DZi-Long%26date%3D2021%26volume%3D107%26spage%3D104520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji Won  Choi</span>, <span class="hlFld-ContribAuthor ">Siwon  Kim</span>, <span class="hlFld-ContribAuthor ">Jong Seok  Yoo</span>, <span class="hlFld-ContribAuthor ">Hyeon Jeong  Kim</span>, <span class="hlFld-ContribAuthor ">Hyeon Ji  Kim</span>, <span class="hlFld-ContribAuthor ">Byung Eun  Kim</span>, <span class="hlFld-ContribAuthor ">Elijah Hwejin  Lee</span>, <span class="hlFld-ContribAuthor ">Yong Sup  Lee</span>, <span class="hlFld-ContribAuthor ">Jong-Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Ki Duk  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113103. <a href="https://doi.org/10.1016/j.ejmech.2020.113103" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113103%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252Boptimization%252Bof%252Bhalogenated%252Bvinyl%252Bsulfones%252Bas%252BNrf2%252Bactivators%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DChoi%26aufirst%3DJi%2BWon%26date%3D2021%26volume%3D212%26spage%3D113103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Limei  Ji</span>, <span class="hlFld-ContribAuthor ">Lailiang  Qu</span>, <span class="hlFld-ContribAuthor ">Cheng  Wang</span>, <span class="hlFld-ContribAuthor ">Wan  Peng</span>, <span class="hlFld-ContribAuthor ">Shang  Li</span>, <span class="hlFld-ContribAuthor ">Huali  Yang</span>, <span class="hlFld-ContribAuthor ">Heng  Luo</span>, <span class="hlFld-ContribAuthor ">Fucheng  Yin</span>, <span class="hlFld-ContribAuthor ">Dehua  Lu</span>, <span class="hlFld-ContribAuthor ">Xingchen  Liu</span>, <span class="hlFld-ContribAuthor ">Lingyi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and optimization of piperlongumine analogues as potential antioxidant and anti-inflammatory agents via activation of Nrf2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112965. <a href="https://doi.org/10.1016/j.ejmech.2020.112965" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112965</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112965%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252Boptimization%252Bof%252Bpiperlongumine%252Banalogues%252Bas%252Bpotential%252Bantioxidant%252Band%252Banti-inflammatory%252Bagents%252Bvia%252Bactivation%252Bof%252BNrf2%26aulast%3DJi%26aufirst%3DLimei%26date%3D2021%26volume%3D210%26spage%3D112965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Bao</span>, <span class="hlFld-ContribAuthor ">Feiyan  Yu</span>, <span class="hlFld-ContribAuthor ">Fu-Sheng  He</span>, <span class="hlFld-ContribAuthor ">Zhimei  Tang</span>, <span class="hlFld-ContribAuthor ">Wei-Ping  Deng</span>, <span class="hlFld-ContribAuthor ">Jie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-light-induced remote C(sp
              3
              )–H sulfonylvinylation: assembly of cyanoalkylated vinyl sulfones. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>351 </em><a href="https://doi.org/10.1039/D1QO00732G" title="DOI URL">https://doi.org/10.1039/D1QO00732G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1QO00732G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1QO00732G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DVisible-light-induced%252Bremote%252BC%252528sp%252B3%252B%252529%2525E2%252580%252593H%252Bsulfonylvinylation%25253A%252Bassembly%252Bof%252Bcyanoalkylated%252Bvinyl%252Bsulfones%26aulast%3DBao%26aufirst%3DPing%26date%3D2021%26date%3D2021%26volume%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji Won  Choi</span>, <span class="hlFld-ContribAuthor ">Geum Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Hyeon Jeong  Kim</span>, <span class="hlFld-ContribAuthor ">Joo-Won  Nam</span>, <span class="hlFld-ContribAuthor ">Jushin  Kim</span>, <span class="hlFld-ContribAuthor ">Jungwook  Chin</span>, <span class="hlFld-ContribAuthor ">Jong-Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Hyukjae  Choi</span>, <span class="hlFld-ContribAuthor ">Ki Duk  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and evaluation of a napyradiomycin as a potent Nrf2 activator: Anti-oxidative and anti-inflammatory activities. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104434. <a href="https://doi.org/10.1016/j.bioorg.2020.104434" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104434%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DIdentification%252Band%252Bevaluation%252Bof%252Ba%252Bnapyradiomycin%252Bas%252Ba%252Bpotent%252BNrf2%252Bactivator%25253A%252BAnti-oxidative%252Band%252Banti-inflammatory%252Bactivities%26aulast%3DChoi%26aufirst%3DJi%2BWon%26date%3D2020%26volume%3D105%26spage%3D104434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Jun  Cai</span>, <span class="hlFld-ContribAuthor ">Li  Tu</span>, <span class="hlFld-ContribAuthor ">Xiao-Mo  Huang</span>, <span class="hlFld-ContribAuthor ">Jia  Huang</span>, <span class="hlFld-ContribAuthor ">Nan  Qiu</span>, <span class="hlFld-ContribAuthor ">Guang-Hong  Xie</span>, <span class="hlFld-ContribAuthor ">Jian-Xiong  Liao</span>, <span class="hlFld-ContribAuthor ">Wei  Du</span>, <span class="hlFld-ContribAuthor ">Ying-Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Jin-Yong  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">Molecular Brain</span><span> <strong>2020,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13041-020-00656-8" title="DOI URL">https://doi.org/10.1186/s13041-020-00656-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13041-020-00656-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13041-020-00656-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Brain%26atitle%3DLncRNA%252BMALAT1%252Bfacilitates%252Binflammasome%252Bactivation%252Bvia%252Bepigenetic%252Bsuppression%252Bof%252BNrf2%252Bin%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DCai%26aufirst%3DLi-Jun%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lun  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Cai</span>, <span class="hlFld-ContribAuthor ">Mingsong  Shi</span>, <span class="hlFld-ContribAuthor ">Linlin  Xue</span>, <span class="hlFld-ContribAuthor ">Shuang  Kuang</span>, <span class="hlFld-ContribAuthor ">Ruiling  Xu</span>, <span class="hlFld-ContribAuthor ">Wenyan  Qi</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Ma</span>, <span class="hlFld-ContribAuthor ">Ruijia  Zhang</span>, <span class="hlFld-ContribAuthor ">Feng  Hong</span>, <span class="hlFld-ContribAuthor ">Haoyu  Ye</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson’s disease via the activation of Nrf2/keap1 pathway. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>199 </em>, 112385. <a href="https://doi.org/10.1016/j.ejmech.2020.112385" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112385</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112385%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252Boptimization%252Bof%252Bpiperine%252Banalogues%252Bas%252Bneuroprotective%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%2525E2%252580%252599s%252Bdisease%252Bvia%252Bthe%252Bactivation%252Bof%252BNrf2%25252Fkeap1%252Bpathway%26aulast%3DWang%26aufirst%3DLun%26date%3D2020%26volume%3D199%26spage%3D112385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Hua  Rong</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Zhang</span>, <span class="hlFld-ContribAuthor ">Miaoxian  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Ferulic Acid Ameliorates MPP+/MPTP-Induced Oxidative Stress via ERK1/2-Dependent Nrf2 Activation: Translational Implications for Parkinson Disease Treatment. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurobiology</span><span> <strong>2020,</strong> <em>57 </em>
                                    (7)
                                     , 2981-2995. <a href="https://doi.org/10.1007/s12035-020-01934-1" title="DOI URL">https://doi.org/10.1007/s12035-020-01934-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12035-020-01934-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12035-020-01934-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurobiology%26atitle%3DFerulic%252BAcid%252BAmeliorates%252BMPP%25252B%25252FMPTP-Induced%252BOxidative%252BStress%252Bvia%252BERK1%25252F2-Dependent%252BNrf2%252BActivation%25253A%252BTranslational%252BImplications%252Bfor%252BParkinson%252BDisease%252BTreatment%26aulast%3DLi%26aufirst%3DXu%26date%3D2020%26date%3D2020%26volume%3D57%26issue%3D7%26spage%3D2981%26epage%3D2995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siwon  Kim</span>, <span class="hlFld-ContribAuthor ">Ambily Nath  Indu Viswanath</span>, <span class="hlFld-ContribAuthor ">Jong-Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Ha Eun  Lee</span>, <span class="hlFld-ContribAuthor ">A.Yeong  Park</span>, <span class="hlFld-ContribAuthor ">Ji Won  Choi</span>, <span class="hlFld-ContribAuthor ">Hyeon Jeong  Kim</span>, <span class="hlFld-ContribAuthor ">Ashwini M.  Londhe</span>, <span class="hlFld-ContribAuthor ">Bo Ko  Jang</span>, <span class="hlFld-ContribAuthor ">Jaeick  Lee</span>, <span class="hlFld-ContribAuthor ">Hayoung  Hwang</span>, <span class="hlFld-ContribAuthor ">Sang Min  Lim</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Ki Duk  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>167 </em>, 107989. <a href="https://doi.org/10.1016/j.neuropharm.2020.107989" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.107989</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.107989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.107989%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DNrf2%252Bactivator%252Bvia%252Binterference%252Bof%252BNrf2-Keap1%252Binteraction%252Bhas%252Bantioxidant%252Band%252Banti-inflammatory%252Bproperties%252Bin%252BParkinson%252527s%252Bdisease%252Banimal%252Bmodel%26aulast%3DKim%26aufirst%3DSiwon%26date%3D2020%26volume%3D167%26spage%3D107989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ariadni  Tzara</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Xanthopoulos</span>, <span class="hlFld-ContribAuthor ">Angeliki P.  Kourounakis</span>. </span><span class="cited-content_cbyCitation_article-title">Morpholine As a Scaffold in Medicinal Chemistry: An Update on Synthetic Strategies. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (5)
                                     , 392-403. <a href="https://doi.org/10.1002/cmdc.201900682" title="DOI URL">https://doi.org/10.1002/cmdc.201900682</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900682%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DMorpholine%252BAs%252Ba%252BScaffold%252Bin%252BMedicinal%252BChemistry%25253A%252BAn%252BUpdate%252Bon%252BSynthetic%252BStrategies%26aulast%3DTzara%26aufirst%3DAriadni%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D5%26spage%3D392%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haishan  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (3)
                                     , 209-225. <a href="https://doi.org/10.1080/13543776.2020.1715365" title="DOI URL">https://doi.org/10.1080/13543776.2020.1715365</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1715365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1715365%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRecent%252Bprogress%252Bin%252Bthe%252Bdevelopment%252Bof%252Bsmall%252Bmolecule%252BNrf2%252Bactivators%25253A%252Ba%252Bpatent%252Breview%252B%2525282017-present%252529%26aulast%3DZhou%26aufirst%3DHaishan%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D3%26spage%3D209%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angeliki P.  Kourounakis</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Xanthopoulos</span>, <span class="hlFld-ContribAuthor ">Ariadni  Tzara</span>. </span><span class="cited-content_cbyCitation_article-title">Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (2)
                                     , 709-752. <a href="https://doi.org/10.1002/med.21634" title="DOI URL">https://doi.org/10.1002/med.21634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21634%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMorpholine%252Bas%252Ba%252Bprivileged%252Bstructure%25253A%252BA%252Breview%252Bon%252Bthe%252Bmedicinal%252Bchemistry%252Band%252Bpharmacological%252Bactivity%252Bof%252Bmorpholine%252Bcontaining%252Bbioactive%252Bmolecules%26aulast%3DKourounakis%26aufirst%3DAngeliki%2BP.%26date%3D2020%26volume%3D40%26issue%3D2%26spage%3D709%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing-Mei  Yuan</span>, <span class="hlFld-ContribAuthor ">Jinnan  Li</span>, <span class="hlFld-ContribAuthor ">Heyang  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiali  Xu</span>, <span class="hlFld-ContribAuthor ">Fengting  Zhu</span>, <span class="hlFld-ContribAuthor ">Qiuli  Liang</span>, <span class="hlFld-ContribAuthor ">Zhiping  Liu</span>, <span class="hlFld-ContribAuthor ">Guobao  Huang</span>, <span class="hlFld-ContribAuthor ">Jun  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-sulfonylquinolines by visible-light promoted metal-free cascade cycloaddition involving
              N
              -propargylanilines and sodium sulfinates. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (8)
                                     , 3189-3193. <a href="https://doi.org/10.1039/C9NJ05248H" title="DOI URL">https://doi.org/10.1039/C9NJ05248H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ05248H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ05248H%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%252Bof%252B3-sulfonylquinolines%252Bby%252Bvisible-light%252Bpromoted%252Bmetal-free%252Bcascade%252Bcycloaddition%252Binvolving%252BN%252B-propargylanilines%252Band%252Bsodium%252Bsulfinates%26aulast%3DYuan%26aufirst%3DJing-Mei%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D8%26spage%3D3189%26epage%3D3193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">You-Chen  Lin</span>, <span class="hlFld-ContribAuthor ">Christina  Martinez-Brokaw</span>, <span class="hlFld-ContribAuthor ">Joshua G.  Pierce</span>. </span><span class="cited-content_cbyCitation_article-title">1,4-Oxazines and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00036-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00036-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00036-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00036-6%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C4-Oxazines%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DLin%26aufirst%3DYou-Chen%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyeon Jeong  Kim</span>, <span class="hlFld-ContribAuthor ">Bo Ko  Jang</span>, <span class="hlFld-ContribAuthor ">Jong-Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Ji Won  Choi</span>, <span class="hlFld-ContribAuthor ">Sun Jun  Park</span>, <span class="hlFld-ContribAuthor ">Seong Rim  Byeon</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Yong Sup  Lee</span>, <span class="hlFld-ContribAuthor ">Eunji  Cheong</span>, <span class="hlFld-ContribAuthor ">Ki Duk  Park</span>. </span><span class="cited-content_cbyCitation_article-title">A novel chalcone derivative as Nrf2 activator attenuates learning and memory impairment in a scopolamine-induced mouse model. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111777. <a href="https://doi.org/10.1016/j.ejmech.2019.111777" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111777</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111777%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bnovel%252Bchalcone%252Bderivative%252Bas%252BNrf2%252Bactivator%252Battenuates%252Blearning%252Band%252Bmemory%252Bimpairment%252Bin%252Ba%252Bscopolamine-induced%252Bmouse%252Bmodel%26aulast%3DKim%26aufirst%3DHyeon%2BJeong%26date%3D2020%26volume%3D185%26spage%3D111777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Wei</span>, <span class="hlFld-ContribAuthor ">Jing  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Xu</span>, <span class="hlFld-ContribAuthor ">Jing  Cui</span>, <span class="hlFld-ContribAuthor ">Feng-Feng  Ping</span>, <span class="hlFld-ContribAuthor ">Jing-Jing  Ling</span>, <span class="hlFld-ContribAuthor ">Ya-Jing  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of coumarin-derived imino sulfonates as a novel class of potential cardioprotective agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>184 </em>, 111779. <a href="https://doi.org/10.1016/j.ejmech.2019.111779" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111779</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111779%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bcoumarin-derived%252Bimino%252Bsulfonates%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bpotential%252Bcardioprotective%252Bagents%26aulast%3DWei%26aufirst%3DBo%26date%3D2019%26volume%3D184%26spage%3D111779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Guo</span>, <span class="hlFld-ContribAuthor ">Junrong  Zhu</span>, <span class="hlFld-ContribAuthor ">Jingwen  Wang</span>, <span class="hlFld-ContribAuthor ">Jialin  Duan</span>, <span class="hlFld-ContribAuthor ">Shanbo  Ma</span>, <span class="hlFld-ContribAuthor ">Ying  Yin</span>, <span class="hlFld-ContribAuthor ">Wei  Quan</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yue  Guan</span>, <span class="hlFld-ContribAuthor ">Yi  Ding</span>, <span class="hlFld-ContribAuthor ">Aidong  Wen</span>, <span class="hlFld-ContribAuthor ">Yingdong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both
              in vivo
              and
              in vitro
              models of Parkinson's disease. </span><span class="cited-content_cbyCitation_journal-name">Aging</span><span> <strong>2019,</strong> <em>11 </em>
                                    (21)
                                     , 9424-9441. <a href="https://doi.org/10.18632/aging.102394" title="DOI URL">https://doi.org/10.18632/aging.102394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/aging.102394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Faging.102394%26sid%3Dliteratum%253Aachs%26jtitle%3DAging%26atitle%3DNeuroprotective%252Beffects%252Bof%252Bprotocatechuic%252Baldehyde%252Bthrough%252BPLK2%25252Fp-GSK3%2525CE%2525B2%25252FNrf2%252Bsignaling%252Bpathway%252Bin%252Bboth%252Bin%252Bvivo%252Band%252Bin%252Bvitro%252Bmodels%252Bof%252BParkinson%252527s%252Bdisease%26aulast%3DGuo%26aufirst%3DChao%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D21%26spage%3D9424%26epage%3D9441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>5</b>–<b>8</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>11</b> and <b>12</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>17</b>–<b>19</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>23</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. <b>17e</b> induces nuclear translocation of Nrf2. (a) The Keap1–Nrf2 functional assay of engineered U2OS cells treated with various concentrations of <b>17e</b> for 6 h. Signal was detected as relative luminescence units of the saturated concentration using a chemiluminescent substrate. Cell viability assay of BV2 cells treated with various concentrations of <b>17e</b> for 24 (b) or 6 h (c, d). The amount of nuclear and total Nrf2 was measured by Western blot with lamin B1 as a nuclear marker; β-actin was used as an internal control. All experiments were performed in triplicate. Data are shown as mean ± standard error of the means and analyzed by Student’s <i>t</i>-test; * <i>P</i> < 0.05, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001 vs the vehicle-treated control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <b>17e</b> dose-dependently induced expression of antioxidant enzymes in BV2 cells. (a, b) BV2 cells were treated with various concentrations of <b>17e</b> for 24 h and then subjected to Western blot analysis of HO-1, GCLM, and GCLC using β-actin as an internal control. (c) BV2 cells were treated with various concentrations of <b>17e</b> for 6 h, and relative mRNA levels of Nrf2-dependent genes were measured by RT-qPCR; hypoxanthine-guanine phosphoribosyltransferase was used as an internal control. All experiments were performed in triplicate. Data are shown as mean ± standard error of the means and analyzed by Student’s <i>t</i>-test. * <i>P</i> < 0.05, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001 vs the vehicle-treated control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>17e</b> attenuates motor abnormalities in MPTP-induced PD mice. (a) Experimental protocols for vertical grid and coat-hanger behavioral tests. (b) Time to turn and total time were measured in the vertical grid test. (c) Coat-hanger test scores measured according to the position of the mouse. Data are shown as means ± standard error of the mean (<i>n</i> = 10 per group); * <i>P</i> < 0.05, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001 vs the MPTP-treated group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/medium/jm-2018-01527d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>17e</b> protects DAergic neurons and reduces microglial activation in MPTP-induced PD mice. (a) Representative immunohistochemical staining (brown, TH) in the striatum and SNpc. Bar graphs summarize TH-immunopositive density and cell numbers. (b) Representative double immunofluorescent staining in the SNpc (green, TH; red, Iba-1). Bar graph summarizing analysis of Iba-1 immunofluorescence intensity. Data are shown as the mean ± standard error of the mean (<i>n</i> = 6 per group); *** <i>P</i> < 0.001 vs the MPTP-treated group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01527/20190116/images/large/jm-2018-01527d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01527&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01758" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01758" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reeve, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simcox, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, D.</span></span> <span> </span><span class="NLM_article-title">Ageing and Parkinson’s Disease: Why Is Advancing Age the Biggest Risk Factor?</span>. <i>Ageing Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/j.arr.2014.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1016%2Fj.arr.2014.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=24503004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltl2ntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=19-30&author=A.+Reeveauthor=E.+Simcoxauthor=D.+Turnbull&title=Ageing+and+Parkinson%E2%80%99s+Disease%3A+Why+Is+Advancing+Age+the+Biggest+Risk+Factor%3F&doi=10.1016%2Fj.arr.2014.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?</span></div><div class="casAuthors">Reeve, Amy; Simcox, Eve; Turnbull, Doug</div><div class="citationInfo"><span class="NLM_cas:title">Ageing Research Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19-30</span>CODEN:
                <span class="NLM_cas:coden">ARRGAK</span>;
        ISSN:<span class="NLM_cas:issn">1568-1637</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  As the second most common age related neurodegenerative disease after Alzheimer's disease, the health, social and economic impact resulting from Parkinson's disease will continue to increase alongside the longevity of the population.  Ageing remains the biggest risk factor for developing idiopathic Parkinson's disease.  Although research into the mechanisms leading to cell death in Parkinson's disease has shed light on many aspects of the pathogenesis of this disorder, we still cannot answer the fundamental question, what specific age related factors predispose some individuals to develop this common neurodegenerative disease.  In this review we focus specifically on the neuronal population assocd. with the motor symptoms of Parkinson's disease, the dopaminergic neurons of the substantia nigra, and try to understand how ageing puts these neurons at risk to the extent that a slight change in protein metab. or mitochondrial function can push the cells over the edge leading to catastrophic cell death and many of the symptoms seen in Parkinson's disease.  We review the evidence that ageing is important for the development of Parkinson's disease and how age related decline leads to the loss of neurons within this disease, before describing exactly how advancing age may lead to substantia nigra neuronal loss and Parkinson's disease in some individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreiLPwxZJJ6bVg90H21EOLACvtfcHk0lgijnz49VVm0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltl2ntbc%253D&md5=2ed35c35b3da7ad23b93a08e06b2905f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.arr.2014.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arr.2014.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DReeve%26aufirst%3DA.%26aulast%3DSimcox%26aufirst%3DE.%26aulast%3DTurnbull%26aufirst%3DD.%26atitle%3DAgeing%2520and%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520Why%2520Is%2520Advancing%2520Age%2520the%2520Biggest%2520Risk%2520Factor%253F%26jtitle%3DAgeing%2520Res.%2520Rev.%26date%3D2014%26volume%3D14%26spage%3D19%26epage%3D30%26doi%3D10.1016%2Fj.arr.2014.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, G. L.</span></span> <span> </span><span class="NLM_article-title">Current Understanding of the Molecular Mechanisms in Parkinson’s Disease: Targets for Potential Treatments</span>. <i>Transl. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">28</span>, <span class="refDoi"> DOI: 10.1186/s40035-017-0099-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1186%2Fs40035-017-0099-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=29090092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlOrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=28&author=P.+Maitiauthor=J.+Mannaauthor=G.+L.+Dunbar&title=Current+Understanding+of+the+Molecular+Mechanisms+in+Parkinson%E2%80%99s+Disease%3A+Targets+for+Potential+Treatments&doi=10.1186%2Fs40035-017-0099-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Current understanding of the molecular mechanisms in parkinson's disease: targets for potential treatments</span></div><div class="casAuthors">Maiti, Panchanan; Manna, Jayeeta; Dunbar, Gary L.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Neurodegeneration</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28/1-28/35</span>CODEN:
                <span class="NLM_cas:coden">TNREAP</span>;
        ISSN:<span class="NLM_cas:issn">2047-9158</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Gradual degeneration and loss of dopaminergic neurons in the substantia nigra, pars compacta and subsequent redn. of dopamine levels in striatum are assocd. with motor deficits that characterize Parkinson's disease (PD).  In addn., half of the PD patients also exhibit frontostriatal-mediated executive dysfunction, including deficits in attention, short-term working memory, speed of mental processing, and impulsivity.  The most commonly used treatments for PD are only partially or transiently effective and are available or applicable to a minority of patients.  Because, these therapies neither restore the lost or degenerated dopaminergic neurons, nor prevent or delay the disease progression, the need for more effective therapeutics is crit.  In this review, we provide a comprehensive overview of the current understanding of the mol. signaling pathways involved in PD, particularly within the context of how genetic and environmental factors contribute to the initiation and progression of this disease.  The involvement of mol. chaperones, autophagy-lysosomal pathways, and proteasome systems in PD are also highlighted.  In addn., emerging therapies, including pharmacol. manipulations, surgical procedures, stem cell transplantation, gene therapy, as well as complementary, supportive and rehabilitation therapies to prevent or delay the progression of this complex disease are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl88QaNqVjT7Vg90H21EOLACvtfcHk0lgijnz49VVm0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlOrtb4%253D&md5=a97bb4699019a09d98b2ba4d43618dd2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2Fs40035-017-0099-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40035-017-0099-z%26sid%3Dliteratum%253Aachs%26aulast%3DMaiti%26aufirst%3DP.%26aulast%3DManna%26aufirst%3DJ.%26aulast%3DDunbar%26aufirst%3DG.%2BL.%26atitle%3DCurrent%2520Understanding%2520of%2520the%2520Molecular%2520Mechanisms%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520Targets%2520for%2520Potential%2520Treatments%26jtitle%3DTransl.%2520Neurodegener.%26date%3D2017%26volume%3D6%26spage%3D28%26doi%3D10.1186%2Fs40035-017-0099-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imam, S.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>, <span class="NLM_elocation-id">904</span> <span class="refDoi"> DOI: 10.3390/ijms17060904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.3390%2Fijms17060904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKktb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&author=S.+Sarkarauthor=J.+Raymickauthor=S.+Imam&title=Neuroprotective+and+Therapeutic+Strategies+against+Parkinson%E2%80%99s+Disease%3A+Recent+Perspectives&doi=10.3390%2Fijms17060904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective and therapeutic strategies against Parkinson's disease: recent perspectives</span></div><div class="casAuthors">Sarkar, Sumit; Raymick, James; Imam, Syed</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">904/1-904/31</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Parkinsonism is a progressive motor disease that affects 1.5 million Americans and is the second most common neurodegenerative disease after Alzheimer's.  Typical neuropathol. features of Parkinson's disease (PD) include degeneration of dopaminergic neurons located in the pars compacta of the substantia nigra that project to the striatum (nigro-striatal pathway) and depositions of cytoplasmic fibrillary inclusions (Lewy bodies) which contain ubiquitin and α-synuclein.  The cardinal motor signs of PD are tremors, rigidity, slow movement (bradykinesia), poor balance, and difficulty in walking (Parkinsonian gait).  In addn. to motor symptoms, non-motor symptoms that include autonomic and psychiatric as well as cognitive impairments are pressing issues that need to be addressed.  Several different mechanisms play an important role in generation of Lewy bodies; endoplasmic reticulum (ER) stress induced unfolded proteins, neuroinflammation and eventual loss of dopaminergic neurons in the substantia nigra of mid brain in PD.  Moreover, these diverse processes that result in PD make modeling of the disease and evaluation of therapeutics against this devastating disease difficult.  Here, we will discuss diverse mechanisms that are involved in PD, neuroprotective and therapeutic strategies currently in clin. trial or in preclin. stages, and impart views about strategies that are promising to mitigate PD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFw5yjGJ5dSrVg90H21EOLACvtfcHk0lgijnz49VVm0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKktb3P&md5=7b71b202aad876c50bdaaf11d497e1e8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fijms17060904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms17060904%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DRaymick%26aufirst%3DJ.%26aulast%3DImam%26aufirst%3DS.%26atitle%3DNeuroprotective%2520and%2520Therapeutic%2520Strategies%2520against%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520Recent%2520Perspectives%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D17%26doi%3D10.3390%2Fijms17060904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">AlDakheel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalia, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, A. E.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">6</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1007/s13311-013-0218-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1007%2Fs13311-013-0218-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=6-23&author=A.+AlDakheelauthor=L.+V.+Kaliaauthor=A.+E.+Lang&title=Pathogenesis-Targeted%2C+Disease-Modifying+Therapies+in+Parkinson+Disease&doi=10.1007%2Fs13311-013-0218-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs13311-013-0218-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-013-0218-1%26sid%3Dliteratum%253Aachs%26aulast%3DAlDakheel%26aufirst%3DA.%26aulast%3DKalia%26aufirst%3DL.%2BV.%26aulast%3DLang%26aufirst%3DA.%2BE.%26atitle%3DPathogenesis-Targeted%252C%2520Disease-Modifying%2520Therapies%2520in%2520Parkinson%2520Disease%26jtitle%3DNeurotherapeutics%26date%3D2014%26volume%3D11%26spage%3D6%26epage%3D23%26doi%3D10.1007%2Fs13311-013-0218-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Factor, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLong, M. R.</span></span> <span> </span><span class="NLM_article-title">Parkinson’s Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1038/npp.2011.212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1038%2Fnpp.2011.212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=21956442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=213-246&author=Y.+Smithauthor=T.+Wichmannauthor=S.+A.+Factorauthor=M.+R.+DeLong&title=Parkinson%E2%80%99s+Disease+Therapeutics%3A+New+Developments+and+Challenges+Since+the+Introduction+of+Levodopa&doi=10.1038%2Fnpp.2011.212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa</span></div><div class="casAuthors">Smith, Yoland; Wichmann, Thomas; Factor, Stewart A.; DeLong, Mahlon R.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">213-246</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The demonstration that dopamine loss is the key pathol. feature of Parkinson's disease (PD), and the subsequent introduction of levodopa have revolutionalized the field of PD therapeutics.  This review will discuss the significant progress that has been made in the development of new pharmacol. and surgical tools to treat PD motor symptoms since this major breakthrough in the 1960s.  However, we will also highlight some of the challenges the field of PD therapeutics has been struggling with during the past decades.  The lack of neuroprotective therapies and the limited treatment strategies for the nonmotor symptoms of the disease (ie, cognitive impairments, autonomic dysfunctions, psychiatric disorders, etc.) are among the most pressing issues to be addressed in the years to come.  It appears that the combination of early PD nonmotor symptoms with imaging of the nigrostriatal dopaminergic system offers a promising path toward the identification of PD biomarkers, which, once characterized, will set the stage for efficient use of neuroprotective agents that could slow down and alter the course of the disease.  Neuropsychopharmacol. Reviews (2012) 37, 213-246; doi:10.1038/npp.2011.212; published online 28 Sept. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKGa2hNY5gcbVg90H21EOLACvtfcHk0lglUB0MIlh2SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejsrbF&md5=d1e259530039c7e35aae30f77a939fe6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.212%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DY.%26aulast%3DWichmann%26aufirst%3DT.%26aulast%3DFactor%26aufirst%3DS.%2BA.%26aulast%3DDeLong%26aufirst%3DM.%2BR.%26atitle%3DParkinson%25E2%2580%2599s%2520Disease%2520Therapeutics%253A%2520New%2520Developments%2520and%2520Challenges%2520Since%2520the%2520Introduction%2520of%2520Levodopa%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D213%26epage%3D246%26doi%3D10.1038%2Fnpp.2011.212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rizek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jog, M. S.</span></span> <span> </span><span class="NLM_article-title">An Update on the Diagnosis and Treatment of Parkinson Disease</span>. <i>Can. Med. Assoc. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>188</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1165</span>, <span class="refDoi"> DOI: 10.1503/cmaj.151179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1503%2Fcmaj.151179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FjtVKrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2016&pages=1157-1165&author=P.+Rizekauthor=N.+Kumarauthor=M.+S.+Jog&title=An+Update+on+the+Diagnosis+and+Treatment+of+Parkinson+Disease&doi=10.1503%2Fcmaj.151179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An update on the diagnosis and treatment of Parkinson disease</span></div><div class="casAuthors">Rizek Philippe; Kumar Niraj; Jog Mandar S</div><div class="citationInfo"><span class="NLM_cas:title">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1157-1165</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJwnJGQ9n_whwLZxei1HN8fW6udTcc2eaq2_PQoh-OXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FjtVKrsQ%253D%253D&md5=965c7ad9631f880d1d91dde7bed09cd3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1503%2Fcmaj.151179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1503%252Fcmaj.151179%26sid%3Dliteratum%253Aachs%26aulast%3DRizek%26aufirst%3DP.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DJog%26aufirst%3DM.%2BS.%26atitle%3DAn%2520Update%2520on%2520the%2520Diagnosis%2520and%2520Treatment%2520of%2520Parkinson%2520Disease%26jtitle%3DCan.%2520Med.%2520Assoc.%2520J.%26date%3D2016%26volume%3D188%26spage%3D1157%26epage%3D1165%26doi%3D10.1503%2Fcmaj.151179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pahwa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacson, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nausieda, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hull, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stempien, M. J.</span></span> <span> </span><span class="NLM_article-title">ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial</span>. <i>JAMA Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">949</span>, <span class="refDoi"> DOI: 10.1001/jamaneurol.2017.0943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1001%2Fjamaneurol.2017.0943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=28604926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A280%3ADC%252BC1cnntlGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2017&pages=941-949&author=R.+Pahwaauthor=C.+M.+Tannerauthor=R.+A.+Hauserauthor=S.+H.+Isaacsonauthor=P.+A.+Nausiedaauthor=D.+D.+Truongauthor=P.+Agarwalauthor=K.+L.+Hullauthor=K.+E.+Lyonsauthor=R.+Johnsonauthor=M.+J.+Stempien&title=ADS-5102+%28Amantadine%29+Extended-Release+Capsules+for+Levodopa-Induced+Dyskinesia+in+Parkinson+Disease+%28EASE+LID+Study%29%3A+A+Randomized+Clinical+Trial&doi=10.1001%2Fjamaneurol.2017.0943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial</span></div><div class="casAuthors">Pahwa Rajesh; Lyons Kelly E; Tanner Caroline M; Tanner Caroline M; Hauser Robert A; Isaacson Stuart H; Nausieda Paul A; Truong Daniel D; Agarwal Pinky; Hull Keith L; Johnson Reed; Stempien Mary Jean</div><div class="citationInfo"><span class="NLM_cas:title">JAMA neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">941-949</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Importance:  Medical treatment of levodopa-induced dyskinesia (LID) in Parkinson disease (PD) is an unmet need.  Objective:  To evaluate the efficacy and safety of ADS-5102 (amantadine) extended-release 274-mg capsules for treatment of LID in patients with PD.  Design, Setting, and Participants:  A randomized, double-blind, placebo-controlled clinical trial was conducted between May 7, 2014, and July 22, 2015, at 44 North American sites among patients with PD treated with levodopa who experienced at least 1 hour of troublesome dyskinesia per day with at least mild functional impact.  Interventions:  Patients were randomized to receive placebo or 274 mg of ADS-5102 administered orally at bedtime for up to 25 weeks.  Main Outcomes and Measures:  The primary efficacy analysis was the change from baseline to week 12 in the Unified Dyskinesia Rating Scale total score for ADS-5102 vs placebo in the modified intent-to-treat population.  OFF time (amount of time the PD medication is not controlling motor symptoms) was a key secondary end point.  Safety analyses included all patients who received the study drug (ADS-5102 or placebo).  Results:  A total of 189 patients were screened, and 126 were randomized; the modified intent-to-treat population included 121 patients (51 women and 70 men; mean [SD] age, 64.7 [9.1] years).  At week 12, the least-squares mean (SE) change in the Unified Dyskinesia Rating Scale score was -15.9 (1.6) for ADS-5102 (n = 63) and -8.0 (1.6) for placebo (n = 58) (treatment difference, -7.9; 95% CI, -12.5 to -3.3; P < .001).  OFF time decreased by a mean (SE) of 0.6 (0.3) hours for ADS-5102 and increased by 0.3 (0.3) hours for placebo (treatment difference, -0.9 hours; 95% CI, -1.6 to -0.2; P = .02).  Common adverse events for ADS-5102 vs placebo included visual hallucinations (15 [23.8%] vs 1 [1.7%]), peripheral edema (15 [23.8%] vs 0), and dizziness (14 [22.2%] vs 0).  Adverse events led to treatment discontinuation for 13 patients receiving ADS-5102 (20.6%) vs 4 patients receiving placebo (6.9%).  Conclusions and Relevance:  ADS-5102, 274 mg at bedtime, may be an effective treatment for LID.  An additional benefit is reduced OFF time.  To our knowledge, this is the first demonstration of an oral treatment reducing both LID and OFF time in patients with PD with dyskinesia.  Trial Registration:  clinicaltrials.gov Identifier: NCT02136914.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBUNsJZAeUhbesJRIHUP1ofW6udTcc2eaq2_PQoh-OXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnntlGhtg%253D%253D&md5=90caa8d3c82cb96280c497501565b129</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1001%2Fjamaneurol.2017.0943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaneurol.2017.0943%26sid%3Dliteratum%253Aachs%26aulast%3DPahwa%26aufirst%3DR.%26aulast%3DTanner%26aufirst%3DC.%2BM.%26aulast%3DHauser%26aufirst%3DR.%2BA.%26aulast%3DIsaacson%26aufirst%3DS.%2BH.%26aulast%3DNausieda%26aufirst%3DP.%2BA.%26aulast%3DTruong%26aufirst%3DD.%2BD.%26aulast%3DAgarwal%26aufirst%3DP.%26aulast%3DHull%26aufirst%3DK.%2BL.%26aulast%3DLyons%26aufirst%3DK.%2BE.%26aulast%3DJohnson%26aufirst%3DR.%26aulast%3DStempien%26aufirst%3DM.%2BJ.%26atitle%3DADS-5102%2520%2528Amantadine%2529%2520Extended-Release%2520Capsules%2520for%2520Levodopa-Induced%2520Dyskinesia%2520in%2520Parkinson%2520Disease%2520%2528EASE%2520LID%2520Study%2529%253A%2520A%2520Randomized%2520Clinical%2520Trial%26jtitle%3DJAMA%2520Neurol.%26date%3D2017%26volume%3D74%26spage%3D941%26epage%3D949%26doi%3D10.1001%2Fjamaneurol.2017.0943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. S.</span></span> <span> </span><span class="NLM_article-title">Toward Neuroprotective Treatments of Parkinson’s Disease</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">3795</span>– <span class="NLM_lpage">3797</span>, <span class="refDoi"> DOI: 10.1073/pnas.1703362114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1073%2Fpnas.1703362114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=3795-3797&author=K.+S.+Kim&title=Toward+Neuroprotective+Treatments+of+Parkinson%E2%80%99s+Disease&doi=10.1073%2Fpnas.1703362114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1703362114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1703362114%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BS.%26atitle%3DToward%2520Neuroprotective%2520Treatments%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D3795%26epage%3D3797%26doi%3D10.1073%2Fpnas.1703362114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, W.</span></span> <span> </span><span class="NLM_article-title">Current Pharmaceutical Treatments and Alternative Therapies of Parkinson’s Disease</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.2174/1570159X14666151120123025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.2174%2F1570159X14666151120123025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=26585523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVOqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=339-355&author=J.+Dongauthor=Y.+Cuiauthor=S.+Liauthor=W.+Le&title=Current+Pharmaceutical+Treatments+and+Alternative+Therapies+of+Parkinson%E2%80%99s+Disease&doi=10.2174%2F1570159X14666151120123025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease</span></div><div class="casAuthors">Dong, Jie; Cui, Yanhua; Li, Song; Le, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">339-355</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Over the decades, pharmaceutical treatments, particularly dopaminergic (DAergic) drugs have been considered as the main therapy against motor symptoms of Parkinson's disease (PD).  It is proposed that DAergic drugs in combination with other medications, such as monoamine oxidase type B inhibitors, catechol-O-Me transferase inhibitors, anticholinergics and other newly developed non-DAergic drugs can make a better control of motor symptoms or alleviate levodopa-induced motor complications.  Moreover, non-motor symptoms of PD, such as cognitive, neuropsychiatric, sleep, autonomic and sensory disturbances caused by intrinsic PD pathol. or drug-induced side effects, are gaining increasing attention and urgently need to be taken care of due to their impact on quality of life.  Currently, neuroprotective therapies have been investigated extensively in pre-clin. studies, and some of them have been subjected to clin. trials.  Furthermore, non-pharmaceutical treatments, including deep brain stimulation (DBS), gene therapy, cell replacement therapy and some complementary managements, such as Tai chi, Yoga, traditional herbs and mol. targeted therapies have also been considered as effective alternative therapies to classical pharmaceutics.  This review will provide us updated information regarding the current drugs and non-drugs therapies for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5zCGF-keur7Vg90H21EOLACvtfcHk0ljolNPfpFktPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVOqt7w%253D&md5=8cc305e81e3126a87967b2488e97b42c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F1570159X14666151120123025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X14666151120123025%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLe%26aufirst%3DW.%26atitle%3DCurrent%2520Pharmaceutical%2520Treatments%2520and%2520Alternative%2520Therapies%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2016%26volume%3D14%26spage%3D339%26epage%3D355%26doi%3D10.2174%2F1570159X14666151120123025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michel, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunot, S.</span></span> <span> </span><span class="NLM_article-title">Understanding Dopaminergic Cell Death Pathways in Parkinson Disease</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2016.03.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1016%2Fj.neuron.2016.03.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=27196972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC28Xotlehsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=675-691&author=P.+P.+Michelauthor=E.+C.+Hirschauthor=S.+Hunot&title=Understanding+Dopaminergic+Cell+Death+Pathways+in+Parkinson+Disease&doi=10.1016%2Fj.neuron.2016.03.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding Dopaminergic Cell Death Pathways in Parkinson Disease</span></div><div class="casAuthors">Michel, Patrick P.; Hirsch, Etienne C.; Hunot, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">675-691</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Parkinson disease (PD) is a multifactorial neurodegenerative disorder, the etiol. of which remains largely unknown.  Progressive impairment of voluntary motor control, which represents the primary clin. feature of the disease, is caused by a loss of midbrain substantia nigra dopamine (DA) neurons.  We present here a synthetic overview of cell-autonomous mechanisms that are likely to participate in DA cell death in both sporadic and inherited forms of the disease.  In particular, we describe how damage to vulnerable DA neurons may arise from cellular disturbances produced by protein misfolding and aggregation, disruption of autophagic catabolism, endoplasmic reticulum (ER) stress, mitochondrial dysfunction, or loss of calcium homeostasis.  Where pertinent, we show how these mechanisms may mutually cooperate to promote neuronal death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvlzkQ3un99bVg90H21EOLACvtfcHk0ljolNPfpFktPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xotlehsbc%253D&md5=82b13858c9daff03ba1fcdf74d2e16e9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.03.038%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DHunot%26aufirst%3DS.%26atitle%3DUnderstanding%2520Dopaminergic%2520Cell%2520Death%2520Pathways%2520in%2520Parkinson%2520Disease%26jtitle%3DNeuron%26date%3D2016%26volume%3D90%26spage%3D675%26epage%3D691%26doi%3D10.1016%2Fj.neuron.2016.03.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puspita, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, J. W.</span></span> <span> </span><span class="NLM_article-title">Oxidative Stress and Cellular Pathologies in Parkinson’s Disease</span>. <i>Mol. Brain</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">53</span>, <span class="refDoi"> DOI: 10.1186/s13041-017-0340-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1186%2Fs13041-017-0340-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=29183391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFWmtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=53&author=L.+Puspitaauthor=S.+Y.+Chungauthor=J.+W.+Shim&title=Oxidative+Stress+and+Cellular+Pathologies+in+Parkinson%E2%80%99s+Disease&doi=10.1186%2Fs13041-017-0340-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and cellular pathologies in Parkinson's disease</span></div><div class="casAuthors">Puspita, Lesly; Chung, Sun Young; Shim, Jae-Won</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53/1-53/12</span>CODEN:
                <span class="NLM_cas:coden">MBORAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-6606</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is a chronic and progressive neurodegeneration of dopamine neurons in the substantia nigra.  The reason for the death of these neurons is unclear; however, studies have demonstrated the potential involvement of mitochondria, endoplasmic reticulum, α-synuclein or dopamine levels in contributing to cellular oxidative stress as well as PD symptoms.  Even though those papers had sep. described the individual roles of each element leading to neurodegeneration, recent publications suggest that neurodegeneration is the product of various cellular interactions.  This review discusses the role of oxidative stress in mediating sep. pathol. events that together, ultimately result in cell death in PD.  Understanding the multi-faceted relationships between these events, with oxidative stress as a common denominator underlying these processes, is needed for developing better therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgYX_i8fchLbVg90H21EOLACvtfcHk0ljolNPfpFktPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFWmtb%252FO&md5=fba063f39209bb90e72a69bf52292d50</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1186%2Fs13041-017-0340-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13041-017-0340-9%26sid%3Dliteratum%253Aachs%26aulast%3DPuspita%26aufirst%3DL.%26aulast%3DChung%26aufirst%3DS.%2BY.%26aulast%3DShim%26aufirst%3DJ.%2BW.%26atitle%3DOxidative%2520Stress%2520and%2520Cellular%2520Pathologies%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DMol.%2520Brain%26date%3D2017%26volume%3D10%26spage%3D53%26doi%3D10.1186%2Fs13041-017-0340-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dallé, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mabandla, M. V.</span></span> <span> </span><span class="NLM_article-title">Early Life Stress, Depression and Parkinson’s Disease: A New Approach</span>. <i>Mol. Brain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">18</span>, <span class="refDoi"> DOI: 10.1186/s13041-018-0356-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1186%2Fs13041-018-0356-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=29551090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1enu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=18&author=E.+Dall%C3%A9author=M.+V.+Mabandla&title=Early+Life+Stress%2C+Depression+and+Parkinson%E2%80%99s+Disease%3A+A+New+Approach&doi=10.1186%2Fs13041-018-0356-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Early life stress, depression and parkinson's disease: a new approach</span></div><div class="casAuthors">Dalle, Ernest; Mabandla, Musa V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18/1-18/13</span>CODEN:
                <span class="NLM_cas:coden">MBORAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-6606</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">This review aims to shed light on the relationship that involves exposure to early life stress, depression and Parkinson's disease (PD).  A systematic literature search was conducted in Pubmed, MEDLINE, EBSCOHost and Google Scholar and relevant data were submitted to a meta-anal.  Early life stress may contribute to the development of depression and patients with depression are at risk of developing PD later in life.  Depression is a common non-motor symptom preceding motor symptoms in PD.  Stimulation of regions contiguous to the substantia nigra as well as dopamine (DA) agonists have been shown to be able to attenuate depression.  Therefore, since PD causes depletion of dopaminergic neurons in the substantia nigra, depression, rather than being just a simple mood disorder, may be part of the pathophysiol. process that leads to PD.  It is plausible that the mesocortical and mesolimbic dopaminergic pathways that mediate mood, emotion, and/or cognitive function may also play a key role in depression assocd. with PD.  Here, we propose that a medication designed to address a deficiency in serotonin is more likely to influence motor symptoms of PD assocd. with depression.  This review highlights the effects of an antidepressant, Fluvoxamine maleate, in an animal model that combines depressive-like symptoms and Parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI2eKfCZ4oZbVg90H21EOLACvtfcHk0liyNTBauKLgiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1enu7fE&md5=ff5d57076fa3ded8bece2dd95c7e4131</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2Fs13041-018-0356-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13041-018-0356-9%26sid%3Dliteratum%253Aachs%26aulast%3DDall%25C3%25A9%26aufirst%3DE.%26aulast%3DMabandla%26aufirst%3DM.%2BV.%26atitle%3DEarly%2520Life%2520Stress%252C%2520Depression%2520and%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520A%2520New%2520Approach%26jtitle%3DMol.%2520Brain%26date%3D2018%26volume%3D11%26spage%3D18%26doi%3D10.1186%2Fs13041-018-0356-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dias, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouradian, M. M.</span></span> <span> </span><span class="NLM_article-title">The Role of Oxidative Stress in Parkinson’s Disease</span>. <i>J. Parkinson’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.3233/JPD-130230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.3233%2FJPD-130230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=24252804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2iur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=461-491&author=V.+Diasauthor=E.+Junnauthor=M.+M.+Mouradian&title=The+Role+of+Oxidative+Stress+in+Parkinson%E2%80%99s+Disease&doi=10.3233%2FJPD-130230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Oxidative Stress in Parkinson's Disease</span></div><div class="casAuthors">Dias, Vera; Junn, Eunsung; Mouradian, M. Maral</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Parkinson's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">461-491</span>CODEN:
                <span class="NLM_cas:coden">JPDOAP</span>;
        ISSN:<span class="NLM_cas:issn">1877-7171</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Oxidative stress plays an important role in the degeneration of dopaminergic neurons in Parkinson's disease (PD).  Disruptions in the physiol. maintenance of the redox potential in neurons interfere with several biol. processes, ultimately leading to cell death.  Evidence has been developed for oxidative and nitrative damage to key cellular components in the PD substantia nigra.  A no. of sources and mechanisms for the generation of reactive oxygen species (ROS) are recognized including the metab. of dopamine itself, mitochondrial dysfunction, iron, neuroinflammatory cells, calcium, and aging.  PD causing gene products including DJ-1, PINK1, parkin, alpha-synuclein and LRRK2 also impact in complex ways mitochondrial function leading to exacerbation of ROS generation and susceptibility to oxidative stress.  Addnl., cellular homeostatic processes including the ubiquitin-proteasome system and mitophagy are impacted by oxidative stress.  It is apparent that the interplay between these various mechanisms contributes to neurodegeneration in PD as a feed forward scenario where primary insults lead to oxidative stress, which damages key cellular pathogenetic proteins that in turn cause more ROS prodn.  Animal models of PD have yielded some insights into the mol. pathways of neuronal degeneration and highlighted previously unknown mechanisms by which oxidative stress contributes to PD.  However, therapeutic attempts to target the general state of oxidative stress in clin. trials have failed to demonstrate an impact on disease progression.  Recent knowledge gained about the specific mechanisms related to PD gene products that modulate ROS prodn. and the response of neurons to stress may provide targeted new approaches towards neuroprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyB_eTkTn3e7Vg90H21EOLACvtfcHk0liyNTBauKLgiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2iur%252FM&md5=f7fb58575347af0b3221675e8f71631d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3233%2FJPD-130230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJPD-130230%26sid%3Dliteratum%253Aachs%26aulast%3DDias%26aufirst%3DV.%26aulast%3DJunn%26aufirst%3DE.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26atitle%3DThe%2520Role%2520of%2520Oxidative%2520Stress%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Parkinson%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D3%26spage%3D461%26epage%3D491%26doi%3D10.3233%2FJPD-130230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavala-Flores, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Rocha, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span> <span> </span><span class="NLM_article-title">Thiol-Redox Signaling, Dopaminergic Cell Death, and Parkinson’s Disease</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1764</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1089/ars.2011.4501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1089%2Fars.2011.4501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=22369136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFagtb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1764-1784&author=A.+Garcia-Garciaauthor=L.+Zavala-Floresauthor=H.+Rodriguez-Rochaauthor=R.+Franco&title=Thiol-Redox+Signaling%2C+Dopaminergic+Cell+Death%2C+and+Parkinson%E2%80%99s+Disease&doi=10.1089%2Fars.2011.4501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Thiol-Redox Signaling, Dopaminergic Cell Death, and Parkinson's Disease</span></div><div class="casAuthors">Garcia-Garcia, Aracely; Zavala-Flores, Laura; Rodriguez-Rocha, Humberto; Franco, Rodrigo</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1764-1784</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Significance: Parkinson's disease (PD) is characterized by the selective loss of dopaminergic neurons of the substantia nigra pars compacta, which has been widely assocd. with oxidative stress.  However, the mechanisms by which redox signaling regulates cell death progression remain elusive.  Recent Advances: Early studies demonstrated that depletion of glutathione (GSH), the most abundant low-mol.-wt. thiol and major antioxidant defense in cells, is one of the earliest biochem. events assocd. with PD, prompting researchers to det. the role of oxidative stress in dopaminergic cell death.  Since then, the concept of oxidative stress has evolved into redox signaling, and its complexity is highlighted by the discovery of a variety of thiol-based redox-dependent processes regulating not only oxidative damage, but also the activation of a myriad of signaling/enzymic mechanisms.  Crit. Issues: GSH and GSH-based antioxidant systems are important regulators of neurodegeneration assocd. with PD.  In addn., thiol-based redox systems, such as peroxiredoxins, thioredoxins, metallothioneins, methionine sulfoxide reductases, transcription factors, as well as oxidative modifications in protein thiols (cysteines), including cysteine hydroxylation, glutathionylation, and nitrosylation, have been demonstrated to regulate dopaminergic cell loss.  Future Directions: In this review, we summarize major advances in the understanding of the role of thiol-redox signaling in dopaminergic cell death in exptl. PD.  Future research is still required to clearly understand how integrated thiol-redox signaling regulates the activation of the cell death machinery, and the knowledge generated should open new avenues for the design of novel therapeutic approaches against PD.  Antioxid. Redox Signal. 17, 1764-1784.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwVBqRQzDPOrVg90H21EOLACvtfcHk0liyNTBauKLgiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFagtb%252FE&md5=95fc98ad0be27fa11022f356a5bebd2b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1089%2Fars.2011.4501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2011.4501%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Garcia%26aufirst%3DA.%26aulast%3DZavala-Flores%26aufirst%3DL.%26aulast%3DRodriguez-Rocha%26aufirst%3DH.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DThiol-Redox%2520Signaling%252C%2520Dopaminergic%2520Cell%2520Death%252C%2520and%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2012%26volume%3D17%26spage%3D1764%26epage%3D1784%26doi%3D10.1089%2Fars.2011.4501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristóvão, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guhathakurta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joh, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidase 1-Mediated Oxidative Stress Leads to Dopamine Neuron Death in Parkinson’s Disease</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1045</span>, <span class="refDoi"> DOI: 10.1089/ars.2011.3960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1089%2Fars.2011.3960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=22098189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVSqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=1033-1045&author=D.+H.+Choiauthor=A.+C.+Crist%C3%B3v%C3%A3oauthor=S.+Guhathakurtaauthor=J.+Leeauthor=T.+H.+Johauthor=M.+F.+Bealauthor=Y.+S.+Kim&title=NADPH+Oxidase+1-Mediated+Oxidative+Stress+Leads+to+Dopamine+Neuron+Death+in+Parkinson%E2%80%99s+Disease&doi=10.1089%2Fars.2011.3960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">NADPH Oxidase 1-Mediated Oxidative Stress Leads to Dopamine Neuron Death in Parkinson's Disease</span></div><div class="casAuthors">Choi, Dong-Hee; Cristovao, Ana Clara; Guhathakurta, Subhrangshu; Lee, Jongmin; Joh, Tong H.; Beal, M. Flint; Kim, Yoon-Seong</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1033-1045, S1033/1-S1033/4</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aim: Oxidative stress has long been considered as a major contributing factor in the pathogenesis of Parkinson's disease.  However, mol. sources for reactive oxygen species in Parkinson's disease have not been clearly elucidated.  Herein, we sought to investigate whether a superoxide-producing NADPH oxidases (NOXs) are implicated in oxidative stress-mediated dopaminergic neuronal degeneration.  Results: Expression of various Nox isoforms and cytoplasmic components were investigated in N27, rat dopaminergic cells.  While most of Nox isoforms were constitutively expressed, Nox1 expression was significantly increased after treatment with 6-hydroxydopamine.  Rac1, a key regulator in the Nox1 system, was also activated.  Striatal injection of 6-hydroxydopamine increased Nox1 expression in dopaminergic neurons in the rat substantia nigra.  Interestingly, it was localized into the nucleus, and immunostaining for DNA oxidative stress marker, 8-oxo-dG, was increased.  Nox1expression was also found in the nucleus of dopaminergic neurons in the substantia nigra of Parkinson's disease patients.  Adeno-assocd. virus-mediated Nox1 knockdown or Rac1 inhibition reduced 6-hydroxydopamine-induced oxidative DNA damage and dopaminergic neuronal degeneration significantly.  Innovation: Nox1/Rac1 could serve as a potential therapeutic target for Parkinson's disease.  Conclusion: We provide evidence that dopaminergic neurons are equipped with the Nox1/Rac1 superoxide-generating system.  Stress-induced Nox1/Rac1 activation causes oxidative DNA damage and neurodegeneration.  Reduced dopaminergic neuronal death achieved by targeting Nox1/Rac1, emphasizes the impact of oxidative stress caused by this system on the pathogenesis and therapy in Parkinson's disease.  Antioxid. Redox Signal. 16, 1033-1045.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoke7Gavp_GZrVg90H21EOLACvtfcHk0ljyWWKq49I9-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVSqsrg%253D&md5=633e2c7369bdb87dbe1fa7a8d633f516</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1089%2Fars.2011.3960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2011.3960%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DD.%2BH.%26aulast%3DCrist%25C3%25B3v%25C3%25A3o%26aufirst%3DA.%2BC.%26aulast%3DGuhathakurta%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJoh%26aufirst%3DT.%2BH.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DNADPH%2520Oxidase%25201-Mediated%2520Oxidative%2520Stress%2520Leads%2520to%2520Dopamine%2520Neuron%2520Death%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2012%26volume%3D16%26spage%3D1033%26epage%3D1045%26doi%3D10.1089%2Fars.2011.3960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, O.</span></span> <span> </span><span class="NLM_article-title">Activation of the Nrf2 Signaling Pathway and Neuroprotection of Nigral Dopaminergic Neurons by a Novel Synthetic Compound KMS99220</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2017.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1016%2Fj.neuint.2017.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=29158022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOiur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2018&pages=96-107&author=J.+A.+Leeauthor=H.+J.+Sonauthor=J.+W.+Choiauthor=J.+Kimauthor=S.+H.+Hanauthor=N.+Shinauthor=J.+H.+Kimauthor=S.+J.+Kimauthor=J.+Y.+Heoauthor=D.+J.+Kimauthor=K.+D.+Parkauthor=O.+Hwang&title=Activation+of+the+Nrf2+Signaling+Pathway+and+Neuroprotection+of+Nigral+Dopaminergic+Neurons+by+a+Novel+Synthetic+Compound+KMS99220&doi=10.1016%2Fj.neuint.2017.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220</span></div><div class="casAuthors">Lee, Ji Ae; Son, Hyo Jin; Choi, Ji Won; Kim, Jinwoo; Han, Se Hee; Shin, Nari; Kim, Ji Hyun; Kim, Soo Jeong; Heo, Jun Young; Kim, Dong Jin; Park, Ki Duk; Hwang, Onyou</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96-107</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 is known to induce gene expression of antioxidant enzymes and proteasome subunits.  Because both oxidative stress and protein aggregation have damaging effects on neurons, activation of the Nrf2 signaling should be beneficial against neurodegeneration.  In this study, we report a novel synthetic morpholine-contg. chalcone KMS99220 that confers neuroprotection.  It showed high binding affinity to the Nrf2 inhibitory protein Keap-1 and increased nuclear translocation of Nrf2 and gene expression of the antioxidant enzymes heme oxygenase-1, NAD(P)H:quinone oxidoreductase-1, and the catalytic and modifier subunits of glutamate-cysteine ligase in dopaminergic CATH.a cells.  KMS99220 also increased expression of the proteasome subunits PSMB5, PSMB7, PSMB8 and PSMA1, and the resp. chymotrypsin and trypsin-like proteasomal enzyme activities, and reduced α-synuclein aggregate in GFP-α-syn A53T-overexpressing cells.  KMS99220 exhibited a favorable pharmacokinetic profile with excellent bioavailability and metabolic stability, did not interfere with activities of the cytochrome P 450 isotypes, and showed no apparent in vivo toxicity when administered up to 2000 mg/kg.  In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, oral administration of KMS99220 prevented degeneration of the nigral dopaminergic neurons, induced the Nrf2 target genes, and effectively prevented the assocd. motor deficits.  These results suggest KMS99220 as a potential candidate for therapy against Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD447oQRdnILVg90H21EOLACvtfcHk0ljyWWKq49I9-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOiur3K&md5=1d50ff474c77fe5d59fdce862754d1ed</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2017.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2017.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DSon%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DS.%2BH.%26aulast%3DShin%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DHeo%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DPark%26aufirst%3DK.%2BD.%26aulast%3DHwang%26aufirst%3DO.%26atitle%3DActivation%2520of%2520the%2520Nrf2%2520Signaling%2520Pathway%2520and%2520Neuroprotection%2520of%2520Nigral%2520Dopaminergic%2520Neurons%2520by%2520a%2520Novel%2520Synthetic%2520Compound%2520KMS99220%26jtitle%3DNeurochem.%2520Int.%26date%3D2018%26volume%3D112%26spage%3D96%26epage%3D107%26doi%3D10.1016%2Fj.neuint.2017.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caporaso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Racchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer’s Disease: A Rational Approach</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1618</span>– <span class="NLM_lpage">1627</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00100</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00100" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt1amu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1618-1627&author=E.+Simoniauthor=M.+M.+Serafiniauthor=R.+Caporasoauthor=C.+Marchettiauthor=M.+Racchiauthor=A.+Minariniauthor=M.+Bartoliniauthor=C.+Lanniauthor=M.+Rosini&title=Targeting+the+Nrf2%2FAmyloid-Beta+Liaison+in+Alzheimer%E2%80%99s+Disease%3A+A+Rational+Approach&doi=10.1021%2Facschemneuro.7b00100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational Approach</span></div><div class="casAuthors">Simoni, Elena; Serafini, Melania M.; Caporaso, Roberta; Marchetti, Chiara; Racchi, Marco; Minarini, Anna; Bartolini, Manuela; Lanni, Cristina; Rosini, Michela</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1618-1627</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amyloid is a prominent feature of Alzheimer's disease (AD).  Yet, a linear linkage between amyloid-β peptide (Aβ) and the disease onset and progression has recently been questioned.  In this context, the crucial partnership between Aβ and Nrf2 pathways is acquiring paramount importance, offering prospects for deciphering the Aβ-centered disease network.  Here, we report on a new class of antiaggregating agents rationally designed to simultaneously activate transcription-based antioxidant responses, whose lead 1 showed interesting properties in a preliminary investigation.  Relying on the requirements of Aβ recognition, we identified the catechol deriv. 12.  In SH-SY5Y neuroblastoma cells, 12 combined remarkable free radical scavenger properties to the ability to trigger the Nrf2 pathway and induce the Nrf2-dependent defensive gene NQO1 by means of electrophilic activation of the transcriptional response.  Moreover, 12 prevented the formation of cytotoxic stable oligomeric intermediates, being significantly more effective, and per se less toxic, than prototype 1.  More importantly, as different chem. features were exploited to regulate Nrf2 and Aβ activities, the two pathways could be tuned independently.  These findings point to compd. 12 and its derivs. as promising tools for investigating the therapeutic potential of the Nrf2/Aβ cellular network, laying foundation for generating new drug leads to confront AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkXBQ0LGYZrLVg90H21EOLACvtfcHk0ljyWWKq49I9-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt1amu7o%253D&md5=29a4aee2a516521ef138729b55665ff9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00100%26sid%3Dliteratum%253Aachs%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DSerafini%26aufirst%3DM.%2BM.%26aulast%3DCaporaso%26aufirst%3DR.%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DLanni%26aufirst%3DC.%26aulast%3DRosini%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520Nrf2%252FAmyloid-Beta%2520Liaison%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Rational%2520Approach%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D1618%26epage%3D1627%26doi%3D10.1021%2Facschemneuro.7b00100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shekh-Ahmad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidu, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovac, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramov, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M. C.</span></span> <span> </span><span class="NLM_article-title">KEAP1 Inhibition Is Neuroprotective and Suppresses the Development of Epilepsy</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">1390</span>– <span class="NLM_lpage">1403</span>, <span class="refDoi"> DOI: 10.1093/brain/awy071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1093%2Fbrain%2Fawy071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2018&pages=1390-1403&author=T.+Shekh-Ahmadauthor=R.+Eckelauthor=S.+D.+Naiduauthor=M.+Higginsauthor=M.+Yamamotoauthor=A.+T.+Dinkova-Kostovaauthor=S.+Kovacauthor=A.+Y.+Abramovauthor=M.+C.+Walker&title=KEAP1+Inhibition+Is+Neuroprotective+and+Suppresses+the+Development+of+Epilepsy&doi=10.1093%2Fbrain%2Fawy071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawy071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawy071%26sid%3Dliteratum%253Aachs%26aulast%3DShekh-Ahmad%26aufirst%3DT.%26aulast%3DEckel%26aufirst%3DR.%26aulast%3DNaidu%26aufirst%3DS.%2BD.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DKovac%26aufirst%3DS.%26aulast%3DAbramov%26aufirst%3DA.%2BY.%26aulast%3DWalker%26aufirst%3DM.%2BC.%26atitle%3DKEAP1%2520Inhibition%2520Is%2520Neuroprotective%2520and%2520Suppresses%2520the%2520Development%2520of%2520Epilepsy%26jtitle%3DBrain%26date%3D2018%26volume%3D141%26spage%3D1390%26epage%3D1403%26doi%3D10.1093%2Fbrain%2Fawy071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lastres-Becker, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Yagüe, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casarejos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kügler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rábano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy against Synucleinopathy in Parkinson’s Disease</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1089/ars.2015.6549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1089%2Fars.2015.6549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=27009601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFegtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=61-77&author=I.+Lastres-Beckerauthor=A.+J.+Garc%C3%ADa-Yag%C3%BCeauthor=R.+H.+Scannevinauthor=M.+J.+Casarejosauthor=S.+K%C3%BCglerauthor=A.+R%C3%A1banoauthor=A.+Cuadrado&title=Repurposing+the+NRF2+Activator+Dimethyl+Fumarate+as+Therapy+against+Synucleinopathy+in+Parkinson%E2%80%99s+Disease&doi=10.1089%2Fars.2015.6549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease</span></div><div class="casAuthors">Lastres-Becker, Isabel; Garcia-Yaguee, Angel J.; Scannevin, Robert H.; Casarejos, Maria J.; Kuegler, Sebastian; Rabano, Alberto; Cuadrado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">61-77</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: This preclin. study was aimed at detg. whether pharmacol. targeting of transcription factor NRF2, a master controller of many homeostatic genes, might provide a disease-modifying therapy in the animal model of Parkinson's disease (PD) that best reproduces the main hallmark of this pathol., i.e., α-synucleinopathy, and assocd. events, including nigral dopaminergic cell death, oxidative stress, and neuroinflammation.  Results: Pharmacol. activation of NRF2 was achieved at the basal ganglia by repurposing di-Me fumarate (DMF), a drug already in use for the treatment of multiple sclerosis.  Daily oral gavage of DMF protected nigral dopaminergic neurons against α-SYN toxicity and decreased astrocytosis and microgliosis after 1, 3, and 8 wk from stereotaxic delivery to the ventral midbrain of recombinant adeno-assocd. viral vector expressing human α-synuclein.  This protective effect was not obsd. in Nrf2-knockout mice.  In vitro studies indicated that this neuroprotective effect was correlated with altered regulation of autophagy markers SQTSM1/p62 and LC3 in MN9D, BV2, and IMA 2.1 and with a shift in microglial dynamics toward a less pro-inflammatory and a more wound-healing phenotype.  In postmortem samples of PD patients, the cytoprotective proteins assocd. with NRF2 expression, NQO1 and p62, were partly sequestered in Lewy bodies, suggesting impaired neuroprotective capacity of the NRF2 signature.  Innovation: These expts. provide a compelling rationale for targeting NRF2 with DMF as a therapeutic strategy to reinforce endogenous brain defense mechanisms against PD-assocd. synucleinopathy.  Conclusion: DMF is ready for clin. validation in PD.  Antioxid. Redox Signal. 25, 61-77.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoATK_XdXYVVbVg90H21EOLACvtfcHk0ljz4u7DmiiktQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFegtrzP&md5=b060eaf4f4030f742054f906cbe09676</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1089%2Fars.2015.6549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2015.6549%26sid%3Dliteratum%253Aachs%26aulast%3DLastres-Becker%26aufirst%3DI.%26aulast%3DGarc%25C3%25ADa-Yag%25C3%25BCe%26aufirst%3DA.%2BJ.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DCasarejos%26aufirst%3DM.%2BJ.%26aulast%3DK%25C3%25BCgler%26aufirst%3DS.%26aulast%3DR%25C3%25A1bano%26aufirst%3DA.%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DRepurposing%2520the%2520NRF2%2520Activator%2520Dimethyl%2520Fumarate%2520as%2520Therapy%2520against%2520Synucleinopathy%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2016%26volume%3D25%26spage%3D61%26epage%3D77%26doi%3D10.1089%2Fars.2015.6549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lastres-Becker, I.</span></span> <span> </span><span class="NLM_article-title">Role of the Transcription Factor Nrf2 in Parkinson’s Disease: New Insights</span>. <i>J. Alzheimer’s Dis. Parkinsonism</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">340</span> <span class="refDoi"> DOI: 10.4172/2161-0460.1000340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.4172%2F2161-0460.1000340" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&author=I.+Lastres-Becker&title=Role+of+the+Transcription+Factor+Nrf2+in+Parkinson%E2%80%99s+Disease%3A+New+Insights&doi=10.4172%2F2161-0460.1000340"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4172%2F2161-0460.1000340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2161-0460.1000340%26sid%3Dliteratum%253Aachs%26aulast%3DLastres-Becker%26aufirst%3DI.%26atitle%3DRole%2520of%2520the%2520Transcription%2520Factor%2520Nrf2%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520New%2520Insights%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%2520Parkinsonism%26date%3D2017%26volume%3D7%26doi%3D10.4172%2F2161-0460.1000340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vomund, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parnham, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Knethen, A.</span></span> <span> </span><span class="NLM_article-title">Nrf2, the Master Regulator of Anti-Oxidative Responses</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>, <span class="NLM_elocation-id">2772</span> <span class="refDoi"> DOI: 10.3390/ijms18122772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.3390%2Fijms18122772" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&author=S.+Vomundauthor=A.+Sch%C3%A4ferauthor=M.+J.+Parnhamauthor=B.+Br%C3%BCneauthor=A.+von+Knethen&title=Nrf2%2C+the+Master+Regulator+of+Anti-Oxidative+Responses&doi=10.3390%2Fijms18122772"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3390%2Fijms18122772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18122772%26sid%3Dliteratum%253Aachs%26aulast%3DVomund%26aufirst%3DS.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DA.%26aulast%3DParnham%26aufirst%3DM.%2BJ.%26aulast%3DBr%25C3%25BCne%26aufirst%3DB.%26aulast%3Dvon%2BKnethen%26aufirst%3DA.%26atitle%3DNrf2%252C%2520the%2520Master%2520Regulator%2520of%2520Anti-Oxidative%2520Responses%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26doi%3D10.3390%2Fijms18122772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pant, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.-W.</span></span> <span> </span><span class="NLM_article-title">The Nrf2 Signaling in Retinal Ganglion Cells under Oxidative Stress in Ocular Neurodegenerative Diseases</span>. <i>Int. J. Biol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1090</span>– <span class="NLM_lpage">1098</span>, <span class="refDoi"> DOI: 10.7150/ijbs.25996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.7150%2Fijbs.25996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=29989056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Kgs7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=1090-1098&author=X.-F.+Liuauthor=D.-D.+Zhouauthor=T.+Xieauthor=J.-L.+Haoauthor=T.+H.+Malikauthor=C.-B.+Luauthor=J.+Qiauthor=O.+P.+Pantauthor=C.-W.+Lu&title=The+Nrf2+Signaling+in+Retinal+Ganglion+Cells+under+Oxidative+Stress+in+Ocular+Neurodegenerative+Diseases&doi=10.7150%2Fijbs.25996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The Nrf2 signaling in retinal ganglion cells under oxidative stress in ocular neurodegenerative diseases</span></div><div class="casAuthors">Liu, Xiu-Fen; Zhou, Dan-Dan; Xie, Tian; Hao, Ji-Long; Malik, Tayyab Hamid; Lu, Cheng-Bo; Qi, Jing; Pant, Om Prakash; Lu, Cheng-Wei</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1090-1098</span>CODEN:
                <span class="NLM_cas:coden">IJBSB9</span>;
        ISSN:<span class="NLM_cas:issn">1449-2288</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Retinal ganglion cells (RGCs) are one of the important cell types affected in many ocular neurodegenerative diseases.  Oxidative stress is considered to be involved in retinal RGCs death in ocular neurodegenerative diseases.  More and more attention has been focused on studying the agents that may have neuroprotective effects.  Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a key nuclear transcription factor for the systemic antioxidant defense system.  This review elucidates the underlying mechanism of the Nrf2-mediated neuroprotective effects on RGCs in ocular neurodegenerative diseases, such as diabetic retinopathy and retinal ischemia-reperfusion injury.  Several Nrf2 inducers that shield RGCs from oxidative stress-induced neurodegeneration via regulating Nrf2 signaling are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOOl0UoA0NN7Vg90H21EOLACvtfcHk0ljz4u7DmiiktQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Kgs7zE&md5=facbc7e11a93617f30e9c251594a5b29</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.7150%2Fijbs.25996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fijbs.25996%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.-F.%26aulast%3DZhou%26aufirst%3DD.-D.%26aulast%3DXie%26aufirst%3DT.%26aulast%3DHao%26aufirst%3DJ.-L.%26aulast%3DMalik%26aufirst%3DT.%2BH.%26aulast%3DLu%26aufirst%3DC.-B.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DPant%26aufirst%3DO.%2BP.%26aulast%3DLu%26aufirst%3DC.-W.%26atitle%3DThe%2520Nrf2%2520Signaling%2520in%2520Retinal%2520Ganglion%2520Cells%2520under%2520Oxidative%2520Stress%2520in%2520Ocular%2520Neurodegenerative%2520Diseases%26jtitle%3DInt.%2520J.%2520Biol.%2520Sci.%26date%3D2018%26volume%3D14%26spage%3D1090%26epage%3D1098%26doi%3D10.7150%2Fijbs.25996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeon, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of Vinyl Sulfones as a Novel Class of Neuroprotective Agents toward Parkinson’s Disease Therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1473</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi"> DOI: 10.1021/jm401788m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401788m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCnu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1473-1487&author=S.+Y.+Wooauthor=J.+H.+Kimauthor=M.+K.+Moonauthor=S.+H.+Hanauthor=S.+K.+Yeonauthor=J.+W.+Choiauthor=B.+K.+Jangauthor=H.+J.+Songauthor=Y.+G.+Kangauthor=J.+W.+Kimauthor=J.+Leeauthor=D.+J.+Kimauthor=O.+Hwangauthor=K.+D.+Park&title=Discovery+of+Vinyl+Sulfones+as+a+Novel+Class+of+Neuroprotective+Agents+toward+Parkinson%E2%80%99s+Disease+Therapy&doi=10.1021%2Fjm401788m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Vinyl Sulfones as a Novel Class of Neuroprotective Agents toward Parkinson's Disease Therapy</span></div><div class="casAuthors">Woo, Seo Yeon; Kim, Ji Hyun; Moon, Mi Kyeong; Han, Se-Hee; Yeon, Seul Ki; Choi, Ji Won; Jang, Bo Ko; Song, Hyo Jung; Kang, Yong Gu; Kim, Jin Woo; Lee, Jaeick; Kim, Dong Jin; Hwang, Onyou; Park, Ki Duk</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1473-1487</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although the etiol. of Parkinson's disease (PD) remains elusive, recent studies suggest that oxidative stress contributes to the cascade leading to dopaminergic (DAergic) neurodegeneration.  The nuclear factor E2-related factor 2 (Nrf2) signaling is the main pathway responsible for cellular defense system against oxidative stress.  Nrf2 is a transcription factor that regulates environmental stress response by inducing expression of antioxidant enzyme genes.  We have synthesized novel vinyl sulfone derivs.  They exhibited a broad range of activities in inducing HO-1, whose gene expression is under the control of Nrf2.  Among them, compd. I was confirmed to activate Nrf2 and induce expression of the Nrf2-dependent antioxidant enzymes NQO1, GCLC, GLCM, and HO-1, at both mRNA and protein levels in DAergic neuronal cells.  This was accompanied by protection of DAergic neurons in both in vitro and MPTP-induced in vivo models of PD.  In addn., compd. I effectively resulted in attenuation of the PD-assocd. behavioral deficits in the mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptlXVsw_3ZfbVg90H21EOLACvtfcHk0ljMzWJ4QFPdyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCnu7c%253D&md5=1b6da05ff9b10771abff6ab2fd5e708a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm401788m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401788m%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DMoon%26aufirst%3DM.%2BK.%26aulast%3DHan%26aufirst%3DS.%2BH.%26aulast%3DYeon%26aufirst%3DS.%2BK.%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DJang%26aufirst%3DB.%2BK.%26aulast%3DSong%26aufirst%3DH.%2BJ.%26aulast%3DKang%26aufirst%3DY.%2BG.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DHwang%26aufirst%3DO.%26aulast%3DPark%26aufirst%3DK.%2BD.%26atitle%3DDiscovery%2520of%2520Vinyl%2520Sulfones%2520as%2520a%2520Novel%2520Class%2520of%2520Neuroprotective%2520Agents%2520toward%2520Parkinson%25E2%2580%2599s%2520Disease%2520Therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1473%26epage%3D1487%26doi%3D10.1021%2Fjm401788m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, O.</span></span> <span> </span><span class="NLM_article-title">A Novel Compound VSC2 Has Anti-Inflammatory and Antioxidant Properties in Microglia and in Parkinson’s Disease Animal Model</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1100</span>, <span class="refDoi"> DOI: 10.1111/bph.12973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1111%2Fbph.12973" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=25297649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=1087-1100&author=J.+A.+Leeauthor=J.+H.+Kimauthor=S.+Y.+Wooauthor=H.+J.+Sonauthor=S.+H.+Hanauthor=B.+K.+Jangauthor=J.+W.+Choiauthor=D.+J.+Kimauthor=K.+D.+Parkauthor=O.+Hwang&title=A+Novel+Compound+VSC2+Has+Anti-Inflammatory+and+Antioxidant+Properties+in+Microglia+and+in+Parkinson%E2%80%99s+Disease+Animal+Model&doi=10.1111%2Fbph.12973"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model</span></div><div class="casAuthors">Lee, Ji Ae; Kim, Ji Hyun; Woo, Seo Yeon; Son, Hyo Jin; Han, Se Hee; Jang, Bo Ko; Choi, Ji Won; Kim, Dong Jin; Park, Ki Duk; Hwang, Onyou</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1087-1100</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Neuroinflammation through microglial activation is involved in the pathogenesis of neurodegenerative diseases including Parkinson's disease (PD), a major neurodegenerative disorder characterized by dopaminergic neuronal death in the substantia nigra.  We examd. our novel synthetic compd. VSC2 for its anti-inflammatory properties towards development of a PD therapy.  Exptl. Approach : We tested the effects of VSC2 on prodn. of various NF-κB-dependent proinflammatory mols. and Nrf2-dependent antioxidant enzymes in BV-2 microglia and in vivo.  Key Results : The vinyl sulfone compd., VSC2, most effectively suppressed the prodn. of NO in LPS-activated microglia.  It also down-regulated expression of inducible NOS (iNOS), COX-2, IL-1β and TNF-α and inhibited nuclear translocalization and transcriptional activity of NF-κB.  VSC2 increased total and nuclear Nrf2 levels, induced Nrf2 transcriptional activity and was bound to Keap1 with high affinity.  Expression of the Nrf2-regulated antioxidant enzyme genes NAD(P)H quinone oxidoreducase-1 (NQO-1), haem oxygenase-1 (HO-1) and glutamylcysteine ligase (GCL) were up-regulated by VSC2.  In the MPTP mouse model of PD, oral administration of VSC2 decreased the no. of activated microglia in the substantia nigra, lowered the levels of iNOS, COX-2 and IL-1β, and protected the dopaminergic neurons.  VSC2 also elevated the levels of NQO1, HO-1, GCL and Nrf2 in the nigrostriatal area.  Conclusions and Implications : VSC2 has both anti-inflammatory and antioxidant properties and prevented neuroinflammation in microglia and in an animal model of PD.  This suggests VSC2 as a potential candidate for PD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkO-es2O8AkLVg90H21EOLACvtfcHk0ljQNmL360HwAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWntro%253D&md5=8112f952e44d1b38cba09c3f473c9aa9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fbph.12973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12973%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DWoo%26aufirst%3DS.%2BY.%26aulast%3DSon%26aufirst%3DH.%2BJ.%26aulast%3DHan%26aufirst%3DS.%2BH.%26aulast%3DJang%26aufirst%3DB.%2BK.%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DPark%26aufirst%3DK.%2BD.%26aulast%3DHwang%26aufirst%3DO.%26atitle%3DA%2520Novel%2520Compound%2520VSC2%2520Has%2520Anti-Inflammatory%2520and%2520Antioxidant%2520Properties%2520in%2520Microglia%2520and%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%2520Animal%2520Model%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D1087%26epage%3D1100%26doi%3D10.1111%2Fbph.12973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vitaku, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njardarson, J. T.</span></span> <span> </span><span class="NLM_article-title">Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10257</span>– <span class="NLM_lpage">10274</span>, <span class="refDoi"> DOI: 10.1021/jm501100b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501100b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Wlu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10257-10274&author=E.+Vitakuauthor=D.+T.+Smithauthor=J.+T.+Njardarson&title=Analysis+of+the+Structural+Diversity%2C+Substitution+Patterns%2C+and+Frequency+of+Nitrogen+Heterocycles+among+U.S.+FDA+Approved+Pharmaceuticals&doi=10.1021%2Fjm501100b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals</span></div><div class="casAuthors">Vitaku, Edon; Smith, David T.; Njardarson, Jon T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10257-10274</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Nitrogen heterocycles are among the most significant structural components of pharmaceuticals.  Anal. of our database of U.S. FDA approved drugs reveals that 59% of unique small-mol. drugs contain a nitrogen heterocycle.  In this review we report on the top 25 most commonly utilized nitrogen heterocycles found in pharmaceuticals.  The main part of our anal. is divided into seven sections: (1) three- and four-membered heterocycles, (2) five-, (3) six-, and (4) seven- and eight-membered heterocycles, as well as (5) fused, (6) bridged bicyclic, and (7) macrocyclic nitrogen heterocycles.  Each section reveals the top nitrogen heterocyclic structures and their relative impact for that ring type.  For the most commonly used nitrogen heterocycles, we report detailed substitution patterns, highlight common architectural cores, and discuss unusual or rare structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5cUk9KxUSkbVg90H21EOLACvtfcHk0ljQNmL360HwAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Wlu7%252FP&md5=7065b3b2fc6f69cede0f87479c7cf472</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm501100b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501100b%26sid%3Dliteratum%253Aachs%26aulast%3DVitaku%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DD.%2BT.%26aulast%3DNjardarson%26aufirst%3DJ.%2BT.%26atitle%3DAnalysis%2520of%2520the%2520Structural%2520Diversity%252C%2520Substitution%2520Patterns%252C%2520and%2520Frequency%2520of%2520Nitrogen%2520Heterocycles%2520among%2520U.S.%2520FDA%2520Approved%2520Pharmaceuticals%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10257%26epage%3D10274%26doi%3D10.1021%2Fjm501100b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, D. T.</span></span> <span> </span><span class="NLM_article-title">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3552</span>– <span class="NLM_lpage">3579</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3552-3579&author=L.+D.+Penningtonauthor=D.+T.+Moustakas&title=The+Necessary+Nitrogen+Atom%3A+A+Versatile+High-Impact+Design+Element+for+Multiparameter+Optimization&doi=10.1021%2Facs.jmedchem.6b01807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span></div><div class="casAuthors">Pennington, Lewis D.; Moustakas, Demetri T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3552-3579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is a continued desire in biomedical research to reduce the no. and duration of design cycles required to optimize lead compds. into high-quality chem. probes or safe and efficacious drug candidates.  The insightful application of impactful mol. design elements is one approach toward achieving this goal.  The replacement of a CH group with a N atom in arom. and heteroarom. ring systems can have many important effects on mol. and physicochem. properties and intra- and intermol. interactions that can translate to improved pharmacol. profiles.  In this Perspective, the "necessary nitrogen atom" is shown to be a versatile high-impact design element for multiparameter optimization, wherein ≥10-, 100-, or 1000-fold improvement in a variety of key pharmacol. parameters can be realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ZLKZMgt6IbVg90H21EOLACvtfcHk0ljQNmL360HwAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D&md5=002aaee48995e7954647a1f75183db4d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMoustakas%26aufirst%3DD.%2BT.%26atitle%3DThe%2520Necessary%2520Nitrogen%2520Atom%253A%2520A%2520Versatile%2520High-Impact%2520Design%2520Element%2520for%2520Multiparameter%2520Optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3552%26epage%3D3579%26doi%3D10.1021%2Facs.jmedchem.6b01807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patil, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavachary, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurpiewska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowska-Tłuścik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dömling, A.</span></span> <span> </span><span class="NLM_article-title">De Novo Assembly of Highly Substituted Morpholines and Piperazines</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">642</span>– <span class="NLM_lpage">645</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.6b03807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b03807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=642-645&author=P.+Patilauthor=R.+Madhavacharyauthor=K.+Kurpiewskaauthor=J.+Kalinowska-T%C5%82u%C5%9Bcikauthor=A.+D%C3%B6mling&title=De+Novo+Assembly+of+Highly+Substituted+Morpholines+and+Piperazines&doi=10.1021%2Facs.orglett.6b03807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">De Novo Assembly of Highly Substituted Morpholines and Piperazines</span></div><div class="casAuthors">Patil, Pravin; Madhavachary, Rudrakshula; Kurpiewska, Katarzyna; Kalinowska-Tluscik, Justyna; Doemling, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">642-645</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The morpholine and piperazine with their remarkable phys. and biochem. properties are popular heterocycles in org. and medicinal chem. used in rational property design.  However, in the majority of cases these rings are added to an existing mol. in a building block approach thus limiting their substitution pattern and diversity.  Here the authors introduce a versatile de novo synthesis of the morpholine and piperazine rings using multicomponent reaction chem.  The large scale amenable building blocks can be further substituted at up to four positions, making this a very versatile scaffold synthesis strategy.  The authors' methods thus fulfill the increasing demand for novel building block design and nontraditional scaffolds which previously were not accessible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9H3Uo_iqSD7Vg90H21EOLACvtfcHk0ljO1L3yBeg05Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yhsLk%253D&md5=9e1413c0d74e626f806916dbe50f22cc</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b03807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b03807%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DP.%26aulast%3DMadhavachary%26aufirst%3DR.%26aulast%3DKurpiewska%26aufirst%3DK.%26aulast%3DKalinowska-T%25C5%2582u%25C5%259Bcik%26aufirst%3DJ.%26aulast%3DD%25C3%25B6mling%26aufirst%3DA.%26atitle%3DDe%2520Novo%2520Assembly%2520of%2520Highly%2520Substituted%2520Morpholines%2520and%2520Piperazines%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D642%26epage%3D645%26doi%3D10.1021%2Facs.orglett.6b03807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rupak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulichi, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suman, K.</span></span> <span> </span><span class="NLM_article-title">Emphasizing Morpholine and its Derivatives (MAID): Typical Candidate of Pharmaceutical Importance</span>. <i>Int. J. Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1777</span>– <span class="NLM_lpage">1788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFantLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=1777-1788&author=K.+Rupakauthor=S.+R.+Vulichiauthor=K.+Suman&title=Emphasizing+Morpholine+and+its+Derivatives+%28MAID%29%3A+Typical+Candidate+of+Pharmaceutical+Importance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Emphasizing morpholine and its derivatives (MAID): typical candidate of pharmaceutical importance</span></div><div class="casAuthors">Rupak, Kumar; Vulichi, Srinivasa R.; Suman, Kapur</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Chemical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1777-1788</span>CODEN:
                <span class="NLM_cas:coden">IJCSIL</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Sadguru Publications</span>)
        </div><div class="casAbstract">The use of chems. (drugs) for both medical and recreational purposes is hardly new.  In fact, drug use seems to have been a part of human science prehistory.  Morpholine (C4H9NO, 1-oxa-4-azacyclohexane) is a synthetic simple heterocyclic org. compd. having characteristic functional groups of amine and ether and great industrial importance.  Chem. manipulations on morpholine based mols. through structure - activity relationship strategy could help developing many interesting candidates of therapeutic significance to tackle broad range of medical ailments.  Feasible physicochem. properties (polarity and soly.), low cost and wide availability make it a suitable candidate for the synthesis of many potent drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT0rs1eUYwRbVg90H21EOLACvtfcHk0ljO1L3yBeg05Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFantLs%253D&md5=5ebc0d446a0813a9ff55edccb0ef62ee</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRupak%26aufirst%3DK.%26aulast%3DVulichi%26aufirst%3DS.%2BR.%26aulast%3DSuman%26aufirst%3DK.%26atitle%3DEmphasizing%2520Morpholine%2520and%2520its%2520Derivatives%2520%2528MAID%2529%253A%2520Typical%2520Candidate%2520of%2520Pharmaceutical%2520Importance%26jtitle%3DInt.%2520J.%2520Chem.%2520Sci.%26date%3D2016%26volume%3D14%26spage%3D1777%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span> <span> </span><span class="NLM_article-title">Antioxidant and Anti-Inflammatory Activities of a Natural Compound, Shizukahenriol, through Nrf2 Activation</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">15989</span>– <span class="NLM_lpage">16003</span>, <span class="refDoi"> DOI: 10.3390/molecules200915989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.3390%2Fmolecules200915989" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=15989-16003&author=J.+H.+Parkauthor=J.+W.+Choiauthor=E.+J.+Juauthor=A.+N.+Paeauthor=K.+D.+Park&title=Antioxidant+and+Anti-Inflammatory+Activities+of+a+Natural+Compound%2C+Shizukahenriol%2C+through+Nrf2+Activation&doi=10.3390%2Fmolecules200915989"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3390%2Fmolecules200915989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules200915989%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DJu%26aufirst%3DE.%2BJ.%26aulast%3DPae%26aufirst%3DA.%2BN.%26aulast%3DPark%26aufirst%3DK.%2BD.%26atitle%3DAntioxidant%2520and%2520Anti-Inflammatory%2520Activities%2520of%2520a%2520Natural%2520Compound%252C%2520Shizukahenriol%252C%2520through%2520Nrf2%2520Activation%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D15989%26epage%3D16003%26doi%3D10.3390%2Fmolecules200915989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzclaw, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Protection against Electrophile and Oxidant Stress by Induction of the Phase 2 Response: Fate of Cysteines of the Keap1 Sensor Modified by Inducers</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">2040</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1073/pnas.0307301101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1073%2Fpnas.0307301101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=14764894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Sku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=2040-2045&author=N.+Wakabayashiauthor=A.+T.+Dinkova-Kostovaauthor=W.+D.+Holtzclawauthor=M.+I.+Kangauthor=A.+Kobayashiauthor=M.+Yamamotoauthor=T.+W.+Kenslerauthor=P.+Talalay&title=Protection+against+Electrophile+and+Oxidant+Stress+by+Induction+of+the+Phase+2+Response%3A+Fate+of+Cysteines+of+the+Keap1+Sensor+Modified+by+Inducers&doi=10.1073%2Fpnas.0307301101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Protecti6on against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers</span></div><div class="casAuthors">Wakabayashi, Nobunao; Dinkova-Kostova, Albena T.; Holtzclaw, W. David; Kang, Moon-Il; Kobayashi, Akira; Yamamoto, Masayuki; Kensler, Thomas W.; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2040-2045</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Induction of a family of phase 2 genes encoding for proteins that protect against the damage of electrophiles and reactive oxygen intermediates is potentially a major strategy for reducing the risk of cancer and chronic degenerative diseases.  Many phase 2 genes are regulated by upstream antioxidant response elements (ARE) that are targets of the leucine zipper transcription factor Nrf2.  Under basal conditions, Nrf2 resides mainly in the cytoplasm bound to its cysteine-rich, Kelch domain-contg. partner Keap1, which is itself anchored to the actin cytoskeleton and represses Nrf2 activity.  Inducers disrupt the Keap1-Nrf2 complex by modifying two (C273 and C288) of the 25 cysteine residues of Keap1.  The crit. role of C273 and C288 was established by (i) their high reactivity when purified recombinant Keap1 was treated with dexamethasone mesylate and the dexamethasone-modified tryptic peptides were analyzed by mass spectrometry, and (ii) transfection of keap1 and nrf2 gene-deficient mouse embryonic fibroblasts with constructs expressing cysteine to alanine mutants of Keap1, and measurement of the ability of cotransfected Nrf2 to repress an ARE-luciferase reporter.  Reaction of Keap1 with inducers results in formation of intermol. disulfide bridges, probably between C273 of one Keap1 mol. and C288 of a second.  Evidence for formation of such dimers was obtained by 2D PAGE of exts. of cells treated with inducers, and by the demonstration that whereas C273A and C288A mutants of Keap1 alone could not repress Nrf2 activation of the ARE-luciferase reporter, an equal mixt. of these mutant constructs restored repressor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHr3yEhR167bVg90H21EOLACvtfcHk0ljO1L3yBeg05Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Sku7k%253D&md5=c36f98ef6b4a30d855497dfaa52b607c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0307301101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0307301101%26sid%3Dliteratum%253Aachs%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHoltzclaw%26aufirst%3DW.%2BD.%26aulast%3DKang%26aufirst%3DM.%2BI.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DProtection%2520against%2520Electrophile%2520and%2520Oxidant%2520Stress%2520by%2520Induction%2520of%2520the%2520Phase%25202%2520Response%253A%2520Fate%2520of%2520Cysteines%2520of%2520the%2520Keap1%2520Sensor%2520Modified%2520by%2520Inducers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D2040%26epage%3D2045%26doi%3D10.1073%2Fpnas.0307301101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fourquet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerois, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledano, M. B.</span></span> <span> </span><span class="NLM_article-title">Activation of NRF2 by Nitrosative Agents and H<sub>2</sub>O<sub>2</sub> Involves KEAP1 Disulfide Formation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">8463</span>– <span class="NLM_lpage">8471</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.051714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.1074%2Fjbc.M109.051714" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=8463-8471&author=S.+Fourquetauthor=R.+Gueroisauthor=D.+Biardauthor=M.+B.+Toledano&title=Activation+of+NRF2+by+Nitrosative+Agents+and+H2O2+Involves+KEAP1+Disulfide+Formation&doi=10.1074%2Fjbc.M109.051714"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.051714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.051714%26sid%3Dliteratum%253Aachs%26aulast%3DFourquet%26aufirst%3DS.%26aulast%3DGuerois%26aufirst%3DR.%26aulast%3DBiard%26aufirst%3DD.%26aulast%3DToledano%26aufirst%3DM.%2BB.%26atitle%3DActivation%2520of%2520NRF2%2520by%2520Nitrosative%2520Agents%2520and%2520H2O2%2520Involves%2520KEAP1%2520Disulfide%2520Formation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D8463%26epage%3D8471%26doi%3D10.1074%2Fjbc.M109.051714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jazwa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Targeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1517</span>– <span class="NLM_lpage">1531</span>, <span class="refDoi"> DOI: 10.2174/1389450111009011517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=10.2174%2F1389450111009011517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=20704549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKrtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1517-1531&author=A.+Jazwaauthor=A.+Cuadrado&title=Targeting+Heme+Oxygenase-1+for+Neuroprotection+and+Neuroinflammation+in+Neurodegenerative+Diseases&doi=10.2174%2F1389450111009011517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases</span></div><div class="casAuthors">Jazwa, Agnieszka; Cuadrado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1517-1531</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Heme oxygenase-1 (HO-1), an enzyme degrading heme to carbon monoxide, free iron, and biliverdin, participates in the cell defense against oxidative stress and it has been speculated that it might be a new therapeutic target for neuroprotection.  In this review, we discuss recent findings on the regulation of the HO-1 gene, Hmox1, in the brain with particular focus on the transcription factors Nrf2 and HIF-1.  Functional polymorphisms in Hmox1 have been assocd. with high risk for Alzheimer's and Parkinson's disease.  Hence, we review the current knowledge on the role of HO-1 and its enzymic products on these two pathologies as well as ischemic brain injury.  HO-1 modulates the inflammatory response in several scenarios, and therefore we discuss its role in modulation of the innate immune cell of the brain, microglia.  From the therapeutic side, the blood brain barrier represents an obstacle to directly modulate heme oxygenase activity, but drugs activating the transcription actor Nrf2, which have a very diverse mol. structure, may be good candidates to induce HO-1 in concert with other antioxidant and detoxification enzymes.  A more complete understanding on the mechanisms regulating HO-1 expression in brain cells and how these mechanisms are involved in neuropathol. changes will be essential to develop these new therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0wq64mTDHb7Vg90H21EOLACvtfcHk0liTvocHShO1ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKrtrbP&md5=a72bf259d5dba4e1cbcca4bba33d9f73</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F1389450111009011517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450111009011517%26sid%3Dliteratum%253Aachs%26aulast%3DJazwa%26aufirst%3DA.%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DTargeting%2520Heme%2520Oxygenase-1%2520for%2520Neuroprotection%2520and%2520Neuroinflammation%2520in%2520Neurodegenerative%2520Diseases%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2010%26volume%3D11%26spage%3D1517%26epage%3D1531%26doi%3D10.2174%2F1389450111009011517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i90"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01527">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_88617"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01527">10.1021/acs.jmedchem.8b01527</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional ADME/Tox results of compound <b>17e</b>; result graph of <i>hERG</i> fluorescence polarization assay for <b>17e</b> (Figure S1); result graph of Ames test for <b>17e</b> (Figure S2); the ability to induce HO-1 by ELISA assay for compound <b>5f</b>, <b>5n</b>, <b>6b</b>, <b>7a</b>, <b>7b</b>, <b>17d</b>, <b>17e</b>, <b>18b</b>, <b>19a</b>, <b>19b</b>, <b>19c</b>, <b>19d</b>, <b>19e</b>, and <b>19f</b> (Table S1); plasma stability of <b>17e</b> (Table S2); PAMPA-BBB data for <b>17e</b> (Table S3); synthetic methods and data for the intermediates <b>2</b>, <b>3</b>, <b>4</b>, <b>9</b>, <b>10</b>, <b>13</b>, <b>14</b>, <b>15</b>, <b>16</b>, <b>20</b>, <b>21</b>, <b>22</b>, supporting methods, and <sup>1</sup>H and <sup>13</sup>C NMR spectra of the final compounds <b>5</b>, <b>6</b>, <b>7</b>, <b>8</b>, <b>11</b>, <b>12</b>, <b>17</b>, <b>18</b>, <b>19</b>, <b>23</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_001.pdf">jm8b01527_si_001.pdf (8.57 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01527/suppl_file/jm8b01527_si_002.csv">jm8b01527_si_002.csv (5.29 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01527&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01527%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-2%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01527" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996a8f590e3de3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
